<!DOCTYPE html>
<html manifest="cache.manifest">
    <head>
        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1"> 
        <title>TEAMS - Top End Antimicrobial Stewardship</title>
        <link rel="shortcut icon" type="image/ico" href="favicon.ico" /> 
        <link rel="apple-touch-icon" href="apple-touch-icon-precomposed.png">
        <link rel="apple-touch-icon-precomposed" href="apple-touch-icon-precomposed.png">
        <link rel="stylesheet" href="bootstrap/css/bootstrap.min.css"/>
        <link rel="stylesheet" href="bootstrap/css/bootstrap-theme.min.css"/>
        <link rel="stylesheet" href="bootstrap/css/basic.css" />
        <link rel="stylesheet" href="bootstrap/css/style.css" />
        <script src="bootstrap/js/jquery-1.11.1.min.js"></script>
        <script>
            var getcode = function () {
                var now = new Date();
                var fullDaysSinceEpoch = Math.floor(now / 8.64e7) - 16550;

                return '' + now.getDay() + fullDaysSinceEpoch;
            }
        </script>
    </head>
    <body>
        <!-- Start of first page: #home -->
        <div data-role="page" id="home">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <div class="alert alert-danger mrgn20t" role="alert">
                    Please note TEAMS is for testing purposes only, please confirm any recommendations which come from TEAMS with a second source
                </div>
                <p class="color-primary bold font16 mrgn20b">Please email any recommendations for improvement (big or small) to john.shanks@nt.gov.au</p>
                
                <div class="form-group-lg">
                    <div class="input-group">
                        <div class="input-group-addon"><span class="glyphicon glyphicon-search"></span></div>
                        <input type="text" class="form-control search-field" placeholder="Filter Items">
                    </div>
                </div>
                <ul data-role="listview" data-filter="true" data-autodividers="true" data-inset="true" id="antimicrobials" class="search-control listview"> 
                    <li><a href="#antibio">Antibiogram TEHS</a></li>
                    <li><a href="#ascho">Ascending cholangitis</a></li>
                    <li><a href="#carble">Carbuncle</a></li> 
                    <li><a href="#cell">Cellulitis</a></li>
                    <li><a href="#diabf">Diabetic foot infection</a></li>
                    <li><a href="#dose">Dosing nomograms and calculators</a></li>
                    <li><a href="#febne">Febrile neutropenia</a></li>
                    <li><a href="#intrab">Intra-abdominal Infection</a></li>
                    <li><a href="#menin">Meningitis</a></li>  
                    <li><a href="#open">Open &#40;Compound&#41; Fracture</a></li>
                    <li><a href="#pelvi">Pelvic inflammatory disease</a></li>
                    <li><a href="#pneum">Pneumonia</a></li>
                    <li><a href="#pyelo">Pyelonephritis</a></li>
                    <li><a href="#scab">Scabies (crusted)</a></li>
                    <li><a href="#sepsis">Severe sepsis</a></li>
                    <li><a href="#shing">Shingles</a></li>
                    <li><a href="#surgpro">Surgical prophylaxis</a></li>
                    <li><a href="#uti">Urinary tract infection (UTI)</a></li> 
                    <li><a href="#ref">References and acknowledgements</a></li>
                </ul>
            </div>
            <!-- /content -->
        </div>
        <!-- /home -->
        
        <!-- Antibiogram Maze Begins -->
        
        <!-- Start of Antibiogram page: #antibio -->
        <div data-role="page" id="antibio" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Choose an organism for local susceptibilities:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <ul data-role="listview"  data-inset="true" id="surgicalprophylaxis" class="listview"> 
                    <li><a href="#staph"><i>Staph aureus</i></a></li>
                    <li><a href="#spneumo"><i>Strep pneumoniae</i></a></li>
                    <li><a href="#efaec"><i>Enterococcus sp</i></a></li>
                    <li><a href="#ecoli"><i>E.coli</i></a></li>
                    <li><a href="#kpneumo"><i>Kleb pneumoniae</i></a></li>
                    <li><a href="#proteus"><i>Proteus mirabilis</i></a></li>
                    <li><a href="#enterob"><i>Enterobacter sp</i></a></li>
                    <li><a href="#salmonel">Salmonella</a></li>
                    <li><a href="#pseudom"><i>Pseudomonas aeruginosa</i></a></li>
                    <li><a href="#acineto"><i>Acinetobacter baumannii</i></a></li>
                    <li><a href="#melioid"><i>Burkholderia pseudomallei</i></a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /antibio -->
        
        <!-- Start of staph sensitivities: #staph -->
        <div data-role="page" id="staph" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary text-center mrgn20b">TEHS <i>Staphylococcus aureus</i> % susceptible</h3>    
                <div class="table-responsive">
                    <table class="table table-striped table-bordered">
                        <tr>
                            <th></th>
                            <th>MSSA</th>
                            <th>nmMRSA</th>
                            <th>MRSA</th>
                        </tr>

                        <tr>
                            <td>Amikacin</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Ampicillin</td>
                            <td class="bg-danger">9</td>
                            <td class="bg-danger">0</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-success">100</td>
                            <td class="bg-danger">0</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Cephazolin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-danger">0</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-success">100</td>
                            <td class="bg-danger">0</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Ceftazidime</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">99</td>
                            <td class="bg-success">99</td>
                            <td class="bg-danger">8</td>
                        </tr> 

                        <tr>
                            <td>Clindamycin</td>
                            <td class="bg-warning">82</td>
                            <td class="bg-warning">76</td>
                            <td class="bg-danger">1</td>
                        </tr> 

                        <tr>
                            <td>Erythromycin</td>
                            <td class="bg-warning">82</td>
                            <td class="bg-warning">76</td>
                            <td class="bg-danger">1</td>
                        </tr> 

                        <tr>
                            <td>Flucloxacillin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-danger">0</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Fusidic acid</td>
                            <td class="bg-success">95</td>
                            <td class="bg-success">95</td>
                            <td class="bg-success">99</td>
                        </tr> 

                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Meropenem</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Penicillin</td>
                            <td class="bg-danger">9</td>
                            <td class="bg-danger">0</td>
                            <td class="bg-danger">0</td>
                        </tr> 

                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Rifampicin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">99</td>
                            <td class="bg-success">99</td>
                        </tr> 

                        <tr>
                            <td>Tobramycin</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-success">99</td>
                            <td class="bg-success">89</td>
                            <td class="bg-danger">9</td>
                        </tr> 

                        <tr>
                            <td>Vancomycin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                        </tr> 

                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>

                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                        </tr> 

                        <tr>
                            <td>Total percentage of isolates:</td>
                            <td class="bg-info"><b>60.0%</b></td>
                            <td class="bg-info"><b>33.8%</b></td>
                            <td class="bg-info"><b>6.2%</b></td>
                        </tr> 
                    </table>
                </div>
                <hr>
                <div class="alert alert-info mrgn20t">
                    Based on all isolates received at RDH laboratory in the first 6 months of 2015
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /staph -->
        
        
        <!-- Start of strep sensitivities: #spneumo -->
        <div data-role="page" id="spneumo" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="text-center color-primary mrgn20b">TEHS <i>Streptococcus pneumoniae</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th><i>S.pneumoniae &lb;meningitis&rb;</i></th>
                            <th><i>S.pneumoniae &lb;non meningitis&rb;</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td>-</td>
                            <td>-</td>

                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-success">98</td>
                            <td class="bg-success">100</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                            <td class="bg-warning">72</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td class="bg-warning">72</td>
                            <td class="bg-success">99</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                    </table>
                </div>
                <hr>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /spneumo -->
        
        <!-- Start of entero faec: #efaec -->
        <div data-role="page" id="efaec" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->

            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b text-center">TEHS <i>Enterococcus faecalis</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-striped table-bordered">
                        <tr>
                            <th></th>
                            <th colspan="2" class="center">E.<i>faecalis</i></th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td class="bg-success">97</td>
                            <td class="bg-danger">3</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-success">97</td>
                            <td class="bg-danger">3</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td class="bg-success">96</td>
                            <td class="bg-danger">27</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td class="bg-success">97</td>
                            <td class="bg-danger">3</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Tobramycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td class="bg-success">98</td>
                            <td class="bg-danger">19</td>
                        </tr>
                        <tr>
                            <td>Teicoplanin</td>
                            <td class="bg-success">99</td>
                            <td class="bg-success">92</td>
                        </tr>
                        <tr>
                            <td>Linezolid</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                        </tr> 
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /efaec -->
        
        <!-- Start of strep sensitivities: #ecoli -->
        <div data-role="page" id="ecoli" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage"><h1>Antibiogram:</h1></div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b text-center">TEHS <i>Eschericiae coli</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>E.<i>coli</i> &lb;urine&rb;</th>
                            <th>E.<i>coli</i> &lb;other&rb;</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td class="bg-danger">44</td>
                            <td class="bg-danger">36</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-warning">76</td>
                            <td class="bg-warning">76</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td class="bg-warning">77</td>
                            <td class="bg-danger">76</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-success">92</td>
                            <td class="bg-warning">86</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td class="bg-success">97</td>
                            <td class="bg-success">94</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">91</td>
                            <td class="bg-success">90</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">91</td>
                            <td class="bg-success">94</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">100</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td class="bg-success">93</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td class="bg-success">92</td>
                            <td class="bg-warning">89</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td class="bg-success">90</td>
                            <td class="bg-success">91</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td class="bg-danger">65</td>
                            <td class="bg-danger">65</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-danger">68</td>
                            <td class="bg-danger">67</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                            <td>-</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
                <div class="footer">
                    <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /content -->
        </div>
        <!-- /ecoli -->
        
        <!-- Start of kleb: #kpneumo -->
        <div data-role="page" id="kpneumo" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b text-center">TEHS <i>Klebsiella pneumoniae</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>K.<i>pneumo</i></th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-warning">85</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td class="bg-warning">82</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-warning">87</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td class="bg-warning">89</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">90</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">92</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">99</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td class="bg-danger">14</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td class="bg-warning">87</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td class="bg-success">90</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td class="bg-warning">79</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-warning">82</td>
                        </tr>
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr>
                    </table>
                </div>
                 <hr/>
                 <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /kpneumo -->
        
        <!-- Start of proteus: #proteus -->
        <div data-role="page" id="proteus" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary text-center mrgn20b">TEHS <i>Proteus mirabilis</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th><i>P.mirabilis</i></th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td class="bg-warning">84</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-success">92</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td class="bg-warning">76</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-success">99</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">97</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">97</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td class="bg-success">99</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td class="bg-warning">84</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-warning">89</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /proteus -->
        
        <!-- Start of enterobacter: #enterob -->
        <div data-role="page" id="enterob" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b text-center">TEHS <i>Enterobacter sp</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>Enterobacter</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-warning">81</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td class="bg-warning">87</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">100</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">96</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">99</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td class="bg-warning">88</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td class="bg-success">96</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-success">91</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /enterob -->
        
        <!-- Start of salmonella: #salmonel -->
        <div data-role="page" id="salmonel" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">TEHS Salmonella <i>sp</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>Salmonella</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td class="bg-success">96</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-success">98</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-success">99</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">99</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-success">98</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /salmonel -->
        
        <!-- Start of pseudomonas: #pseudom -->
        <div data-role="page" id="pseudom" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">        
                <h3 class="color-primary mrgn30b text-center">TEHS <i>Pseudomonas aeruginosa</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>Pseudomonas</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td class="bg-success">97</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ceftazidime</td>
                            <td class="bg-success">93</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">96</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">97</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">95</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td class="bg-success">91</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td class="bg-success">98</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr> 
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pseudom -->
        
        <!-- Start of acinetobacter: #acineto -->
        <div data-role="page" id="acineto" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b text-center">TEHS <i>Acinetobacter sp</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>Acinetobacter</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td class="bg-success">98</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td class="bg-warning">72</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td class="bg-danger">21</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td class="bg-warning">88</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td class="bg-success">95</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td class="bg-success">98</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">97</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td class="bg-success">93</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td class="bg-success">98</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-warning">88</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr> 
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /acineto -->
        
        <!-- Start of acinetobacter: #melioid -->
        <div data-role="page" id="melioid" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Antibiogram:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b text-center">TEHS <i>Burkholderia pseudomallei</i> % susceptible</h3>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th></th>
                            <th>Melioid</th>
                        </tr>
                        <tr>
                            <td>Amikacin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Ampicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Amoxy-Clavulanate</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Cephazolin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftriaxone</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Ceftazidime</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Ciprofloxacin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Clindamycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Erythromycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Flucloxacillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Fusidic acid</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Gentamicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Meropenem</td>
                            <td class="bg-success">100</td>
                        </tr>
                        <tr>
                            <td>Nitrofurantoin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Penicillin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Piperacillin/tazobactam</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Rifampicin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Tobramycin</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim</td>
                            <td>-</td>
                        </tr>
                        <tr>
                            <td>Trimethoprim-SMX</td>
                            <td class="bg-success">100</td>
                        </tr> 
                        <tr>
                            <td>Vancomycin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Teicoplanin</td>
                            <td>-</td>
                        </tr> 
                        <tr>
                            <td>Linezolid</td>
                            <td>-</td>
                        </tr> 
                    </table>
                </div>
                <hr/>
                <div class="alert alert-info">Based on all isolates received at RDH laboratory in the first 6 months of 2015</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /melioid -->
        <!-- END OF Antibiogram Maze -->
        
        <!-- Ascending Cholangitis Maze Begins -->
        <!-- Start of ascending cholangitis page: #ascho -->
        <div data-role="page" id="ascho" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Ascending Cholangitis:</h1>
            </div>
            <!-- /header -->
            <h3 class="color-primary mrgn20b text-center">Does the patient have a penicillin allergy? <span class="font15 color-info">(See below for details on penicillin allergy severity)</span></h3>
            
            <div data-role="content" class="container-fluid">	
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ascho3">No penicillin allergy</a></li>    
                    <li><a href="#ascho1">Minor penicillin allergy</a></li>
                    <li><a href="#ascho2">Penicillin anaphylaxis</a></li>
                </ul>
                <hr/>
                <div class="alert alert-info">Anaphylactic penicillin allergy is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</div>
                <div class="alert alert-info">There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho -->
        
        <!-- Start of cholangitis PEN BAD, Gent Q: #ascho2 -->
        <div data-role="page" id="ascho2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Ascending Cholangitis:</h1>
            </div>
            <!-- /header -->
            <h3 class="color-primary mrgn20b text-center">Is gentamicin contraindicated in this patient? <span class="color-info font15">(See below for contraindications)</span></h3>
    
            <div data-role="content" class="container-fluid">	
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ascho2a">Gentamicin contraindicated</a></li>
                    <li><a href="#ascho2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho2 -->
        
        <!-- Start of cholangitis PEN OK, Gent Q: #ascho3 -->
        <div data-role="page" id="ascho3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Ascending Cholangitis</h1>
            </div>
            <!-- /header -->
            <h3 class="color-primary mrgn20b text-center">Is gentamicin contraindicated in this patient? <span class="color-info font15">(See below for contraindications)</span></h3>
            
            <div data-role="content" class="container-fluid">	
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ascho3a">Gentamicin contraindicated</a></li>
                    <li><a href="#ascho3b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho3 -->
        
        <!-- Start of cholangitis PEN MILD, Gent OK: #ascho1 -->
        <div data-role="page" id="ascho1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Ascending Cholangitis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For ascending cholangitis in a patient with non-life threatening penicillin hypersensitivity:</h3>
                <h4 class="color-primary mrgn20b">Ceftriaxone 1g IV, (child 1 month or older: 50 mg/kg up to 1 g) <span class="font15 color-info">Daily</span></h4>
                <p class="bold">OR</p>
                <h4 class="color-primary mrgn20b">Cefotaxime 1 g (child: 50 mg/kg up to 1 g) IV, <span class="font15 color-info">every 8 hours</span></h4>
                <div class="color-info font15"><b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b></div>
                <h4 class="color-primary mrgn20b">Metronidazole 500mg IV, (child 1 month or older: 12.5 mg/kg up to 500mg) <span class="font15 color-info">12 hourly</span></h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for cefotaxime is: </span>
                    <span class="font15 bold">2<script> document.write(getcode())</script>asc</span>
                </h4>
                <hr/>
                <div class="alert alert-info text-center">This code is valid for TWO days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <ul class="line30">
                    <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as Eschericia.coli or Enterococcus faecalis, infrequently it is caused by anaerobic bacteria</li>
                    <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                    <li>
                        Total antibiotic therapy (IV and PO) should not exceed 7 days treatment. Antibiotic therapy should be ceased within 24 hours of cholecystectomy
                        <ul>
                            <li>Metronidazole is not normally required unless the patient has a history of biliary obstruction</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho1 -->
        
        <!-- Start of cholangitis PEN BAD, Gent OK: #ascho2a -->
        <div data-role="page" id="ascho2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Ascending Cholangitis Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For ascending cholangitis in a patient with life threatening penicillin hypersensitivity intolerant of gentamicin:</h3>
                <h4 class="color-danger mrgn20b">Please contact IFD for advice</h4>
                <hr/>
                <ul class="line30">
                    <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli</i> or <i>Enterococcus faecalis</i>, infrequently it is caused by anaerobic bacteria</li>
                    <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment. Antibiotic therapy should be ceased within 24 hours of cholecystectomy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho2a -->
        
        <!-- Start of cholangitis PEN BAD, Gent OK: #ascho2b -->
        <div data-role="page" id="ascho2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Ascending Cholangitis Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For ascending cholangitis in a patient with life threatening penicillin hypersensitivity use as a single agent:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span> dosed as per table below<br/>
                    <b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg IV, (child 1 month or older: 12.5 mg/kg up to 500mg)</span> 12 hourly
                </h4>
                <p>Please contact IFD for advice for ongoing therapy past 72 hours</p>
                <hr/> 
                <h4 class="color-primary mrgn20b text-center">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing (Age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli</i> or <i>Enterococcus faecalis</i>, infrequently it is caused by anaerobic bacteria</li>
                    <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment. Antibiotic therapy should be ceased within 24 hours of cholecystectomy</li>
                    <li>Metronidazole is not normally required unless the patient has a history of biliary obstruction</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho2b -->
        
        <!-- Start of cholangitis PEN OK, Gent OK: #ascho3b -->
        <div data-role="page" id="ascho3b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Ascending Cholangitis Treatment:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For ascending cholangitis in a patient who can tolerate penicillin and gentamicin:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2 g (child: 50 mg/kg up to 2 g) IV, </span>6-hourly
                </h4>
                <h4 class="bold">AND</h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>dosed as per table below<br/>
                    <b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b>
                </h4>
                <h4>
                    <span class="color-primary">Metronidazole 500mg IV, (child 1 month or older: 12.5 mg/kg up to 500mg) </span>12 hourly
                </h4>
                <p>If IV treatment is required after 72 hours change to ceftriaxone 1g daily +/- metronidazole if biliary obstruction present, or use piperacillin 4g and tazobactam 500mg 8 hourly</p>
                <hr/>
                <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli</i> or <i>Enterococcus faecalis</i>, infrequently it is caused by anaerobic bacteria</li>
                    <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment. Antibiotic therapy should be ceased within 24 hours of cholecystectomy</li>
                    <li>Metronidazole is not normally required unless the patient has a history of biliary obstruction</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho3b -->
        
        <!-- Start of cholangitis PEN OK, Gent BAD: #ascho3a -->
        <div data-role="page" id="ascho3a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Ascending Cholangitis Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For ascending cholangitis in a patient tolerant of penicillin but intolerant of gentamicin:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1g IV, (child 1 month or older: 50 mg/kg up to 1 g) </span>Daily
                </h4>
                <strong>OR</strong>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 1 g (child: 50 mg/kg up to 1 g) IV, </span>every 8 hours
                </h4>
                <p class="font15 mrgn20b"><b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg IV, (child 1 month or older: 12.5 mg/kg up to 500mg) </span>12 hourly
                </h4>
                <p class="font15 mrgn20b"><b>OR</b> as a single agent (without metronidazole)</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>every 8 hours
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for either piperacillin or cefotaxime is: </span>
                    <span class="font15 bold">2<script> document.write(getcode())</script>asc</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment. Antibiotic therapy should be ceased within 24 hours of cholecystectomy</li>
                    <li>Metronidazole is not normally required unless the patient has a history of biliary obstruction</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ascho3a -->
        <!-- END OF Ascending Cholangitis Maze -->
        
        <!-- Carbuncle Maze Begins -->
        <!-- Start of carbuncle page: #carble -->
        <div data-role="page" id="carble" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <br>
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Are there signs of spreading cellulitis or significant systemic features?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec">Yes</a></li>
                    <li><a href="#carble2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble -->
        
        <!-- Start of carbuncle page: #carble2 -->
        <div data-role="page" id="carble2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Carbuncle:</h1>
            </div>
            <!-- /header -->
            <br>
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15">(See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carble2c">No penicillin allergy</a></li> 
                    <li><a href="#carble2a">Minor penicillin allergy</a></li>
                    <li><a href="#carble2b">Penicillin anaphylaxis</a></li>  
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2 -->
        
        <!-- Start of carbuncle page: #carble2a -->
        <div data-role="page" id="carble2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Is the patient a child or adult?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carble2a1">Paediatric patient</a></li>
                    <li><a href="#carble2a2">Adult Patient</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2a -->
        
        <!-- Start of carbuncle page: #carble2b -->
        <div data-role="page" id="carble2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Is the patient a child or adult?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carble2b1">Paediatric patient</a></li>
                    <li><a href="#carble2b2">Adult Patient</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2b -->
        
        <!-- Start of carbuncle page: #carble2c -->
        <div data-role="page" id="carble2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Is the patient a child or adult?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carble2c1">Paediatric patient</a></li>
                    <li><a href="#carble2c2">Adult Patient</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2c -->
        
        <!-- Start of carbuncle Tx page: #carble2a1 -->
        <div data-role="page" id="carble2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Child carbuncle antibiotic treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Most carbuncles will require only excision and drainage with no antibiotic treatment. If antibiotic treatment is necessary while awaiting the results of cultures and susceptibility, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 12.5 mg/kg (up to 500 mg) orally, </span>
                    <span class="font15">6-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If compliance is unlikely with QID dosing</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 25mg/kg orally </span>
                    <span class="font15">12 hourly</span>
                    <hr/>
                </h4>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2a1 -->
        
        <!-- Start of carbuncle Tx page: #carble2a2 -->
        <div data-role="page" id="carble2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Adult carbuncle antibiotic treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Most carbuncles will require only excision and drainage with no antibiotic treatment. If antibiotic treatment is necessary while awaiting the results of cultures and susceptibility, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 6-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If compliance is unlikely with QID dosing</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 1g orally</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <hr>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2a2 -->
        
        <!-- Start of carbuncle Tx page: #carble2b1 -->
        <div data-role="page" id="carble2b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Child carbuncle antibiotic treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Most carbuncles will require only excision and drainage with no antibiotic treatment. If antibiotic treatment is necessary while awaiting the results of cultures and susceptibility, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 10 mg/kg (up to 450 mg) orally,</span>
                    <span class="font15"> 8-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 4+20 mg/kg (up to 160+800 mg) orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is: </span>
                    <span class="font15 bold">5<script> document.write(getcode())</script>car</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past five days. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2b1 -->
        
        <!-- Start of carbuncle Tx page: #carble2b2 -->
        <div data-role="page" id="carble2b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Adult carbuncle antibiotic treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Most carbuncles will require only excision and drainage with no antibiotic treatment. If antibiotic treatment is necessary while awaiting the results of cultures and susceptibility, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450 mg orally,</span>
                    <span class="font15"> 8-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR </b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getcode())</script>car</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past five days. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr>
                <ul>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2b2 -->
        
        <!-- Start of carbuncle Tx page: #carble2c1 -->
        <div data-role="page" id="carble2c1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Child carbuncle antibiotic treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Most carbuncles will require only excision and drainage with no antibiotic treatment. If antibiotic treatment is necessary while awaiting the results of cultures and susceptibility, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Flucloxacillin 12.5 mg/kg (up to 500 mg) orally,</span>
                    <span class="font15"> 6-hourly for 5 days.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2c1 -->
        
        <!-- Start of carbuncle Tx page: #carble2c2 -->
        <div data-role="page" id="carble2c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Adult carbuncle antibiotic treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Most carbuncles will require only excision and drainage with no antibiotic treatment. If antibiotic treatment is necessary while awaiting the results of cultures and susceptibility, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dicloxacillin 500 mg orally,</span>
                    <span class="font15"> 6-hourly for 5 days.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carble2c2 -->
        <!-- Carbuncle (SOLE) Maze ENDS -->
        
        <!-- Carbuncle Sourced Cellulitis Maze Begins -->
        <!-- Start of carbuncle sourced cellulitis page: #carblec -->
        <div data-role="page" id="carblec" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec3">No penicillin allergy</a></li>
                    <li><a href="#carblec1">Minor penicillin allergy</a></li>
                    <li><a href="#carblec2">Penicillin anaphylaxis</a></li>    
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy: #carblec1 -->
        <div data-role="page" id="carblec1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b color-primary">Would you class the cellulitis as mild/moderate or severe?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec1a">Mild/Moderate</a></li>
                    <li><a href="#carblec1b">Severe</a></li>      
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1 -->
        
        <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy: #carblec2 -->
        <div data-role="page" id="carblec2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Would you class the cellulitis as mild/moderate or severe?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec2a2">Mild/Moderate</a></li>
                    <li><a href="#carblec2b">Severe</a></li>     
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec2 -->
        
        <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy: #carblec3 -->
        <div data-role="page" id="carblec3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Would you class the cellulitis as mild/moderate or severe?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec3a">Mild/Moderate</a></li>
                    <li><a href="#carblec3b">Severe</a></li>           
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec3 -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD: #carblec1a -->
        <div data-role="page" id="carblec1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Is the patient from an area with high nMRSA prevalence?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec1a2">Low nMRSA risk</a></li>
                    <li><a href="#carblec1a3">High nMRSA risk</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Areas with a high level of nMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1a -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy SEVERE: #carblec1b -->
        <div data-role="page" id="carblec1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Is the patient from an area with high nMRSA prevalence?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec1b2">Low nMRSA risk</a></li>
                    <li><a href="#carblec1b3">High nMRSA risk</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Areas with a high level of nMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1b -->
        
        <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy mild: #carblec3a -->
        <div data-role="page" id="carblec3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Is the patient from an area with high nMRSA prevalence?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec3a2">Low nMRSA risk</a></li>
                    <li><a href="#carblec1a3">High nMRSA risk</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Areas with a high level of nMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec3a -->
        
        <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy Severe: #carblec3b -->
        <div data-role="page" id="carblec3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitic Carbuncle:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Is the patient from an area with high nMRSA prevalence?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec3b2">Low nMRSA risk</a></li>
                    <li><a href="#carblec3b3">High nMRSA risk</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Areas with a high level of nMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec3b -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD: #carblec1a2 -->
        <div data-role="page" id="carblec1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Mild cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Mild cellulitis from carbuncle with non-life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg (child 12.5mg/kg up to 500mg) orally,</span>
                    <span class="font15"> 6-hourly for 5 to 10 days</span>
                </h4>
                <p class="mrgn20b"><strong>OR, </strong>If compliance is unlikely with QID dosing</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 1 g (child 25mg/kg up to 1g) orally,</span>
                    <span class="font15"> 12-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1a2 -->
        
        <!-- Start of carbuncle sourced cellulitis with Anaphylactic Penicillin Allergy MILD: #carblec2a2 -->
        <div data-role="page" id="carblec2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Mild cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Mild cellulitis from carbuncle with life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450 mg (child 10mg/kg up to 450mg) orally,</span>
                    <span class="font15"> 8-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getcode());</script>cac</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past ten days. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>   
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec2a2 -->
        
        <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy MILD: #carblec3a2 -->
        <div data-role="page" id="carblec3a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Mild cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Mild cellulitis from carbuncle with no penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dicloxacillin 500 mg (child flucloxacillin 12.5mg/kg up to 500mg) orally,</span>
                    <span class="font15"> 6-hourly for 5 to 10 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR, </b>If compliance is unlikely with QID dosing</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 1 g (child 25mg/kg up to 1g) orally,</span>
                    <span class="font15"> 12-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec3a2 -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy SEVERE: #carblec1b2 -->
        <div data-role="page" id="carblec1b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For empirical therapy in a patient with mild penicillin allergy; while awaiting the results of cultures and susceptibility testing, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 8-hourly until systemic features improve then switch to oral</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li>
                </ul>    
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1b2 -->
        
        <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy SEVERE, adult: #carblec3b2 -->
        <div data-role="page" id="carblec3b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For empirical therapy in a patient with no penicillin allergy, while awaiting the results of cultures and susceptibility use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Flucloxacillin 2 g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 6-hourly until systemic features improve then switch to oral</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li>
                </ul>     
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec3b2 -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD, nMRSA: #carblec1a3 -->
        <div data-role="page" id="carblec1a3" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Mild cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Mild cellulitis from a carbuncle in a patient from an nMRSA endemic community or with non-life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim/sulfamethoxazole 160/800mg (child 1 month or older 4/20 mg/kg up to 160/800mg) orally,</span>
                    <span class="font15"> 12-hourly for 5 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally</span>
                    <span class="font15"> 8-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is: </span>
                    <span class="font15 bold"> 5<script> document.write(getcode());</script>cac</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past ten days. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>    
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1a2 -->
        
        <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy SEVERE, nMRSA: #carblec1b3 -->
        <div data-role="page" id="carblec1b3" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Severe cellulitis from carbuncle in a patient where nMRSA is endemic can be treated with vancomycin and cephazolin:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> as per nomograms below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode());</script>cac</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours
                </div>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li>
                </ul>	
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec1b3 -->
        
        <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy SEVERE, nMRSA or no nMRSA: #carblec2b -->
        <div data-role="page" id="carblec2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Severe cellulitis from carbuncle in patients where nMRSA is endemic with penicillin hypersensitivity can be treated with vancomycin:</h3>
                <h4 class="color-primary mrgn20b">As a single agent use vancomycin as per nomograms below;</h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode());</script>cac</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if treatment is to continue past 48 hours</div>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Actual body weight (kg)</th>
                            <th>CrClr &lt; 20 mL/min</th>
                            <th>CrClr 20-60 mL/min</th>
                            <th>CrClr &gt; 60 mL/min</th>
                            <th class="bg-success">Administer over<sup>(1)</sup></th>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec2b -->
        
        <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy SEVERE, adult nMRSA: #carblec3b3 -->
        <div data-role="page" id="carblec3b3" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment in a patient from an nMRSA environment with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20">Severe cellulitis from carbuncle in adult patients where nMRSA is endemic can be treated with vancomycin and flucloxacillin:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Flucloxacillin 2g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin,</span>
                    <span class="font15"> as per nomogram below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cac</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Actual body weight (kg)</th>
                            <th>CrClr &lt; 20 mL/min</th>
                            <th>CrClr 20-60 mL/min</th>
                            <th>CrClr &gt; 60 mL/min</th>
                            <th class="bg-success">Administer over<sup>(1)</sup></th>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li>
                </ul>	
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /carblec3b3 -->
        <!-- END of Carbuncle Sourced CELLULITIS treatment maze -->
        
        <!-- Cellulitis Maze Begins -->
        <!-- Start of cellulitis page: #cell -->
        <div data-role="page" id="cell" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Is there a purulent focus for infection such as an abscess or carbuncle?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#carblec">Yes, purulent focus present</a></li>
                    <li><a href="#cellu">No, non-discharging wound</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cell -->
        
        <!-- Start of cellulitis page: #cellu -->
        <div data-role="page" id="cellu" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cellu3">No penicillin allergy</a></li>
                    <li><a href="#cellu1">Minor penicillin allergy</a></li>
                    <li><a href="#cellu2">Penicillin anaphylaxis</a></li>   
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu -->
        
        <!-- Start of cellulitis Tx with mild Penicillin Allergy ?severity : #cellu1 -->
        <div data-role="page" id="cellu1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Would you class the cellulitis as mild/moderate or severe?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cellu1a1">Mild/Moderate</a></li>
                    <li><a href="#cellu1b">Severe</a></li>      
                </ul>
                <hr/>
                <ul type="circle" class="line30"><li>Choose severe if there are significant systemic features or no improvement in &gt;48hours</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu1 -->
        
        <!-- Start of cellulitis Tx with BAD Penicillin Allergy ?severity : #cellu2 -->
        <div data-role="page" id="cellu2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <h3 class="color-primary mrgn20b">Would you class the cellulitis as mild/moderate or severe?</h3>
            <div data-role="content" class="container-fluid">	
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cellu2a1">Mild/Moderate</a></li>
                    <li><a href="#cellu2b">Severe</a></li>      
                </ul>
            </div>
            <hr/>
            <ul type="circle" class="line30"><li>Choose severe if there are significant systemic features or no improvement in &gt;48hours</li></ul>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu2 -->
        
        <!-- Start of cellulitis Tx with NO Penicillin Allergy ?severity : #cellu3 -->
        <div data-role="page" id="cellu3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Would you class the cellulitis as mild/moderate or severe?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cellu3a">Mild/Moderate</a></li>
                    <li><a href="#cellu3b">Severe</a></li>      
                </ul>
                <hr/>
                <ul type="circle" class="line30"><li>Choose severe if there are significant systemic features or no improvement in &gt;48hours</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu3 -->
        
        <!-- Start of cellulitis Tx with NO Penicillin Allergy MILD ?strep : #cellu3a -->
        <div data-role="page" id="cellu3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cellulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Are there signs of S.<i>pyogenes</i>?</span>
                    <span class="font15"> (i.e. erysipelas? or rapid progression)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cellu3a1">Yes</a></li>
                    <li><a href="#cellu3a2">No</a></li>      
                </ul>
                <hr>
                <ul class="line30">
                    <li>Erysipelas typically presents as a rapidly progressing erythematous skin lesion which has a sharply demarcated, raised edge</li>
                    <li>Classically, erysipelas involves either facial skin in a butterfly pattern, or the lower legs</li>
                    <li>Spontaneous rapid spreading cellulitis is most commonly due to S.<i>pyogenes</i> or another streptococci</li>
                </ul>	
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu3a -->
        
        <!-- Start of cellulitis, Pen MILD, Cellu MILD, Strep YES or NO: #cellu1a1 -->
        <div data-role="page" id="cellu1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20">For mild/moderate cellulitis in a patient with penicillin hypersensitivity (non-life threatening) use as a single agent:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally,</span>
                    <span class="font15"> 6-hourly for 5 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b>If compliance is unlikely with QID dosing</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 1000mg (child:25 mg/kg up to 1g)</span>
                    <span class="font15">, 12-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <ul type="circle" class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu1a1 -->
        
        <!-- Start of cellulitis, Pen BAD, Cellu MILD, Strep YES OR NO: #cellu2a1 -->
        <div data-role="page" id="cellu2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For mild/moderate cellulitis in a patient with immediate (life threatening) penicillin hypersensitivity use as a single agent:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally, </span>
                    <span class="font15"> 8-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getcode())</script>cel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past ten days. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <ul type=circle class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu2a1 -->
        
        <!-- Start of cellulitis, Pen OK, Cellu MILD, Strep YES : #cellu3a1 -->
        <div data-role="page" id="cellu3a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For mild/moderate cellulitis in a patient with signs of S.<i>pyogenes</i> use as a single agent:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Phenoxymethylpenicillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally,</span>
                    <span class="font15"> 6-hourly for 5 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Procaine penicillin 1.5 g (child: 50 mg/kg up to 1.5 g) IM, </span>
                    <span class="font15"> daily for at least 3 days</span>
                </h4>
                <hr/>
                <ul type=circle class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu3a1 -->
        
        <!-- Start of cellulitis, Pen OK, Cellu MILD, Strep NO : #cellu3a2 -->
        <div data-role="page" id="cellu3a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For mild/moderate cellulitis in a patient with signs of S.<i>pyogenes</i> use as a single agent:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dicloxacillin 500 mg (child: Flucloxacillin 12.5 mg/kg up to 500 mg) orally,</span>
                    <span class="font15"> 6-hourly for 5 to 10 days</span>
                </h4>
                <hr/>
                <ul type=circle class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu3a2 -->
        
        <!-- Start of cellulitis Tx with mild Penicillin Allergy SEVERE: #cellu1b -->
        <div data-role="page" id="cellu1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For empirical therapy of mild to moderate cellulitis in an adult with mild penicillin allergy; while awaiting the results of cultures and susceptibility testing, use: </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g IV (child: 50 mg/kg up to 2 g), </span>
                    <span class="font15"> 8-hourly</span>
                </h4>
                <p class="mrgn20b">Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</p>
                <hr/>
                <ul class="line30" type="circle">
                    <li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li>
                    <li>As with all skin and soft tissue infections patients with cellulitis can benefit from an early switch to oral within the first 48 hours of treatment</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu1b -->
        
        <!-- Start of cellulitis Tx with anaphylactic Penicillin Allergy SEVERE,: #cellu2b -->
        <div data-role="page" id="cellu2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For empirical treatment of severe cellulitis in a patient with life threatening penicillin hypersensitivity use either vancomycin or lincomycin.</h3>
                <h4 class="color-primary mrgn20b">Vancomycin as per nomogram below;</h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600 mg (child: 15 mg/kg up to 600 mg) IV,</span>
                    <span class="font15"> 8-hourly.</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin or vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode());</script>cel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if treatment is to continue past 48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Actual body weight (kg)</th>
                            <th>CrClr &lt; 20 mL/min</th>
                            <th>CrClr 20-60 mL/min</th>
                            <th>CrClr &gt; 60 mL/min</th>
                            <th class="bg-success">Administer over<sup>(1)</sup></th>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Consider an early switch to oral clindamycin (within 48 hours), clindamycin has excellent oral bioavailability (90% orally bioavailable)</li>
                    <li>In addition to treating cellulitis, examine patient for tinea of the feet and treat if necessary</li>
                    <li>As with all skin and soft tissue infections patients with cellulitis can benefit from an early switch to oral within the first 48 hours of treatment</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu2b -->
        
        <!-- Start of cellulitis Tx with no Penicillin Allergy SEVERE, #cellu3b -->
        <div data-role="page" id="cellu3b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe cellulitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For empirical therapy in a patient with no penicillin allergy, while awaiting the results of cultures and susceptibility use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Flucloxacillin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> 6-hourly</span>
                </h4>
                <hr/>
                <ul type="circle" class="line30">
                    <li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li>
                    <li>As with all skin and soft tissue infections patients with cellulitis can benefit from an early switch to oral within the first 48 hours of treatment</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cellu3b -->
        <!-- END of CELLULITIS treatment maze -->
        
        <!-- start of DIABETIC FOOT treatment maze -->
        <!-- Start of Diabet foot page: #diabf -->
        <div data-role="page" id="diabf" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic Foot Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15">(See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#diabf3">No penicillin allergy</a></li> 
                    <li><a href="#diabf1">Minor penicillin allergy</a></li>
                    <li><a href="#diabf2">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf -->
        
        <!-- Start of Diabet foot page Penicillin MILD: #diabf1 -->
        <div data-role="page" id="diabf1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic Foot Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the infection?</span>
                    <span class="font15"> (see table below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#diabf1a">Mild</a></li>
                    <li><a href="#diabf1b">Moderate</a></li>
                    <li><a href="#diabf1b">Severe</a></li>    
                </ul>
                <h4 class="color-primary mrgn20b">Classification of diabetic foot infection</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Severity</th>
                            <th>Features</th>
                        </tr>
                        <tr>
                            <td><b>Uninfected</b></td>
                            <td><ul><li>Wound lacking purulence or any manifestation of inflammation</li></ul></td>
                        </tr>
                        <tr>
                            <td><b>Mild</b></td>
                            <td>
                                <ul>
                                    <li>Presence of 2 or more manifestations of inflammation (purulence, or erythema, pain, tenderness,warmth, or induration) </li>
                                    <li>Extent of cellulitis/erythema: 0.5 - 2cm around ulcer, and infection is limited to the skin or superficial subcutaneous tissues </li>
                                    <li>No other local complications or systemic illness.</li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Moderate</b></td>
                            <td>
                                <ul>
                                    <li>Infection (as above) in a patient who is systemically well and metabolically stable, but which has
                                        greater than 1 of the following characteristics:
                                        <ul>
                                            <li>cellulitis > 2 cm, lymphangitic streaking, spread beneath the superficial fascia, deeptissue
                                            abscess, gangrene and involvement of muscle, tendon, joint or bone.</li>
                                        </ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Severe</b></td>
                            <td>
                                <ul>
                                    <li>Infection in a patient with systemic toxicity or metabolic instability
                                        <ul>
                                            <li>
                                                eg. Fever, chills, tachycardia, hypotension, confusion, vomiting, leukocytosis,
                                                acidosis, severe hyperglycaemia, renal impairment</li>
                                        </ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1 -->
        
        <!-- Start of Diabet foot page penicillin BAD: #diabf2 -->
        <div data-role="page" id="diabf2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic Foot Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the infection?</span>
                    <span class="font15"> (see table below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview">
                    <li><a href="#diabf2a">Mild</a></li>
                    <li><a href="#diabf1b">Moderate</a></li>
                    <li><a href="#diabf1b">Severe</a></li>    
                </ul>
                <h4 class="color-primary mrgn20b">Classification of diabetic foot infection</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Severity</th>
                            <th>Features</th>
                        </tr>
                        <tr>
                            <td><b>Uninfected</b></td>
                            <td><ul><li>Wound lacking purulence or any manifestation of inflammation</li></ul></td>
                        </tr>
                        <tr>
                            <td><b>Mild</b></td>
                            <td>
                                <ul>
                                    <li> Presence of 2 or more manifestations of inflammation (purulence, or erythema, pain, tenderness,
                                        warmth, or induration) </li>
                                    <li> Extent of cellulitis/erythema: 0.5 - 2cm around ulcer, and infection is limited to the skin or
                                        superficial subcutaneous tissues </li>
                                    <li> No other local complications or systemic illness. </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Moderate</b></td>
                            <td>
                                <ul>
                                    <li>Infection (as above) in a patient who is systemically well and metabolically stable, but which has
                                        greater than 1 of the following characteristics:
                                        <ul><li>
                                            cellulitis > 2 cm, lymphangitic streaking, spread beneath the superficial fascia, deeptissue
                                            abscess, gangrene and involvement of muscle, tendon, joint or bone.</li></ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Severe</b></td>
                            <td>
                                <ul>
                                    <li>Infection in a patient with systemic toxicity or metabolic instability
                                        <ul type=circle><li>
                                            eg. Fever, chills, tachycardia, hypotension, confusion, vomiting, leukocytosis,
                                            acidosis, severe hyperglycaemia, renal impairment</li></ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2 -->
        
        <!-- Start of Diabet foot page Penicillin MILD: #diabf3 -->
        <div data-role="page" id="diabf3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic Foot Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the infection?</span>
                    <span class="font15"> (see table below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#diabf3a">Mild</a></li>
                    <li><a href="#diabf3b">Moderate</a></li>
                    <li><a href="#diabf3b">Severe</a></li>    
                </ul>
                <h4 class="color-primary mrgn20b">Classification of diabetic foot infection</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Severity</th>
                            <th>Features</th>
                        </tr>
                        <tr>
                            <td><b>Uninfected</b></td>
                            <td><ul><li>Wound lacking purulence or any manifestation of inflammation</li></ul></td>
                        </tr>
                        <tr>
                            <td><b>Mild</b></td>
                            <td>
                                <ul>
                                    <li> Presence of 2 or more manifestations of inflammation (purulence, or erythema, pain, tenderness,
                                        warmth, or induration) </li>
                                    <li> Extent of cellulitis/erythema: 0.5 - 2cm around ulcer, and infection is limited to the skin or
                                        superficial subcutaneous tissues </li>
                                    <li> No other local complications or systemic illness. </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Moderate</b></td>
                            <td>
                                <ul>
                                    <li>Infection (as above) in a patient who is systemically well and metabolically stable, but which has
                                        greater than 1 of the following characteristics:
                                        <ul type=circle>
                                            <li>
                                                cellulitis > 2 cm, lymphangitic streaking, spread beneath the superficial fascia, deeptissue
                                                abscess, gangrene and involvement of muscle, tendon, joint or bone.
                                            </li>
                                        </ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Severe</b></td>
                            <td>
                                <ul>
                                    <li>
                                        Infection in a patient with systemic toxicity or metabolic instability
                                        <ul type=circle><li>
                                            eg. Fever, chills, tachycardia, hypotension, confusion, vomiting, leukocytosis,
                                            acidosis, severe hyperglycaemia, renal impairment</li></ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3 -->
        
        <!-- Start of diab foot pen MILD, Diab MILD: #diabf1a -->
        <div data-role="page" id="diabf1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For mild diabetic foot in a patient with non-life-threatening penicillin allergy:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500mg PO,</span>
                    <span class="font15"> every 6 hours for 1-2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400mg PO,</span>
                    <span class="font15"> every 12 hours for 1-2 weeks</span>
                </h4>
                <hr/>
                <ul type=circle>
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> ciprofloxacin or piperacillin with tazobactam may be required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1a -->
        
        <!-- Start of diab foot pen BAD, Diab MILD: #diabf2a -->
        <div data-role="page" id="diabf2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For mild diabetic foot in a patient with life-threatening penicillin allergy:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 500mg PO,</span>
                    <span class="font15"> every 12 hours for 1-2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450mg PO,</span>
                    <span class="font15"> every 8 hours for 1-2 weeks</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin and clindamycin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode());</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week. Please annotate when IFD are to be contacted on eMMa and patient notes
                </div>
                <hr>
                <ul class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> the empirical dosage of ciprofloxacin may need to be modified</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2a -->
        
        <!-- Start of diab foot pen OK, Diab MILD: #diabf3a -->
        <div data-role="page" id="diabf3a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For mild diabetic foot in a patient with no penicillin allergy:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin 875mg/Clavulanic acid 125mg PO,</span>
                    <span class="font15"> every 12 hours for 1-2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500mg PO,</span>
                    <span class="font15"> every 6 hours for 1-2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400mg PO,</span>
                    <span class="font15"> every 12 hours for 1-2 weeks.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>In patients with severe renal failure amoxycillin dose may need to be reduced</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> ciprofloxacin or piperacillin with tazobactam may be required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3a -->
        
        <!-- Start of Diabet foot page: #diabf1b -->
        <div data-role="page" id="diabf1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic Foot Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Are there systemic signs of sepsis, or is MRSA suspected?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#diabf1b1">Yes</a></li>
                    <li><a href="#diabf1b2">No</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Signs of Sepsis</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>SIRS response: &ge;2 of:</th>
                            <th>AND presence of refractory hypotension or hypoperfusion</th>
                        </tr>
                        <tr>
                            <td>
                                <p>Temp &lt;36 or &gt;38</p>
                                <p>Heart rate &gt; 90</p>
                                <p>Resp Rate &gt; 20</p>
                                <p>WCC &gt; 12.0 or &lt; 4.0</p>
                            </td>
                            <td>
                                <p align="left"><b>Hypotension:</b></p>
                                <ul type=circle><li>systolic BP&lt; 90mmHg <b>OR</b> 40mmHg below premorbid BP <b> AFTER</b> at least 500mL fluid challenge.</li></ul>
                                <p align="left"><b>Hypoperfusion:</b></p>
                                <ul type=circle><li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li></ul>
                            </td>
                        </tr>
                    </table>
                </div>
                <p align="left"><b>Hypotension:</b></p>
                <ul type=circle><li>systolic BP< 90mmHg <b>OR</b> 40mmHg below premorbid BP <b> AFTER</b> at least 500mL fluid challenge.</li></ul>
                <p align="left"><b>Hypoperfusion:</b></p>
                <ul type=circle><li>Lactate >=4 mmol/L <b>OR</b> Bicarbonate <16mmol/L</li></ul>
                <hr>
                <ul type=circle><li>Currently nearly half of all RDH patients are infected or colonised with MRSA (46%). Consult IFD promptly if the patient is not improving, septic, or MRSA is suspected.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1b -->
        
        <!-- Start of Diabet foot page: #diabf3b -->
        <div data-role="page" id="diabf3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic Foot Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">Are there systemic signs of sepsis, or is MRSA suspected?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview">
                    <li><a href="#diabf3b1">Yes</a></li>
                    <li><a href="#diabf3b2">No</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Signs of Sepsis</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>SIRS response: &ge;2 of:</th>
                            <th>AND presence of refractory hypotension or hypoperfusion</th>
                        </tr>
                        <tr>
                            <td>
                                <p>Temp &lt;36 or &gt;38</p>
                                <p>Heart rate &gt; 90</p>
                                <p>Resp Rate &gt; 20</p>
                                <p>WCC &gt; 12.0 or &lt; 4.0</p>
                            </td>
                            <td>
                                <p align="left"><b>Hypotension:</b></p>
                                <ul type=circle><li>systolic BP&lt; 90mmHg <b>OR</b> 40mmHg below premorbid BP <b> AFTER</b> at least 500mL fluid challenge.</li></ul>
                                <p align="left"><b>Hypoperfusion:</b></p>
                                <ul type=circle><li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li></ul>
                            </td>
                        </tr>
                    </table>
                </div>
                <hr>
                <ul type=circle><li>Currently nearly half of all RDH patients are infected or colonised with MRSA (46%). Consult IFD promptly if the patient is not improving, septic, or MRSA is suspected.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3b -->
        
        <!-- Start of diab foot pen BAD, Diab BAD, MRSA YES: #diabf1b1 -->
        <div data-role="page" id="diabf1b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For moderate/severe diabetic foot with potential for MRSA in patient intolerant of penicillin use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 500mg PO,</span>
                    <span class="font15"> every 12 hours for 2-4 weeks</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below until cultures return</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450mg PO,</span>
                    <span class="font15"> every 6 hours for 2-4 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600mg IV,</span>
                    <span class="font15"> every 8 hours until stable then step down to oral clindamycin 450mg tds</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin, vancomycin, clindamycin or lincomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode());</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if treatment is to continue past 48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Please note clindamycin has excellent oral bioavailability (90% orally bioavailable), consider an early switch to oral if lincomycin is to be used</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with Pseudomonas aeruginosa the empirical dosage of ciprofloxacin may need to be modified</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1b1 -->
        
        <!-- Start of diab foot pen BAD, Diab BAD, MRSA NO: #diabf1b2 -->
        <div data-role="page" id="diabf1b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For moderate/severe diabetic foot in patient intolerant of penicillin use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 500mg PO,</span>
                    <span class="font15"> every 12 hours for 2-4 weeks</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 450mg PO,</span>
                    <span class="font15"> every 6 hours for 2-4 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600mg IV,</span>
                    <span class="font15"> every 8 hours until stable then step down to oral clindamycin 450mg tds</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin or clindamycin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode());</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Please note clindamycin has excellent oral bioavailability (90% orally bioavailable), consider an early switch to oral if lincomycin is to be used</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with Pseudomonas aeruginosa the empirical dosage of ciprofloxacin may need to be modified</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1b2 -->
        
        <!-- Start of diab foot pen OK, Diab BAD, MRSA YES: #diabf3b1 -->
        <div data-role="page" id="diabf3b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">For moderate/severe diabetic foot in patient at risk of MRSA use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin 4g and tazobactam 0.5g IV,</span>
                    <span class="font15"> every 8 hours until patient meets switch to oral criteria</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below until cultures return</span>
                </h4>
                <hr>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 14<script> document.write(getcode());</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FOURTEEN</b> days only. IFD must be contacted if IV treatment is to continue past 2 weeks</div>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr>
                <ul type=circle>
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                    <li>If cultures return sensitive to clindamycin this is often a good alternative to vancomycin with excellent tissue penetration</li>
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>If <i>Pseudomonas aeruginosa</i> is isolated from cultures of deep tissue specimens then the empirical dose of piperacillin and tazobactam may need to be increased to 6 hourly dosing.</li>
                    <li>See the switch to oral protocol on the PGC for details on when to make the switch to oral antibiotics</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3b1 -->
        
        <!-- Start of diab foot pen OK, Diab BAD, MRSA NO: #diabf3b2 -->
        <div data-role="page" id="diabf3b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic Foot Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn20b">For mild to moderate diabetic foot in a patient with non-life-threatening penicillin allergy:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin 4g and tazobactam 500mg, IV</span>
                    <span class="font15"> every 8 hours until patient meets switch to oral criteria</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 14<script> document.write(getcode())</script>dfi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FOURTEEN</b> days only. IFD must be contacted if IV treatment is to continue past 2 weeks</div>
                <hr/>
                <ul type=circle class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>If <i>Pseudomonas aeruginosa</i> is isolated from cultures of deep tissue specimens then the empirical dose of piperacillin and tazobactam may need to be increased to 6 hourly dosing.</li>
                    <li>See the switch to oral protocol on the PGC for details on when to make the switch to oral antibiotics</li>
                </ul>
            </div>
            <!-- /content -->
            
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3b2 -->
        <!-- END of DIABETIC FOOT treatment maze -->
        
        <!-- Start of dosing nomograms -->
        <!-- Start Dosing nomogram page ?type #dose -->
        <div data-role="page" id="dose" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Display dosing nomograms for:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#dose7">Cockcroft Gault &#40;CrCl&#41; Calculator</a></li>
                    <li><a href="#dose1">Gentamicin nomogram</a></li>
                    <li><a href="#dose5">Gentamicin empiric dose calculator</a></li>
                    <li><a href="#dose2">Vancomycin nomogram</a></li> 
                    <li><a href="#dose3">Vancomycin load calculator</a></li> 
                    <li><a href="#dose4">Vancomycin dose adjustment calculator</a></li>
                    <li><a href="#dose6">Vancomycin empiric dose calculator</a></li> 
                </ul>
                <hr>
                <div class="alert alert-danger">
                    Please note these calculators and nomograms are for testing purposes only, please confirm any dose recommendations with a second source before prescribing treatment
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose -->
        
        <!-- Start of dose nomogram page gent #dose1 -->
        <div data-role="page" id="dose1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Gentamicin dosing nomogram:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Gentamicin dose should be based on ideal body weight for patients with actual body weight more than 20% over ideal weight. Contact pharmacy for dose recommendation in morbidly obese patients.</h3>
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (Age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                </ul>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose1 -->
        
        <!-- Start of dose nomogram page vanc #dose2 -->
        <div data-role="page" id="dose2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Vancomycin dosing nomograms:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Vancomycin dosing should be based on weight and renal function for adult patients or age and weight for neonates and children:</h3>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                    <div class="alert alert-info">
                        <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                        <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                    </div>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose2 -->
        
        <!-- Start of dose3 page: #dose3 -->
        <div data-role="page" id="dose3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Adult Vancomycin Loading Dose Calculator</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <!--Vancomycin dose calculator body content-->
                <script>
                    var calcvancload = function () {
                        //console.log('updating value');
                        //console.log($('#vancweight').val());
                        var loadresult = 0;
                        var vancweight = $('#vancweight').val();
                        if (vancweight * 28 > 2000) {

                            loadresult = 2000
                        } else if (vancweight * 28 > 1750) {

                            loadresult = 1750
                        } else if (vancweight * 28 > 1500) {

                            loadresult = 1500
                        } else if (vancweight * 28 > 1250) {

                            loadresult = 1250
                        } else if (vancweight * 28 > 1000) {

                            loadresult = 1000
                        } else if (vancweight * 28 <= 1000) {

                            alert("Seek specialist advice for low body weight or paediatric patients")
                        }

                        loadresult =
                                $('#vancloadresult').text(loadresult);
                    }
                </script>
                <form onsubmit="return false">
                    <h4 class="color-primary mrgn20b">Enter the patients actual body weight to calculate the vancomycin loading dose</h4>
                    <div class="form-group">
                        <label for="vancweight">Weight (Kg):</label>
                        <input type="number" min="10" id="vancweight" name="vancweight" value="0" onchange="calcvancload();" class="form-control"/>
                    </div>
                    <p class="mrgn20t mrgn20b"><b>Vancomycin dose:</b><strong><span id="vancloadresult"></span></strong>  <b>mg</b></p>
                    <button onClick="calcvancload" class="btn btn-primary btn-lg">Calculate</button>
                </form>
                <hr>
                <ul class="line30">
                    <li>Please note this calculator is for testing purposes only, please confirm any dose recommendations with a second source before prescribing treatment</li>
                    <li>A loading dose of vancomycin may be considered to help achieve a therapeutic concentration more quickly, particularly in patients with serious infections who are critically ill. However, there are no strong clinical data to show that this approach improves outcomes.</li>
                    <li>Weight-based dosing is recommended for the loading dose, since both volume of distribution and clearance of vancomycin are correlated with actual body weight.</li>
                    <li>This calculator is for adult patients only, for paediatric or underweight patients (&lt;36Kg) please seek specialist advice</li>
                    <li>This calculator aims for a load of 25 to 30 mg/kg (actual body weight)</li>
                </ul>
            </div>
            <!--/vanc load body content-->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose3 -->
        
        <!-- Start of dose4 vanc dose adjustment page: #dose4 -->
        <div data-role="page" id="dose4" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Adult Vancomycin Dose Adjustment Calculator</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <!--Vancomycin dose adjust calculator body content-->
                <script>
                    var calcvancdose = function () {

                        var vanclevel = parseFloat($("#vanclevel").val());
                        var prevdosevanc = parseInt($("#prevdosevanc").val());
                        var vancinterval = parseInt($("#vancinterval").val());
                        var vanccomp = parseInt($("#vanccomp").val());
                        var vancsever = (parseInt($("#vanccomp").val()) * parseInt($("#vanclevel").val()));
                        var newtotaldose = parseInt($("#newtotaldose").val());

                        if (prevdosevanc < 250) {
                            alert("Please enter previous vancomycin dose in milligrams. i.e 1500mg for a 1.5g dose")
                        }

                        if ((vancsever < 20) && (vancsever >= 10)) {
                            alert("There is no need to adjust vancomycin dose for non-severe infection with a steady state trough level of 10-20");
                        } else if (parseFloat($("#vanclevel").val()) < 10) {
                            alert("Please contact IFD for advice for level adjustment for steady state trough of less than 10 or greater than 25")
                        } else if (parseFloat($("#vanclevel").val()) > 25) {
                            alert("Please contact IFD for advice for level adjustment for steady state trough of less than 10 or greater than 25")
                        } else if ((vancsever < 1500) && (vancsever >= 1000)) {
                            newtotaldose = (17.5 / (parseFloat($("#vanclevel").val()))) * ((prevdosevanc * parseInt($("#vancinterval").val())) / 2)
                        } else if ((vancsever <= 2500) && (vancsever > 2000)) {
                            newtotaldose = (((17.5 / (parseFloat($("#vanclevel").val()))) * ((prevdosevanc * parseInt($("#vancinterval").val()) / 2))))
                        } else if ((vancsever <= 2000) && (vancsever >= 1500)) {
                            alert("There is no need to adjust dose, vancomycin is already in therapeutic range")
                        }

                        if ((newtotaldose >= 250) && (newtotaldose < 750)) {
                            $('#frequency').text("250mg twice daily")
                        } else if ((newtotaldose < 1250) && (newtotaldose >= 750)) {
                            $('#frequency').text("500mg twice daily")
                        } else if ((newtotaldose < 1750) && (newtotaldose >= 1250)) {
                            $('#frequency').text("750mg twice daily")
                        } else if ((newtotaldose < 2250) && (newtotaldose >= 1750)) {
                            $('#frequency').text("1000mg twice daily")
                        } else if ((newtotaldose < 2750) && (newtotaldose >= 2250)) {
                            $('#frequency').text("1250mg twice daily")
                        } else if ((newtotaldose < 3250) && (newtotaldose >= 2750)) {
                            $('#frequency').text("1500mg twice daily")
                        } else if ((newtotaldose < 3750) && (newtotaldose >= 3250)) {
                            $('#frequency').text("1750mg twice daily")
                        } else if ((newtotaldose < 4250) && (newtotaldose >= 3750)) {
                            $('#frequency').text("2000mg twice daily")
                        } else if ((newtotaldose < 4750) && (newtotaldose >= 4250)) {
                            $('#frequency').text("2250mg twice daily")
                        } else if ((newtotaldose < 5250) && (newtotaldose >= 4750)) {
                            $('#frequency').text("2500mg twice daily")
                        } else if ((newtotaldose < 5750) && (newtotaldose >= 5250)) {
                            $('#frequency').text("1750mg three times daily")
                        } else if ((newtotaldose < 6250) && (newtotaldose >= 5750)) {
                            $('#frequency').text("2000mg three times daily")
                        } else if ((newtotaldose < 6750) && (newtotaldose >= 6250)) {
                            $('#frequency').text("2250mg three times daily")
                        } else if ((newtotaldose < 7250) && (newtotaldose >= 6750)) {
                            $('#frequency').text("2250mg three times daily")
                        } else if ((newtotaldose < 7750) && (newtotaldose >= 7250)) {
                            $('#frequency').text("2500mg three times daily")
                        } else if (newtotaldose >= 7750) {
                            alert("Please contact IFD for dose adjustments above 2500mg tds")
                        }

                        //$('#newtotaldose').text(newtotaldose);

                        if ((newtotaldose / (prevdosevanc * (parseInt($("#vancinterval").val()) / 2))) > 1.3) {
                            alert("Please be cautious if considering a dose adjustment of greater than 30% of the previous dose. This calculator can not take into account clinical context and a lower dose than the one suggested may be more appropriate")
                        }

                    }
                </script>

                <form onsubmit="return false">
                    <h4 class="color-primary mrgn20b">Enter the patients previous vancomycin level and previous dose to acheive steady state below</h4>
                    <div class="form-group">
                        <label for="vanclevel"><b>Last trough vancomycin level:</b></label>
                        <input type="number" min="1" step="0.1" id="vanclevel" name="vanclevel" value = "0" class="form-control"/>
                    </div>
                    <div class="form-group">
                        <label for="prevdosevanc"><b>Previous dose (in milligrams):</b></label>
                        <input type="number" min="0" id="prevdosevanc" name="prevdosevanc" class="form-control"><b>milligrams</b>
                    </div>
                    <div class="form-group">
                        <label for="vancinterval"><b>Previous dosage interval:</b></label>
                        <select name="vancinterval" id="vancinterval" onchange="calcvancdose();" class="form-control">
                            <option value="1">every 48 hours</option>
                            <option value="2">every 24 hours</option>
                            <option value="4">every 12 hours</option>
                            <option value="6">every 8 hours</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="vanccomp"><b>Would you rate the infection as complicated (major) or uncomplicated (minor)&#63;</b></label>
                        <select name="vanccomp" id="vanccomp" onchange="calcvancdose();" class="form-control">
                            <option value="100">Complicated</option>
                            <option value="1">Uncomplicated</option>
                        </select>
                    </div>
                    <p align ="left"><b>Suggested new vancomycin dose: <span id="frequency"></span></b></p>
                    <button onClick ="calcvancdose();" class="btn btn-primary">Calculate</button>
                </form>
                <hr>
                <div class="alert alert-danger">Please note this calculator is for testing purposes only, please confirm any dose recommendations with a second source before prescribing treatment</div>
                <ul class="line30">
                    <li>Please note the values from this calculator are to be used as a <b>guide</b> only. This calculator provides a dose which targets a level of 17.5, however there are numerous clinical reasons this would not be an appropriate target. This tool is to be used as a guide only and should never replace clinical judgement</li>
                    <li>This tool should not be used in paediatrics, patients with severe sepsis, rapidly changing renal function, on haemodialysis or CRRT or other nephrotoxic medications</li>
                    <li>efore changing a dose, please check that the timing of the previous dose was as intended, that the level was taken at the appropriate time and that the patient has had adequate time to reach steady state since the last dose change (see the vancomycin protocol on PGC for details)</li>
                </ul>
            </div>
            <!--/vanc dose adjust body content-->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose4 -->
        
        <!-- Start of dose5 page: #dose5 -->
        <div data-role="page" id="dose5" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Gentamicin empiric dose calculator</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <!--gentamicin dose calculator body content-->
                <script>
                    var calcgentdose = function () {

                        var gentheight = parseInt($('#gentheight').val());
                        var gentweight = parseFloat($('#gentweight').val());
                        var genderweight = parseInt($('#genderweight').val());
                        var extracm = (gentheight - 152);
                        var crcl = parseInt($('#crcl').val());

                        if (parseInt($('#gentweight').val()) < (parseInt($('#genderweight').val()) + (0.9 * extracm))) {
                            idbw = parseFloat($('#gentweight').val());} else if (gentheight > 152) {
                            idbw = (parseInt($('#genderweight').val()) + (0.9 * extracm))} else if (gentheight <= 152) {
                            idbw = parseInt($('#genderweight').val())}

                        if ((idbw * 2) <= parseFloat($('#gentweight').val())) {
                            alert("please contact infectious diseases for gentamicin dosing advice for morbidly obese patients")}

                        if ((idbw * 1.2) < parseFloat($('#gentweight').val())) {
                            gentbw = idbw} else if ((idbw * 1.2) >= parseFloat($('#gentweight').val())) {
                            gentbw = gentweight
                        }

                        if (gentbw > 30) {
                            gentdose1=
                                    Math.round((gentbw * 4) / 40) * 40
                        } else if (gentbw < 30) {
                            alert("Please confirm weight, this calculator is for adult patients only")
                        }

                        if (gentbw < 30) {
                            gentdose2 = 0
                        } else if (parseInt($('#crcl').val()) == 1) {
                            gentdose2=
                                    Math.round((gentbw * 5) / 40) * 40
                        } else if (parseInt($('#crcl').val()) == 2) {
                            gentdose2=
                                    Math.round((gentbw * 5) / 40) * 40
                        } else if (parseInt($('#crcl').val()) == 3) {
                            gentdose2=
                                    Math.round((gentbw * 4) / 40) * 40
                        }

                        if (parseInt($('#crcl').val()) == 1) {
                            $('#duration').text("for a maximum of 3 empirical doses at 0, 24 and 48 hours")
                        } else if (parseInt($('#crcl').val()) == 2) {
                            $('#duration').text("for a maximum of 2 empirical doses at 0 and 36 hours")
                        } else if (parseInt($('#crcl').val()) == 3) {
                            $('#duration').text("for a single dose, then contact infectious diseases for subsequent dosing or for selection of an alternative agent")
                        }

                        $('#gentbw').text(gentbw);
                        $('#gentdose1').text(gentdose1);
                        $('#gentdose2').text(gentdose2);
                    }
                </script>
                
                <form onsubmit="return false">
                    <h4 class="color-primary mrgn20b">Enter the patient details to calculate the gentamicin loading dose:</h4>
                    <div class="form-group">
                        <label for="genderweight"><b>Gender:</b></label>
                        <select name="genderweight" id="genderweight" onchange="calcgentbw();" class="form-control">
                            <option value="50.0">Male</option>
                            <option value="45.5">Female</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="gentheight"><b>Height (cm):</b></label>
                        <input type="number" min="10" id="gentheight" name="gentheight" class="form-control">
                    </div>
                    <div class="form-group">
                        <label for="gentweight"><b>Actual weight (kg):</b></label>
                        <input type="number" min="10" id="gentweight" name="gentweight" onchange="calcgentdose();" class="form-control">
                    </div>
                    <div class="form-group">
                        <label for="crcl"><b>Creatinine clearance:</b></label>
                        <select name="crcl" id="crcl" onchange="calcgentdose();" class="form-control">
                            <option value="1">More than 60mL/min</option>
                            <option value="2">40-60mL/min</option>
                            <option value="3">Less than 40mL/min</option>
                        </select>
                    </div>
                    <p><b>Gentamicin dose weight:</b><strong><span id="gentbw">0</span></strong>  <b>Kg</b></p>
                    <p><b>Gentamicin dose:</b><strong><span id="gentdose1">0</span></strong>  <b>mg</b> to <strong><span id="gentdose2">0</span></strong> <b>mg</b> <span id="duration"> </span></p>
                    <button onclick ="calcgentdose();" class="btn btn-primary">Calculate</button>
                </form>
                <hr/>
                <div class="alert alert-danger">Please note this calculator is for testing purposes only, please confirm any dose recommendations with a second source before prescribing treatment</div>
                <ul class="line30">
                    <li>
                        This calculator is for use as a guide only. The following patient groups may have altered pharmacokinetics and modified doses may be required. Please contact infectious diseases for advice with the following:
                        <ul class="line30">
                            <li>critically ill patients with severe sepsis or septic shock</li>
                            <li>patients receiving renal replacement therapy</li>
                            <li>patients with severe burns</li>
                            <li>patients with cystic fibrosis</li>
                            <li>pregnant women</li>
                            <li>patients with ascites</li>
                            <li>morbidly obese patients</li>
                        </ul>
                    </li>
                    <li>In low body weight patients or patients with an eGFR &lt; 60mL/min it is important to calculate CrCl using the cockcroft gault formula.</li>
                    <li>This calculator is not for use in critically ill patients with severe sepsis, who may require a dose of up to 7mg/kg (IDBW if obese or actual body weight if not obese)</li>
                    <li>This calculator is not for use paediatric patients &lt; 12 years old</li>
                </ul>
            </div>
            <!--/gentamicin dose calculator body content-->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose5 -->
        
        <!-- Start of dose6 page: #dose6 -->
        <div data-role="page" id="dose6" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Adult Vancomycin Loading Dose Calculator</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">
                <!--Vancomycin dose calculator body content-->
                <script>
                    var calcvdose = function () {
                        var vheight = parseInt($('#vheight').val());
                        var vweight = parseFloat($('#vweight').val());
                        var vcreat = parseInt($('#vcreat').val());
                        var vload = 0;
                        var vdose1 = 0;
                        var vage = parseInt($('#vage').val());
                        var vcrcl = 0;
                        var extracm = (parseInt($('#vheight').val()) - 152);
                        var vangen = 0;

                        if (parseInt($('#vgenderweight').val()) > 47) {
                            vangen = 1} else if (parseInt($('#vgenderweight').val()) < 47) {
                            vangen = 0.85}

                        if (parseInt($('#vweight').val()) < (parseInt($('#vgenderweight').val()) + (0.9 * extracm))) {
                            idbw = parseFloat($('#vweight').val());} else if (vheight > 152) {
                            idbw = (parseFloat($('#vgenderweight').val()) + (0.9 * extracm))} else if (vheight <= 152) {
                            idbw = parseFloat($('#vgenderweight').val())}

                        vcrcl = ((((140 - vage) * idbw) / (0.815 * vcreat)) * vangen) * (parseInt($('#vframe').val()) / 10)

                        if (vcrcl < 20 && vweight >= 40 && vweight <= 110) {
                            $('#vinterval').text("48 hourly, take trough level before the first dose")} else if (vcrcl >= 20 && vcrcl <= 60 && vweight >= 40 && vweight <= 110) {
                            $('#vinterval').text("24 hourly, take trough level before the third dose")} else if (vcrcl >= 60 && vweight >= 40 && vweight <= 110) {
                            $('#vinterval').text("12 hourly, take trough level before the fourth dose")
                        }

                        if (vweight < 40) {
                            $('#vdose').text("Please contact infectious diseases for dosing in underweight patients")
                        } else if ((vweight >= 40) && (vweight <= 49)) {
                            $('#vdose').text("750")
                        } else if ((vweight >= 50) && (vweight <= 64)) {
                            $('#vdose').text("1000")
                        } else if ((vweight >= 65) && (vweight <= 79)) {
                            $('#vdose').text("1250")
                        } else if ((vweight >= 80) && (vweight <= 94)) {
                            $('#vdose').text("1500")
                        } else if ((vweight >= 95) && (vweight <= 110)) {
                            $('#vdose').text("1750")
                        } else if (vweight < 40) {
                            $('#vdose').text("Please contact infectious diseases for dosing in obese patients")
                        }

                        if ((vweight >= 40) && (vweight < 50)) {

                            vload = 1250
                        } else if ((vweight >= 50) && (vweight < 60)) {

                            vload = 1500
                        } else if ((vweight >= 60) && (vweight < 69)) {

                            vload = 1750
                        } else if ((vweight >= 69) && (vweight < 78)) {

                            vload = 2000
                        } else if ((vweight >= 78) && (vweight < 87)) {

                            vload = 2250
                        } else if ((vweight >= 87) && (vweight < 96)) {

                            vload = 2500
                        } else if ((vweight >= 96) && (vweight <= 105)) {

                            vload = 2750
                        } else if (vweight > 105) {

                            alert("Please contact infectious diseases for advice for patients weighing over 105Kg")
                        }

                        $('#vload').text(vload);

                    }
                </script>

                <form onsubmit="return false">
                    <h4 class="color-primary mrgn20b">Enter the patient details to calculate the vancomycin maintenance and loading dose:</h4>
                    <div class="form-group">
                        <label for="vgenderweight"><b>Gender:</b></label>
                        <select name="vgenderweight" id="vgenderweight" class="form-control">
                            <option value="50.0">Male</option>
                            <option value="45.5">Female</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="vframe"><b>Body type:</b></label>
                        <select name="vframe" id="vframe" class="form-control">
                            <option value="10">Normal frame</option>
                            <option value="11">Heavy frame</option>
                            <option value="9">Light Frame</option>
                        </select>
                    </div>
                    <div class="form-group"><label for="vheight"><b>Height (cm):</b></label><input type="number" min="70" step="0.1" id="vheight" name="vheight" class="form-control"></div>
                    <div class="form-group"><label for="vweight"><b>Actual weight (kg):</b></label><input type="number" min="40" step="0.01" id="vweight" name="vweight" class="form-control"></div>
                    <div class="form-group"><label for="vage"><b>Age (years):</b></label><input type="number" min="12" id="vage" name="vage" class="form-control"></div>
                    <div class="form-group"><label for="vcreat"><b>Creatinine:</b></label><input type="number" min="20" id="vcreat" name="vcreat" class="form-control"></div>
                    <p align ="left">vancomycin loading dose (optional):<strong><span id="vload">0</span></strong>  <b>mg</b></p>
                    <p align ="left">vancomycin maintenance dose:<strong><span id="vdose">0</span> mg, </strong> <span id="vinterval">-</span></p>
                    <br>
                    <button onclick ="calcvdose();" class="btn btn-primary">Calculate</button>
                </form>
                <hr/>
                <div class="alert alert-danger">Please note this calculator is for testing purposes only, please confirm any dose recommendations with a second source before prescribing treatment</div>
                <ul class="line30">
                    <li>
                        This calculator must not be used on large muscular patients, it assumes that all weights above IDBW are due to fatty tissue, large muscular patients are likely to be underdosed when using this calculator, please contact IFD for advice with these patients
                    </li>
                    <li>
                        This calculator is for use as a guide only. The following patient groups may have altered pharmacokinetics and modified doses may be required. Please contact infectious diseases for advice with the following:
                        <ul class="line30">
                            <li>critically ill patients with severe sepsis or septic shock</li>
                            <li>patients receiving renal replacement therapy</li>
                            <li>pregnant women</li>
                            <li>patients with ascites or fluid overload</li>
                            <li>morbidly obese or very low body weight patients</li>
                        </ul>
                    </li>
                    <li>This calculator must not be used on large muscular patients, it assumes that all weights above IDBW are due to fatty tissue, large muscular patients are likely to be underdosed when using this calculator, please contact IFD for advice with these patients</li>
                    <li>This calculator is not for use in critically ill patients with severe sepsis, who may require higher doses</li>
                    <li>This calculator is not for use paediatric patients &lt; 12 years old</li>
                    <li>A loading dose of vancomycin may be considered to help achieve a therapeutic concentration more quickly, particularly in patients with serious infections who are critically ill. However, there are no strong clinical data to show that this approach improves outcomes.</p>
                    <li>This calculator aims for a load of 25 to 30 mg/kg (actual body weight)</li>
                </ul>
            </div>
            <!--/vanc load body content-->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose6 -->
        
        <!-- Start of dose7 page: #dose7 -->
        <div data-role="page" id="dose7" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Adult Creatinine Clearance Calculator</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <!--Vancomycin dose calculator body content-->
                <h4 class="color-primary mrgn20b">Cockcroft Gault Creatinine Clearance Calculator for &gt;12 years only:</h4>
                <script>
                    var calccrcl = function () {
                        var cheight = parseInt($('#cheight').val());
                        var cweight = parseFloat($('#cweight').val());
                        var ccreat = parseInt($('#ccreat').val());
                        var cage = parseInt($('#cage').val());
                        var ccrcl = 0;
                        var cextracm = (parseInt($('#cheight').val()) - 152);
                        var cangen = 0;

                        if (parseInt($('#cgenderweight').val()) > 47) {
                            cangen = 1} else if (parseInt($('#cgenderweight').val()) < 47) {
                            cangen = 0.85}

                        if (parseInt($('#cweight').val()) < (parseInt($('#cgenderweight').val()) + (0.9 * cextracm))) {
                            idbw = parseFloat($('#cweight').val());} else if (cheight > 152) {
                            idbw = (parseFloat($('#cgenderweight').val()) + (0.9 * cextracm))} else if (cheight <= 152) {
                            idbw = parseFloat($('#cgenderweight').val())}

                        if (cage < 12) {
                            ccrcl = 0} else if (cage > 12) {
                            ccrcl = Math.round(((((140 - cage) * idbw) / (0.815 * ccreat)) * cangen) * (parseInt($('#cframe').val()) / 10))
                        }

                        if (cage < 12) {
                            alert("Please use the modified Schwartz equation to calculate a dose for paediatric patients. Do not use this calculator")
                        }

                        $('#ccrcl').text(ccrcl);

                    }

                </script>
                <hr/>
                <form onsubmit="return false">
                    <h4 class="mrgn20b color-success">Enter the patient details to calculate the creatinine clearance:</h4>
                    <div class="form-group">
                        <label for="cgenderweight"><b>Gender:</b></label>
                        <select name="cgenderweight" id="cgenderweight" class="form-control">
                            <option value="50.0">Male</option>
                            <option value="45.5">Female</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="cframe"><b>Body type:</b></label>
                        <select name="cframe" id="cframe" class="form-control">
                            <option value="10">Normal frame</option>
                            <option value="11">Heavy frame</option>
                            <option value="9">Light Frame</option>
                        </select>
                    </div>
                    <div class="form-group"><label for="cheight"><b>Height (cm):</b></label><input type="number" min="70" step="0.1" id="cheight" name="cheight" class="form-control"></div>
                    <div class="form-group"><label for="cweight"><b>Actual weight (kg):</b></label><input type="number" min="40" step="0.01" id="cweight" name="cweight" class="form-control"></div>
                    <div class="form-group"><label for="cage"><b>Age (years):</b></label><input type="number" min="12" id="cage" name="cage" class="form-control"></div>
                    <div class="form-group"><label for="ccreat"><b>Creatinine:</b></label><input type="number" min="20" id="ccreat" name="ccreat" class="form-control"></div>
                    <p align ="left">Creatinine Clearance:<strong><span id="ccrcl">0</span></strong>  <b>mL/min</b></p>
                    <br>
                    <button onclick ="calccrcl();" class="btn btn-primary">Calculate</button>
                </form>
                <hr/>
                <div class="alert alert-danger">Please note this calculator is for testing purposes only, please confirm any dose recommendations with a second source before prescribing treatment</div>
                <ul class="line30">
                    <li>
                        This calculator is for use as a guide only. The following patient groups may have altered pharmacokinetics and modified doses may be required. Please contact infectious diseases for advice with the following:
                        <ul class="line30">
                            <li>critically ill patients with severe sepsis or septic shock</li>
                            <li>patients receiving renal replacement therapy</li>
                            <li>pregnant women</li>
                            <li>patients with ascites or fluid overload</li>
                            <li>morbidly obese or very low body weight patients</li>
                        </ul>
                    </li>                    
                    <li>This calculator is not for use in critically ill patients with severe sepsis, who may require higher doses</li>
                    <li>This calculator is not for use paediatric patients &lt; 12 years old</li>
                    <li>A loading dose of vancomycin may be considered to help achieve a therapeutic concentration more quickly, particularly in patients with serious infections who are critically ill. However, there are no strong clinical data to show that this approach improves outcomes.</li>
                    <li>This calculator aims for a load of 25 to 30 mg/kg (actual body weight)</li>
                </ul>
            </div>
            <!--/vanc load body content-->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /dose7 -->
        
        <!-- START of febne Febrile neutropenia treatment maze -->
        <!-- Start of febne page: penicillin Q? #febne -->
        <div data-role="page" id="febne" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15">(See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne3">No penicillin allergy</a></li> 
                    <li><a href="#febne1">Minor penicillin allergy</a></li>
                    <li><a href="#febne2">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne -->
        
        <!-- Start of febne page pen mild: ?age #febne1 -->
        <div data-role="page" id="febne1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Is the patient an adult or child?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1a">Adult patient</a></li>
                    <li><a href="#febne1b">Paediatric patient</a></li>     
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1 -->
        
        <!-- Start of febne page pen BAD: ?age #febne2 -->
        <div data-role="page" id="febne2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Is the patient an adult or child?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne2a">Adult patient</a></li>
                    <li><a href="#febne2b">Paediatric patient</a></li>     
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne2 -->
        
        <!-- Start of febne page pen OK: ?age #febne3 -->
        <div data-role="page" id="febne3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Is the patient an adult or child?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne3a">Adult patient</a></li>
                    <li><a href="#febne3b">Paediatric patient</a></li>     
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3 -->
        
        <!-- Start of febne page pen mild, adult: ?sepsis #febne1a -->
        <div data-role="page" id="febne1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Does the patient have severe sepsis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1a1">Yes</a></li>
                    <li><a href="#febne1a2">No</a></li>     
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>Any patient with a systolic blood pressure &lt;90 or heart rate &gt; 110 BPM despite having adequate fluid resuscitation should be regarded as having severe sepsis</li>
                    <li>Any patient which has been accepted for admission into ICU or HDU should be treated as having severe sepsis</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1a -->
        
        <!-- Start of febne page pen BAD, adult: ?sepsis #febne2a -->
        <div data-role="page" id="febne2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn30b">Does the patient have severe sepsis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne2a1">Yes</a></li>
                    <li><a href="#febne2a2">No</a></li>     
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>Any patient with a systolic blood pressure &lt;90 or heart rate &gt; 110 BPM despite having adequate fluid resuscitation should be regarded as having severe sepsis</li>
                    <li>Any patient which has been accepted for admission into ICU or HDU should be treated as having severe sepsis</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne2a -->
        
        <!-- Start of febne page pen OK, adult: ?sepsis #febne3a -->
        <div data-role="page" id="febne3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Does the patient have severe sepsis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne3a1">Yes</a></li>
                    <li><a href="#febne3a2">No</a></li>     
                </ul>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Any patient with a systolic blood pressure &lt;90 or heart rate &gt; 110 BPM despite having adequate fluid resuscitation should be regarded as having severe sepsis</li>
                    <li>Any patient which has been accepted for admission into ICU or HDU should be treated as having severe sepsis</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3a -->
        
        <!-- Start of febne page pen OK, adult: ?sepsis #febne3a2 -->
        <div data-role="page" id="febne3a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for MRSA?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne3a2a">Yes</a></li>
                    <li><a href="#febne3a2b">No</a></li>     
                </ul>
                <hr>
                <ul type=circle><li>Risk factors include; central or PICC line inflammation, known MRSA colonisation, severe mucositis, haemodynamic compromise BP&lt;90 or HR&gt;110, residence at a gaol or detention centre, or previous ciprofloxacin prophylaxis)</li></ul>
            </div>
            <!-- /conent -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3a2 -->
        
        <!-- Start of febne page pen MILD, kid: ?sepsis #febne1b -->
        <div data-role="page" id="febne1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Does the patient have severe sepsis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1b1">Yes</a></li>
                    <li><a href="#febne1a2">No</a></li>     
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Any patient with a systolic blood pressure &lt;90 or heart rate &gt; 110 BPM despite having adequate fluid resuscitation should be regarded as having severe sepsis</li>
                    <li>Any patient which has been accepted for admission into ICU or HDU should be treated as having severe sepsis</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1b -->
        
        <!-- Start of febne page pen BAD, kid: ?sepsis #febne2b -->
        <div data-role="page" id="febne2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Does the patient have severe sepsis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne2a1">Yes</a></li>
                    <li><a href="#febne2b2">No</a></li>     
                </ul>
                <hr/>
                <ul class="line30" type="circle">
                    <li>Any patient with a systolic blood pressure &lt;90 or heart rate &gt; 110 BPM despite having adequate fluid resuscitation should be regarded as having severe sepsis</li>
                    <li>Any patient which has been accepted for admission into ICU or HDU should be treated as having severe sepsis</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne2b -->
        
        <!-- Start of febne page pen OK, kid: ?sepsis #febne3b -->
        <div data-role="page" id="febne3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Does the patient have severe sepsis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne3b1">Yes</a></li>
                    <li><a href="#febne3b2">No</a></li>     
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Any patient with a systolic blood pressure &lt;90 or heart rate &gt; 110 BPM despite having adequate fluid resuscitation should be regarded as having severe sepsis</li>
                    <li>Any patient which has been accepted for admission into ICU or HDU should be treated as having severe sepsis</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3b -->
        
        <!-- Start of febne page pen MIL, ADULT, septic: ?wet #febne1a1 -->
        <div data-role="page" id="febne1a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">Is the patient being treated during the wet or dry season?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1a1a">Wet season</a></li>
                    <li><a href="#febne1a1b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on management of severe sepsis in a patient with febrile neutropenia see the IFD - febrile neutropenia initial management guideline on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1a1-->
        
        <!-- Start of febne page pen OK, ADULT, septic: ?wet #febne3a1 -->
        <div data-role="page" id="febne3a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Is the patient being treated during the wet or dry season?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1a1a">Wet season</a></li>
                    <li><a href="#febne3a1b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on management of severe sepsis in a patient with febrile neutropenia see the IFD - febrile neutropenia initial management guideline on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3a1-->
        
        <!-- Start of febne page pen MILD, KID, septic: ?wet #febne1b1 -->
        <div data-role="page" id="febne1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Is the patient being treated during the wet or dry season?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1a1a">Wet season</a></li>
                    <li><a href="#febne1b1b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on management of severe sepsis in a patient with febrile neutropenia see the IFD - febrile neutropenia initial management guideline on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1b1-->
        
        <!-- Start of febne page pen OK, KID, septic: ?wet #febne3b1 -->
        <div data-role="page" id="febne3b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Febrile Neutropenia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Is the patient being treated during the wet or dry season?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#febne1a1a">Wet season</a></li>
                    <li><a href="#febne3b1b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on management of severe sepsis in a patient with febrile neutropenia see the IFD - febrile neutropenia initial management guideline on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3b1-->
        
        <!-- Start of febne page pen MILD, ADULT, septic, wet #febne1a1a -->
        <div data-role="page" id="febne1a1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">If patient has a mild penicillin allergy use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Meropenem 1g (child 20mg/Kg to a maximum of 1g) IV, </span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for meropenem and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1a1a -->
        
        <!-- Start of febne page pen MILD, ADULT, septic, DRY #febne1a1b -->
        <div data-role="page" id="febne1a1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If patient has a mild penicillin allergy use:</h3>
                <h4 class="color-primary mrgn20b">A vancomycin loading dose of 25mg/Kg IV</h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftazidime 2g IV, </span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and ceftazidime is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                        </tbody>
                    </table>
                </div>
                <ol class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1a1b -->
        
        <!-- Start of febne page pen MILD, ADULT/CHILD, not septic #febne1a2 -->
        <div data-role="page" id="febne1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">If patient has a mild penicillin allergy give:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftazidime 2g (child 50mg/Kg up to 2g) IV, </span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if an abdomino-peritoneal infection is suspected <b>ADD</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg (child 12.5mg/Kg up to 500mg) IV, </span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ceftazidime and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td>Neonates less than 34 weeks postconceptional age</td>
                            <td>25mg/kg 24 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>Neonates 34 to 44 weeks postconceptional age</td>
                            <td>25mg/kg 12 hourly</td>
                            <td>Before the fourth dose</td>       
                        </tr>
                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                        </tbody>
                    </table>
                </div>
                <ol class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type=circle class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1a2 -->
        
        
        
        <!-- Start of febne page pen MILD, KID, septic, DRY #febne1b1b -->
        <div data-role="page" id="febne1b1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If patient has a mild penicillin allergy use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftazidime 50mg/Kg up to 2g IV, </span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and ceftazidime is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h2 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h2>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                </ul>
                <hr/>
                <h2 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h2>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td>Neonates less than 34 weeks postconceptional age</td>
                            <td>25mg/kg 24 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>Neonates 34 to 44 weeks postconceptional age</td>
                            <td>25mg/kg 12 hourly</td>
                            <td>Before the fourth dose</td>       
                        </tr>
                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call about the patient</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne1b1b -->
        
        <!-- Start of febne page pen BAD, ADULT, septic #febne2a1 -->
        <div data-role="page" id="febne2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">If patient has a severe penicillin allergy use meropenem very cautiously. Please ensure patient is in a critical care area before administering:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Meropenem 1g (child 20mg/Kg to a maximum of 1g) IV, </span>
                    <span class="font15"> 8 hourly given cautiously in a critical care area to monitor for reaction</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for meropenem and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                        </tbody>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne2a1 -->
        
        <!-- Start of febne page pen BAD, ADULT, not septic #febne2a2 -->
        <div data-role="page" id="febne2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->


            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">If patient has a severe penicillin allergy give:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 400mg IV, </span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if an abdomino-peritoneal infection is suspected <b>ADD</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg (child 12.5mg/Kg up to 500mg) IV, </span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the haematologist on call about patient admission</li></ul>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne2a2 -->
        
        <!-- Start of febne page pen BAD, CHILD, not septic #febne2b2 -->
        <div data-role="page" id="febne2b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If patient has a severe penicillin allergy but is not showing signs of sepsis:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">A decision must be made on whether the patient should be initiated on a carbapenem or cephalosporin depening on severity of previous penicillin reaction and current clinical state</p>
                <hr/>
                <ul class="line30">
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne2b2 -->
        
        <!-- Start of febne page pen OK, ADULT, septic, DRY #febne3a1b -->
        <div data-role="page" id="febne3a1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">If patient has no penicillin allergy use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin/tazobactam 4/0.5g IV, </span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and piperacillin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>  
                <h2 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h2>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                </ul>  
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3a1b -->
        
        <!-- Start of febne page pen OK, KID, septic, DRY #febne3b1b -->
        <div data-role="page" id="febne3b1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If patient has no penicillin allergy use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin/tazobactam 100mg/Kg (dosed on piperacillin component only) up to 4g IV, </span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and ceftazidime is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>

                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>

                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>

                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>    
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td>Neonates less than 34 weeks postconceptional age</td>
                            <td>25mg/kg 24 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>Neonates 34 to 44 weeks postconceptional age</td>
                            <td>25mg/kg 12 hourly</td>
                            <td>Before the fourth dose</td>       
                        </tr>
                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the ICU consultant and haematologist on call about the patient</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3b1b -->
        
        <!-- Start of febne page pen OK, ADULT/CHILD, not septic, MRSA YES #febne3a2a -->
        <div data-role="page" id="febne3a2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If patient has no penicillin allergy give:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin 4/0.5g (child 100mg/Kg up to 4g dosed on piperacillin component only) IV, </span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>In the abscence of resistant organisms on blood culture vancomycin may be ceased after 48-72 hours</li>
                    <li>Please notify the haematologist on call of patient admission</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3a2a -->
        
        <!-- Start of febne page pen OK, ADULT/CHILD, not septic, NO MRSA #febne3a2b -->
        <div data-role="page" id="febne3a2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Febrile neutropenia treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If patient has no penicillin allergy give:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin 4/0.5g (child 100mg/Kg up to 4g dosed on piperacillin component only) IV, </span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>feb</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>THREE</b> days only. IFD must be contacted once treatment is to continue past 72 hours
                </div>
                <hr/>
                <ul class="line30">
                    <li>Please notify the haematologist on call of patient admission</li>
                    <li>The median time to defervescence in patients with febrile neutropenia treated with frontline antibiotics is 3-5 days and thus escalation of antibiotic coverage should not occur prior to this period in the absence of clinical instability, isolation of a resistant organism or emergence of new infective foci</li>
                    <li>In the absence of clinical evidence of viral or fungal infection, empiric frontline coverage for these pathogens is not required. Some haematology patients on high dose or T cell suppressing chemotherapy will be on prophylactic Posaconazole and/ or Bactrim and that should be continued during the management of febrile neutropenia</li>
                    <li>If the patient has persistent fever of unknown origin for 96 hours or recurrent fevers after an afebrile period 48 hours despite broad spectrum antibacterial therapy then investigation and potential treatment for fungal therapy should be considered and the Infectious Diseases unit consulted.</li>
                    <li>If the patient becomes afebrile within 3-5 days of parenteral antibiotic therapy, and no causative organism is isolated it is preferable to stop antibiotic treatment when the neutrophil count recovers to at least 0.5 x 10<sup>9</sup> cells/L.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /febne3a2b -->
        <!-- END of febne febrile neutropenia treatment maze -->
        
        <!-- START of INTRA ABDOMINAL treatment maze -->
        <!-- Start of intrab. ?Type: #intrab -->
        <div data-role="page" id="intrab" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Intra-abdominal Infection</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn20b">What type of infection is suspected/confirmed?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1">Appendicitis</a></li>
                    <li><a href="#intrab2">Cholecystitis</a></li>    
                    <li><a href="#intrab3">Diverticulitis</a></li>      
                    <li><a href="#intrab4">Pancreatitis</a></li>
                    <li><a href="#intrab5">Peritonitis</a></li>    
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1 -->
        
        <!-- Start of intrab1. ?penicillin: #intrab1-->
        <div data-role="page" id="intrab1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font-"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1c">No penicillin allergy</a></li> 
                    <li><a href="#intrab1a">Minor penicillin allergy</a></li>
                    <li><a href="#intrab1b">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab -->
        
        <!-- Start of intrab. Pen MILD, Appendix ? surgery: #intrab1a -->
        <div data-role="page" id="intrab1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Has an appendicectomy been performed?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1a1">Yes</a></li>
                    <li><a href="#intrab1a2">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1a -->
        
        <!-- Start of intrab. Pen MILD, Appendix surg YES: #intrab1a1 -->
        <div data-role="page" id="intrab1a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Was the appendix ruptured or was there an appendiceal abscess?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1a1a">Yes</a></li>
                    <li><a href="#intrab1a1b">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1a1 -->
        
        <!-- Start of intrab. Pen MILD, Appendix, surgery NO: #intrab1a2 -->
        <div data-role="page" id="intrab1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empirical appendicitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient has a mild penicillin allergy cover with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> daily until surgery</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV, </span>
                    <span class="font15"> every 12 hours until surgery</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then consider step down to oral after initial improvement:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15">12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> every 12 hours to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving</li>
                    <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post appendicectomy</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1a -->
        
        <!-- Start of intrab. Pen MILD, Appendix, surgery YES, Rupture YES: #intrab1a1a-->
        <div data-role="page" id="intrab1a1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Appendicitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient has a mild penicillin allergy and the appendix was ruptured or had an appendiceal abscess treat with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> daily until patients clinical condition improves</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV, </span>
                    <span class="font15"> every 12 hours until patients clinical condition improves</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> every 12 hours to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving. Please see the switch to oral guideline on the PGC for information on how to identify when to switch to oral</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1a1a -->
        <!-- Start of intrab. Pen MILD, Appendix, surgery YES, Rupture NO: #intrab1a1a-->
        <div data-role="page" id="intrab1a1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Appendicitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the appendix was not perforated and no appendiceal abscess was uncovered:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">No further antibiotic therapy should be necessary</span>
                    <span class="font15"></span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1a1a -->
        
        <!----------- PEN BAD -------->
        <!-- Start of intrab. Pen BAD, Appendix ? surgery: #intrab1b -->
        <div data-role="page" id="intrab1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Has an appendicectomy been performed?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1b1">Yes</a></li>
                    <li><a href="#intrab1b2">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b -->
        
        <!-- Start of intrab. Pen BAD, Appendix surg YES: #intrab1b1 -->
        <div data-role="page" id="intrab1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Was the appendix ruptured or was there an appendiceal abscess?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1b1a">Yes</a></li>
                    <li><a href="#intrab1a1b">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b1 -->
        
        <!-- Start of intrab. Pen BAD, Appendix surg YES ?GENT: #intrab1b1a -->
        <div data-role="page" id="intrab1b1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15">(See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1b2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab1b1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b1a -->
        
        <!-- Start of intrab. Pen BAD, Appendix surg YES ?GENT: #intrab1b1a -->
        <div data-role="page" id="intrab1b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid"> 
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15">(See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1b2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab1b2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>    
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b2 -->
        
        <!-- Start of intrab. Pen BAD, Appendix, surgery NO, Gent OK: #intrab1b2b -->
        <div data-role="page" id="intrab1b2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empirical appendicitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient has a severe penicillin allergy cover with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600 mg (child: 15 mg/kg up to 600 mg) IV, </span>
                    <span class="font15"> every 8 hours until surgery</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then consider a step down to oral after initial improvement:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> every 12 hours to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>

                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (Age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving</li>
                    <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post appendicectomy</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
                
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b -->
        
        
        <!-- Start of intrab. Pen BAD, Appendix, surgery YES, Rupture YES, GENT OK: #intrab1b1a-->
        <div data-role="page" id="intrab1b1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Appendicitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient has a severe penicillin allergy and the appendix was ruptured or had an appendiceal abscess treat with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600 mg (child: 15 mg/kg up to 600 mg) IV, </span>
                    <span class="font15"> every 8 hours until patients clinical condition improves</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> every 12 hours to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Please note clindamycin has excellent oral bioavailability (90% orally bioavailable), consider an early switch to oral therapy once patients clinical condition has improved</li>
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving. Please see the switch to oral guideline on the PGC for information on how to identify when to switch to oral</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b1a2 -->
        
        <!-- Start of intrab. Pen BAD, Appendix, surgery YES, Rupture NO: #intrab1b2a-->
        <div data-role="page" id="intrab1b2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Appendicitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid"> 
                <h3 class="color-primary mrgn20b">If the patient has a contraindication to gentamicin and a severe penicillin allergy:</h3>
                <h4 class="color-primary mrgn20b">Please contact IFD for advice</h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1b2a -->
        
        <!---- Intrab Pen OK treatment --->
        <!-- Start of intrab. Pen OK, Appendix ? surgery: #intrab1c -->
        <div data-role="page" id="intrab1c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->            
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Has an appendicectomy been performed?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1c1">Yes</a></li>
                    <li><a href="#intrab1c2">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c -->
        
        <!-- Start of intrab. Pen OK, Appendix surg YES: #intrab1c1 -->
        <div data-role="page" id="intrab1c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Was the appendix ruptured or was there an appendiceal abscess?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1c1a">Yes</a></li>
                    <li><a href="#intrab1a1b">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c1 -->
        
        <!-- Start of intrab. Pen OK, Appendix surg YES ?GENT: #intrab1c1a -->
        <div data-role="page" id="intrab1c1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15">(See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1c1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab1c1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c1a -->
        
        <!-- Start of intrab. Pen OK, Appendix surg YES ?GENT: #intrab1c2 -->
        <div data-role="page" id="intrab1c2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Appendicitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15">(See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab1c2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab1c2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c2 -->
        
        <!-- Start of intrab. Pen OK, Appendix, surgery NO, Gent OK: #intrab1c2b -->
        <div data-role="page" id="intrab1c2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empirical appendicitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient tolerates penicillin cover with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> every 6 hours until surgery</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> every 12 hours until surgery</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then consider step down to oral after initial improvement:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/> 
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (Age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving</li>
                    <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post appendicectomy</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c -->
        
        <!-- Start of intrab. Pen OK, Appendix, surgery YES, Rupture YES, GENT BAD: #intrab1c1a-->
        <div data-role="page" id="intrab1c1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Appendicitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient tolerates penicillin but not gentamicin and the appendix was ruptured or had an appendiceal abscess treat with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>
                    <span class="font15"> 8 hourly until clinical condition improves</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving. Please see the switch to oral guideline on the PGC for information on how to identify when to switch to oral</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c1a1 -->
        
        <!-- Start of intrab. Pen OK, Appendix, surgery YES, Rupture NO: #intrab1c2a-->
        <div data-role="page" id="intrab1c2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Appendicitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient has a contraindication to gentamicin and a severe penicillin allergy:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c2a -->
        
        <!-- Start of intrab. Pen OK, Appendix, surgery NO: #intrab1c2a -->
        <div data-role="page" id="intrab1c2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empirical appendicitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient tolerates penicillin but not gentamicin cover with:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>
                    <span class="font15"> 8 hourly until surgery</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then consider step down to oral after initial improvement:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving</li>
                    <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post appendicectomy</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c2a -->
        
        <!-- Start of intrab. Pen OK, Appendix, surgery YES, Gent OK: #intrab1c1a2 -->
        <div data-role="page" id="intrab1c1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empirical appendicitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">If the patient tolerates penicillin and gentamicin give:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> every 6 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> every 12 hours until clinical condition improves</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves switch to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment post appendicectomy</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is improving. Please see the switch to oral guideline on the PGC for information on how to identify when to switch to oral</li>
                    <li>If the appendix was perforated or an appendiceal abscess was uncovered then total treatment duration (IV and oral) should usually only continue for 7 days</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab1c1a2 -->
        
        <!--Start of cholecystitis-->
        <!-- Start of intrab2. ?penicillin: #intrab2-->
        <div data-role="page" id="intrab2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2c">No penicillin allergy</a></li>
                    <li><a href="#intrab2a">Minor penicillin allergy</a></li>
                    <li><a href="#intrab2b">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2 -->
        
        <!-- Start of intrab. Pen MILD, cholecystectomy ? surgery: #intrab2a -->
        <div data-role="page" id="intrab2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Has a cholecystectomy been performed?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2a1">Yes</a></li>
                    <li><a href="#intrab2a2a">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2a -->
        
        <!-- Start of intrab. Pen MILD, cholecystectomy, surgery NO, Gent NO: #intrab2a2a -->
        <div data-role="page" id="intrab2a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical cholecystitis treatment intolerant of gentamicin or penicillin:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has a mild penicillin allergy or does not tolerate gentamicin treat empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> daily until surgery or until clinical improvement then switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> 8 hourly, until surgery or until clinical improvement then switch to oral</span>
                </h4>
                <p class="mrgn20b">Once the patient's condition has improved,</b> change to:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, </span>
                    <span class="font15"> 12 hourly until surgery or for a maximum of 7 days total treatment (IV and oral)</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for cefotaxime is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Antibiotic therapy should be stopped within 24 hours of cholecystectomy as the source of the infection has been removed</li>
                    <li>If surgery is not performed the total treatment duration should not exceed 7 days (IV + oral).</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                    <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by anaerobic bacteria.</li>
                    <li>Please see the switch to oral guideline on the PGC for information on how to identify when to switch to oral</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2a2a -->
        
        <!-- Start of intrab. Pen MILD, cholecystectomy, surgery YES: #intrab2a1-->
        <div data-role="page" id="intrab2a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>cholecystitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Treatment post cholecystectomy should normally be ceased within 24 hours. If a further dose of surgical prophylaxis is deemed necessary give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>If surgery is not performed the total treatment duration should not exceed 7 days (IV + oral).</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                    <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by anaerobic bacteria.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2a1a -->
        
        <!----------- PEN BAD -------->
        <!-- Start of intrab. Pen BAD, cholecystectomy ? surgery: #intrab2b -->
        <div data-role="page" id="intrab2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystisis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Has a cholecystectomy been performed?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2b2a">Yes</a></li>
                    <li><a href="#intrab2b2">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2b -->
        
        <!-- Start of intrab. Pen BAD, cholecystectomy surg YES ?GENT: #intrab2b1 -->
        <div data-role="page" id="intrab2b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2b1a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab2b1b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2b1 -->
        
        <!-- Start of intrab. Pen BAD, cholecystectomy surg NO ?GENT: #intrab2b2 -->
        <div data-role="page" id="intrab2b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2b2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab2b2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2b2 -->
        
        <!-- Start of intrab. Pen BAD, cholecystectomy, surgery NO, Gent OK: #intrab2b2b -->
        <div data-role="page" id="intrab2b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical cholecystitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has a severe penicillin allergy cover with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below:</span>
                </h4>
                <p class="mrgn20b"><b>Then, after clinical improvement or after 72 hours</b> consider step down to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up a maximum of 7 days total treatment or until cholecystectomy</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Antibiotic therapy should be stopped within 24 hours of cholecystectomy as the source of the infection has been removed</li>
                    <li>If surgery is not performed the total treatment duration should not exceed 7 days (IV + oral).</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                    <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by anaerobic bacteria.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2b -->
        
        <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, GENT OK: #intrab2b1a-->
        <div data-role="page" id="intrab2b1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>cholecystitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Following cholecystectomy antibiotic treatment should cease within 24 hours as the source of the infection has been removed. If a further dose of surgical prophylaxis is deemed necessary give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> as a single dose as the per nomogram below</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>                
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                    <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by anaerobic bacteria.</li>
                </ul>                
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2b1a2 -->
        
        <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, Rupture NO: #intrab2b2a-->
        <div data-role="page" id="intrab2b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical cholecystitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has a contraindication to gentamicin and a severe penicillin allergy:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Please note, following cholecystectomy antibiotic treatment should cease within 24 hours as the source of the infection has been removed.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2b2a -->
        
        <!----- Start of Intrab 3b pen OK treatment ---->
        <!-- Start of intrab. Pen OK, Cholecystecomy ? surgery: #intrab2c -->
        <div data-role="page" id="intrab2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecysitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">Has a cholecystectomy been performed?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2c1a">Yes</a></li>
                    <li><a href="#intrab2c2">No</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2c -->
        
        <!-- Start of intrab. Pen MILD, Chole surg NO ?GENT: #intrab2c2 -->
        <div data-role="page" id="intrab2c2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab2c2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab2c2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2c2 -->
        
        <!-- Start of intrab. Pen OK, cholec surgery YES, GENT BAD: #intrab2c1a-->
        <div data-role="page" id="intrab2c1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Cholecystitis treatment post surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
               <h3 class="mrgn20b">
                    <span class="color-primary">If the patient tolerates penicillin but not gentamicin and a cholecystectomy has been performed:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ongoing antibiotic treatment should be continued for a maximum of 24 hours only:</span>
                    <span class="font15"></span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>
                    <span class="font15"> 8 hourly for 24 hours</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1g IV (child: 50 mg/kg up to 1g) IV, </span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient is tolerating orals:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly for 24 hours</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>ONE</b> day only. IFD must be contacted if IV treatment is to continue past 24 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Following successful surgery antibiotic therapy can normally be ceased within 24 hours </li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                    <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by anaerobic bacteria.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2c1a -->
        
        <!-- Start of intrab. Pen OK, chole surgery NO, Gent OK: #intrab2c2b -->
        <div data-role="page" id="intrab2c2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical cholecystitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient tolerates penicillin cover with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> every 6 hours until surgery</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical improvement switch to:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Patients with severe sepsis have higher volumes of distribution and therefore require a higher mg/kg dose</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Following successful cholecystectomy all antibiotic therapy should be ceased within 24 hours as the source of infection has been removed</li>
                    <li>Total treatment duration (IV + oral) should not exceed 7 days if surgery is not performed</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                    <li>If IV therapy is required beyond 72 hours, cease the gentamicin-containing regimen and use ceftriaxone, cefotaxime or piperacillin+tazobactam (see the therapeutic guidelines for details)</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2c2b -->
        
        <!-- Start of intrab. Pen OK, Cholecystecomy, surgery NO: #intrab2c2a -->
        <div data-role="page" id="intrab2c2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical cholecystitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient tolerates penicillin but not gentamicin cover with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>
                    <span class="font15"> 8 hourly until surgery or clinically improved then switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1g IV (child: 50 mg/kg up to 1g) IV, </span>
                    <span class="font15"> daily until surgery or clinically improved then switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 1g IV (child: 50 mg/kg up to 1g) IV, </span>
                    <span class="font15"> 8 hourly until surgery or clinically improved then switch to oral</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical improvement:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up a maximum of 7 days total treatment (IV and oral)</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin or cefotaxime is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Antibiotic therapy should be stopped within 24 hours of cholecystectomy as the source of the infection has been removed</li>
                    <li>If surgery is not performed the total treatment duration should not exceed 7 days (IV + oral).</li>
                    <li>When available the results of susceptibility testing should always guide treatment</li>
                    <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by anaerobic bacteria.</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab2c2a -->
        
        <!-- diverticulitis Maze Begins -->
        <!-- Start of diverticulitis page: #intrab3 -->
        <div data-role="page" id="intrab3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How would you grade the diverticulitis?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab3a">Mild</a></li>
                    <li><a href="#intrab3b">Severe</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Patients with mild abdominal pain and tenderness who do not have significant systemic signs or symptoms should be considered to have mild diverticulitis.</li>
                    <li>Patients with peritonism, or those who have signs of diverticulitis and significant systemic signs or symptoms (eg fever, elevated white cell count), should be treated as severe or complicated diverticulitis.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3 -->
        
        <!-- Start of diverticulitis MILD page ?systemic: #intrab3a -->
        <div data-role="page" id="intrab3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient showing any systemic symptoms?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab3a1">Yes</a></li>
                    <li><a href="#intrab3a2">No</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Antibiotics should only be considered for patients showing systemic symptoms such as fever or elevated white cell count, or patients who have failed to respond to conservative management (IV fluids and bowel rest)</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3a -->
        
        <!-- Start of diverticulitis MILD, no systemic symptoms: #intrab3a2 -->
        <div data-role="page" id="intrab3a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For mild diverticulitis with no systemic involvement:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Antibiotic treatment may not be required.</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Recent trials have suggested that antibiotic therapy may not be required for patients with mild abdominal pain and tenderness who do not have significant systemic signs or symptoms. If antibiotic therapy is deemed necessary then use the link below to continue to treatment:</p>
                <div data-role="content" class="container-fluid">  
                    <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                        <li><a href="#intrab3a1">Treatment</a></li>   
                    </ul>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3a2 -->
        
        <!-- Start of diverticulitis page: #intrab3b -->
        <div data-role="page" id="intrab3a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab3a1c">No penicillin allergy</a></li>
                    <li><a href="#intrab3a1a">Minor penicillin allergy</a></li>
                    <li><a href="#intrab3a1a">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Anaphylactic penicillin allergy is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b -->
        
        <!-- Start of diverticulitis: #intrab3a1a -->
        <div data-role="page" id="intrab3a1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For diverticulitis in a patient with mild penicillin allergy use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15"> 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> 12-hourly</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Total antibiotic therapy should not normally exceed 5 days treatment.</li> 
                </ul>
            </div>
            <!-- /content -->
            
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3a1a -->
        
        <!-- Start of diverticulitis: #intrab3a1c -->
        <div data-role="page" id="intrab3a1c" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For diverticulitis in a patient tolerant of penicillin use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally,</span>
                    <span class="font15"> 12-hourly</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Total antibiotic therapy should not normally exceed 5 days treatment.</li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3a1c -->
        
        <!-- Start of diverticulitis page: #intrab3b -->
        <div data-role="page" id="intrab3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab3b3">No penicillin allergy</a></li>
                    <li><a href="#intrab3b1">Minor penicillin allergy</a></li>
                    <li><a href="#intrab3b2">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Anaphylactic penicillin allergy is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b -->
        
        
        <!-- Start of diverticulitis PEN BAD, Gent Q: #intrab3b2 -->
        <div data-role="page" id="intrab3b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab3b2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab3b2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b2 -->
        
        <!-- Start of diverticulitis PEN OK, Gent Q: #intrab3b3 -->
        <div data-role="page" id="intrab3b3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab3b3a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab3b3b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b3 -->
        
        <!-- Start of diverticulitis PEN MILD, Gent BAD: #intrab3b1 -->
        <div data-role="page" id="intrab3b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">For diverticulitis in a patient with non-life threatening penicillin hypersensitivity use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1g IV, (child 1 month or older: 50 mg/kg up to 1 g)</span>
                    <span class="font15"> Daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg IV, (child 1 month or older: 7.5 mg/kg up to 500 mg)</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal infections</li> 
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment.</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b1 -->
        
        <!-- Start of diverticulitis PEN BAD, Gent OK: #intrab3b2a -->
        <div data-role="page" id="intrab3b2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">For diverticulitis in a patient with life threatening penicillin hypersensitivity intolerant of gentamicin:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal infections</li> 
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment.</li>     
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b2a -->
        
        <!-- Start of diverticulitis PEN BAD, Gent OK: #intrab3b2b -->
        <div data-role="page" id="intrab3b2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">For diverticulitis in a patient with life threatening penicillin hypersensitivity use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> dosed as per table below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600 mg (child: 15 mg/kg up to 600 mg) IV,</span>
                    <span class="font15"> 8-hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/> 
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (Age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal infections</li> 
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment.</li>     
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b2b -->
        
        <!-- Start of diverticulitis PEN OK, Gent OK: #intrab3b3b -->
        <div data-role="page" id="intrab3b3b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">For diverticulitis in a patient who can tolerate penicillin and gentamicin:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15">  6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg IV, (child 1 month or older: 12.5 mg/kg up to 500 mg)</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> dosed as per table below</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">If IV treatment is required after 72 hours change to Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 8-hourly.</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>
                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (Age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                    <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50 mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                    <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal infections</li> 
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment.</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b3b -->
        
        <!-- Start of diverticulitis PEN OK, Gent BAD: #intrab3b3a -->
        <div data-role="page" id="intrab3b3a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diverticulitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">For diverticulitis in a patient tolerant of penicillin but intolerant of gentamicin use:</h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> every 8 hours</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal infections</li> 
                    <li>Total antibiotic therapy (IV and PO) should not exceed 7 days treatment.</li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab3b3a -->
        <!-- END OF diverticulitis Maze -->
        
        <!-- Start of Pancreatitis MAZE -->
        <!-- Start of intrab4. ?severe: #intrab4-->
        <div data-role="page" id="intrab4" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pancreatitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="color-primary mrgn20b">How severe is the pancreatitis?</h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab4a">Mild or Moderate</a></li>
                    <li><a href="#intrab4b">Severe (for ICU/HDU)</a></li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Severe pancreatitis occurs in approximately 10-20&#37; of patients with pancreatitis and is characterised by development of a systemic inflammatory response in the first 7-10 days, and/or pancreatic necrosis and infection in the late phase</li>
                    <li>All patients with severe pancreatitis should be referred to ICU for assessment</li>
                    <li>Most episodes of acute pancreatitis are due to prolonged excessive alcohol consumption, are associated with gallstones (particularly bile duct stones), or are idiopathic. The recognition of persisting obstruction and acute cholangitis in patients with severe acute pancreatitis is important</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab4 -->
        
        <!-- Start of intrab4b. severe, necrosis YES: #intrab4b-->
        <div data-role="page" id="intrab4b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pancreatitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab4b3">No penicillin allergy</a></li> 
                    <li><a href="#intrab4b1">Minor penicillin allergy</a></li>
                    <li><a href="#intrab4b2">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Anaphylactic penicillin allergy is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab4b -->
        
        <!-- Start of intrab4. severe, necrosis YES, pen mild: #intrab4b1-->
        <div data-role="page" id="intrab4b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pancreatitis:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For severe infected/necrotising pancreatitis in a patient with mild penicillin allergy:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <p><b>AND</b> either</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 1 g (child: 50 mg/kg up to 1 g) IV,</span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for cefotaxime is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours
                </div>
                <hr/>
                <ul class="line30">
                    <li>Patients with severe pancreatitis can intermittently appear septic during a prolonged hospitalisation. Before giving antibiotics, every effort should be made to perform image-guided percutaneous aspiration of any pancreatic collection, with Gram stain and cultures of the aspirate</li> 
                    <li>Data to support the use of carbapenems in empirical treatment are lacking</li> 
                    <li>This is a guide for empirical therapy only. Modify therapy according to the results of cultures and susceptibility testing. Reserve carbapenems for infections caused by resistant pathogens.</li>
                    <li>Antibiotics are not indicated in the management of mild to moderate acute pancreatitis</li>
                    <li>The optimal duration for treatment with antibiotics for infective pancreatitits is uncertain. An initial treatment course of 7 days is commonly used</li>
                    <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li>
                    <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the patient is taking should be considered a possible cause</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab4b1 -->
        
        <!-- Start of intrab4. severe, necrosis YES, pen BAD: #intrab4b2-->
        <div data-role="page" id="intrab4b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pancreatitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For infected/necrotising pancreatitis in a patient with major penicillin allergy:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Patients with severe pancreatitis can intermittently appear septic during a prolonged hospitalisation. Before giving antibiotics, every effort should be made to perform image-guided percutaneous aspiration of any pancreatic collection, with Gram stain and cultures of the aspirate</li> 
                    <li>Data to support the use of carbapenems in empirical treatment are lacking</li> 
                    <li>This is a guide for empirical therapy only. Modify therapy according to the results of cultures and susceptibility testing. Reserve carbapenems for infections caused by resistant pathogens.</li>
                    <li>Antibiotics are not indicated in the management of mild to moderate acute pancreatitis</li>
                    <li>The optimal duration for treatment with antibiotics for infective pancreatitits is uncertain. An initial treatment course of 7 days is commonly used</li>
                    <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li>
                    <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the patient is taking should be considered a possible cause</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab4b2 -->
        
        <!-- Start of intrab4b3. severe, necrosis YES, pen OK: #intrab4b3-->
        <div data-role="page" id="intrab4b3" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pancreatitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For infected necrotising pancreatitis in a patient with no penicillin allergy:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <ul type=circle>
                    <li>Patients with severe pancreatitis can intermittently appear septic during a prolonged hospitalisation. Before giving antibiotics, every effort should be made to perform image-guided percutaneous aspiration of any pancreatic collection, with Gram stain and cultures of the aspirate</li> 
                    <li>Data to support the use of carbapenems in empirical treatment are lacking</li> 
                    <li>This is a guide for empirical therapy only. Modify therapy according to the results of cultures and susceptibility testing. Reserve carbapenems for infections caused by resistant pathogens.</li>
                    <li>Antibiotics are not indicated in the management of mild to moderate acute pancreatitis</li>
                    <li>The optimal duration for treatment with antibiotics for infective pancreatitits is uncertain. An initial treatment course of 7 days is commonly used</li>
                    <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li>
                    <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the patient is taking should be considered a possible cause</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab4b3 -->
        
        <!-- Start of intrab4. severe, necrosis YES, pen BAD: #intrab4a-->
        <div data-role="page" id="intrab4a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pancreatitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For mild to moderate pancreatitis:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Antibiotics are not indicated for the management of mild or moderate pancreatitis</span>
                    <span class="font15"></span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Antibiotics are only indicated if necrosis or systemic signs of infection are observed in severe cases of pancreatitis. These cases should be managed in the ICU/HDU. Gut rest, fluid administration and pain management are the mainstay of treatment for most cases of mild or moderate pancreatitis</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Severe pancreatitis occurs in approximately 10-20&#37; of patients with pancreatitis and is characterised by development of a systemic inflammatory response in the first 7-10 days, or pancreatic necrosis on imaging</li>
                    <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li> 
                    <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the patient is taking should be considered a possible cause</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab4a -->
        <!-- End of Pancreatitis Maze -->
        
        <!-- Start of Peritonitis Maze -->
        <!-- Start of peritonitis page ?type: #intrab5 -->
        <div data-role="page" id="intrab5" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">What is the cause of the peritonitis?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab5a">Perforated viscus</a></li>
                    <li><a href="#intrab5b">Spontaneous (SBP)</a></li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5 -->
        
        <!-- Start of peritonitis page, perforated, ?allergy: #intrab5a -->
        <div data-role="page" id="intrab5a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy??</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab5a3">No penicillin allergy</a></li> 
                    <li><a href="#intrab5a1">Minor penicillin allergy</a></li>
                    <li><a href="#intrab5a2">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Anaphylactic penicillin allergy is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a -->
        
        <!-- Start of peritonitis page, spontaneous, ?allergy: #intrab5b -->
        <div data-role="page" id="intrab5b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab5b3">No penicillin allergy</a></li>
                    <li><a href="#intrab5b1">Minor penicillin allergy</a></li>
                    <li><a href="#hap2b">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Anaphylactic penicillin allergy is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5b -->
        
        <!-- Start of peritonitis page, perf, PEN OK ? Gent OK: #intrab5a2 -->
        <div data-role="page" id="intrab5a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab5a2a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab5a2b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>    
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a2 -->
        
        <!-- Start of peritonitis page, perf, PEN OK ? Gent OK: #intrab5a3 -->
        <div data-role="page" id="intrab5a3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab5a3a">Gentamicin contraindicated</a></li>
                    <li><a href="#intrab5a3b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a3 -->
        
        <!-- Start of peritonitis page, perf, Pen MILD: #intrab5a1 -->
        <div data-role="page" id="intrab5a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has a mild penicillin allergy, until the return of susceptibility results cover with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV, </span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV, </span>
                    <span class="font15"> every 12 hours</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical improvement is observed (patient is afebrile for at least 24 hours) switch to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, </span>
                    <span class="font15"> 12 hourly. Usually to make up 7 days total treatment (IV &#43; oral) if there are no complications</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> every 12 hours. Usually to make up 7 days total treatment (IV &#43; oral) if there are no complications</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts are uncovered from deep surgical site samples</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                    <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis from a perforated viscus normally requires surgery</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a1 -->
        
        <!-- Start of peritonitis page, perf, Pen BAD, Gent OK: #intrab5a2b -->
        <div data-role="page" id="intrab5a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical peritonitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has a severe penicillin allergy cover with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600 mg (child: 15 mg/kg up to 600 mg) IV, </span>
                    <span class="font15"> every 8 hours</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical improvement is observed (patient is afebrile for at least 24 hours) switch to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+Sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, </span>
                    <span class="font15"> 12 hourly to make up 7 days total treatment</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally,</span>
                    <span class="font15"> every 12 hours. Usually to make up 7 days total treatment (IV &#43; oral) if there are no complications</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li> 
                </ul>
                <hr/>
                <ul class="line30">
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts are uncovered from deep surgical site samples</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                    <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis from a perforated viscus normally requires surgery</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a2b -->
        
        <!-- Start of peritonitis page, perf, Pen BAD, Gent BAD: #intrab5a2a -->
        <div data-role="page" id="intrab5a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical peritonitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has a severe penicillin allergy and can not tolerate gentamicin:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD</b> there are limited treatment options if a patient can not tolerate penicillin or gentamicin</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts are uncovered from deep surgical site samples</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                    <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis from a perforated viscus normally requires surgery</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a2a -->
        
        <!-- Start of peritonitis page, perf, Pen OK, Gent OK: # intrab5a3b -->
        <div data-role="page" id="intrab5a3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical peritonitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient tolerates penicillin cover with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV, </span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> every 6 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> every 12 hours</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical improvement is observed (patient is afebrile for at least 24 hours) switch to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly. Usually to make up 7 days total treatment (IV &#43; oral) if there are no complications</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>If further IV treatment is required after 72 hours of empirical treatment with gentamicin, change patient to piperacillin and tazobactam (4/0.5g or 100mg/kg piperacillin for child) every 8 hours until clinically improved as for patients not tolerant of gentamicin</li>
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts are uncovered from deep surgical site samples</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                    <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis from a perforated viscus normally requires surgery</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a3b -->
        
        <!-- Start of peritonitis page, perf, Pen OK, Gent BAD: #intrab5a3a -->
        <div data-role="page" id="intrab5a3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical peritonitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient tolerates penicillin but not gentamicin, prior to release of culture results treat empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>
                    <span class="font15"> 8 hourly until clinical condition improves</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly. Usually to make up 7 days total treatment (IV &#43; oral) if there are no complications</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts are uncovered from deep surgical site samples</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                    <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis from a perforated viscus normally requires surgery</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5a3a -->
        
        <!-- Start of peritonitis page, SBP, Pen MILD, ?prophylaxis: #intrab5b1 -->
        <div data-role="page" id="intrab5b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Has the patient been on SBP prophylaxis?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap2b">Yes</a></li>
                    <li><a href="#intrab5b1b">No</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Answer yes if patient has been on SBP prophylaxis such as trimethoprim and sulphamethoxazole or norfloxacin</li>
                    <li>Patients who develop SBP while on prophylactic medications are at greater risk of developing <i>Streptococcus</i> or <i>Enterococcus</i> infections which are resistant to cephalosporins</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5b1 -->
        
        <!-- Start of peritonitis page, SBP, PEN OK, ?proph: #intrab5b3 -->
        <div data-role="page" id="intrab5b3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Peritonitis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Has the patient been on SBP prophylaxis?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#intrab5b3a">Yes</a></li>
                    <li><a href="#intrab5b1b">No</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Answer yes if patient has been on SBP prophylaxis such as trimethoprim and sulphamethoxazole or norfloxacin</li>
                    <li>Patients who develop SBP while on prophylactic medications are at greater risk of developing <i>Streptococcus</i> or <i>Enterococcus</i> infections which are resistant to cephalosporins</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5b3 -->
        
        <!-- Start of peritonitis page, SBP, Pen MILD, Proph NO: #intrab5b1b -->
        <div data-role="page" id="intrab5b1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Empirical peritonitis treatment:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient has not previously been on prophylactic antibiotics treat empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2 g (child 1 month or older: 50 mg/kg up to 2 g) IV, </span>
                    <span class="font15"> daily, until clinical condition improves then switch to oral.</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">If signs and symptoms resolve rapidly consider a total treatment length of 5 days.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>The most likely pathogens in SBP are enteric Gram-negative bacilli, such as Escherichia coli and Klebsiella species. Streptococcus pneumoniae, other streptococci, and enterococci occasionally cause infection and are more likely in patients previously on prophylactic treatment. Anaerobic bacteria are uncommon in SBP.</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5b1b -->
        
        <!-- Start of peritonitis page, SBP, Pen MILD, Proph NO: #intrab5b3a -->
        <div data-role="page" id="intrab5b3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Spontaneous bacterial peritonitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If the patient tolerates penicillin and has previously been on prophylactic antibiotics treat empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV, </span>
                    <span class="font15"> 8 hourly until clinical condition improves or culture results available</span>
                </h4>
                <hr/>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally, </span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>int</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if patient is improving (generally within the first 48 hours after intiating IV therapy).</li>
                    <li>The most likely pathogens in SBP are enteric Gram-negative bacilli, such as Escherichia coli and Klebsiella species. Streptococcus pneumoniae, other streptococci, and enterococci occasionally cause infection and are more likely in patients previously on prophylactic treatment. Anaerobic bacteria are uncommon in SBP.</li>
                    <li>When available, the results of susceptibility testing should always guide treatment</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /intrab5b3a -->
        
        <!-- Start of meningitis treatment maze -->
        <!-- Start of meningitis page: #menin -->
        <div data-role="page" id="menin" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Meningitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How old is the patient?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#menin1">2 months or younger</a></li>
                    <li><a href="#menin2">Adult or child &gt; 2 months</a></li> 
                </ul>
                <hr/>
                <ul class="line30">
                    <li>For neonates and children younger than 2 months the likely casuative organisms are <i>Streptococcus agalactiae</i> (group B streptococcus), enteric Gram-negative rods or, rarely, <i>Listeria monocytogenes</i> which will require different</li>
                    <li>There is insufficient evidence to support the use of dexamethasone in neonates and children under 2 months.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin -->
        
        <!-- Start of meningitis page: #menin -->
        <div data-role="page" id="menin1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Meningitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#meninx">Yes</a></li>
                    <li><a href="#menin1b">No</a></li>    
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin -->
        
        <!-- Start of meningitis old page: #menin2 -->
        <div data-role="page" id="menin2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Meningitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#menin2c">No penicillin allergy</a></li> 
                    <li><a href="#menin2a">Minor penicillin allergy</a></li>
                    <li><a href="#menin2b">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2 -->
        
        <!-- Start of meningitis old, pen BAD, page: #menin2a -->
        <div data-role="page" id="menin2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Meningitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Listeria</i> cover required?</span>
                    <span class="font15"> (See below for listeria risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#menin2a1"><i>Listeria</i> suspected</a></li>
                    <li><a href="#menin2a2"><i>Listeria</i> not suspected</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Patient groups with risk factors for listeria infection include adults over 50 years of age, patients with a history of hazardous alcohol consumption and pregnant or debilitated patients</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2a -->
        
        <!-- Start of meningitis old, pen BAD, page: #menin2b -->
        <div data-role="page" id="menin2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Meningitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Listeria</i> cover required?</span>
                    <span class="font15"> (See below for listeria risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#menin2b1"><i>Listeria</i> suspected</a></li>
                    <li><a href="#menin2b2"><i>Listeria</i> not suspected</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Patient groups with risk factors for listeria infection include adults over 50 years of age, patients with a history of hazardous alcohol consumption and pregnant or debilitated patients</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2b -->
        
        <!-- Start of meningitis old, pen OK, page: #menin2c -->
        <div data-role="page" id="menin2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Meningitis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Listeria</i> cover required?</span>
                    <span class="font15"> (See below for listeria risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#menin2c1"><i>Listeria</i> suspected</a></li>
                    <li><a href="#menin2a2"><i>Listeria</i> not suspected</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Patient groups with risk factors for listeria infection include adults over 50 years of age, patients with a history of hazardous alcohol consumption and pregnant or debilitated patients</li>
                </ul>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2c -->
        
        <!-- Start of meningitis old, pen MILD, Listeria YES page: #menin2a1 -->
        <div data-role="page" id="menin2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) IV,</span>
                    <span class="font15"> starting before or with the first dose of antibiotic, then 6 hourly for <b>4</b> days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) IV,</span>
                    <span class="font15"> 6 hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 4g (child 100mg/kg up to 4g) IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if patient meets any criteria outlined below <b>ADD:</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> dosed as per nomograms below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin if required is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <p class="mrgn20b"><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                <p class="mrgn20b"><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Add vancomycin if Gram-positive diplococci are seen on Gram stain, if pneumococcal antigen assay of CSF is positive, or if the patient has known or suspected otitis media or sinusitis, or has been recently treated with a beta lactam.</li>
                    <li>There is no evidence of any net benefit if dexamethasone is given after a patient has received antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics and dexamethasone if the CSF examination is consistent with viral meningitis. Stop dexamethasone if a cause other than <i>Haemophilus influenzae</i> type b (Hib) or <i>S. pneumoniae</i> is confirmed</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2a1 -->
        
        <!-- Start of meningitis old, pen MILD, Listeria NO page: #menin2a2 -->
        <div data-role="page" id="menin2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) IV,</span>
                    <span class="font15"> starting before or with the first dose of antibiotic, then 6 hourly for <b>4</b> days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 4g (child 100mg/kg up to 4g) IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if patient meets any criteria outlined below <b>ADD:</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> dosed as per nomograms below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin if required is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Add vancomycin if Gram-positive diplococci are seen on Gram stain, if pneumococcal antigen assay of CSF is positive, or if the patient has known or suspected otitis media or sinusitis, or has been recently treated with a beta lactam.</li>
                    <li>Patients older than 50 years, immunocompromised patients, patients with a history of alcohol abuse or pregnant or debilitated patients are likely to need <i>Listeria</i> cover. The above regimen does not cover <i>Listeria</i></li>
                    <li>There is no evidence of any net benefit if dexamethasone is given after a patient has received antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics and dexamethasone if the CSF examination is consistent with viral meningitis. Stop dexamethasone if a cause other than <i>Haemophilus influenzae</i> type b (Hib) or <i>S. pneumoniae</i> is confirmed</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2a2 -->
        
        <!-- Start of meningitis old, pen BAD, page: #menin2b1 -->
        <div data-role="page" id="menin2b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) IV,</span>
                    <span class="font15"> starting before or with the first dose of antibiotic, then 6 hourly for <b>4</b> days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) IV,</span>
                    <span class="font15"> 6 hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> dosed as per nomograms below;</span>
                </h4>
                <p><b>OR</b>as a single drug in place of ciprofloxacin and vancomycin use:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400 mg (child: 10 mg/kg up to 400 mg) IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and ciprofloxacin, or moxifloxacin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Add vancomycin if Gram-positive diplococci are seen on Gram stain, if pneumococcal antigen assay of CSF is positive, or if the patient has known or suspected otitis media or sinusitis, or has been recently treated with a beta lactam.</li>
                    <li>There is no evidence of any net benefit if dexamethasone is given after a patient has received antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics and dexamethasone if the CSF examination is consistent with viral meningitis. Stop dexamethasone if a cause other than <i>Haemophilus influenzae</i> type b (Hib) or <i>S. pneumoniae</i> is confirmed</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2b -->
        
        <!-- Start of meningitis old, pen BAD, page: #menin2b2 -->
        <div data-role="page" id="menin2b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) IV,</span>
                    <span class="font15"> starting before or with the first dose of antibiotic, then 6 hourly for <b>4</b> days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <p class="mrgn20b"><b>OR</b>as a single drug in place of ciprofloxacin and vancomycin use:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400 mg (child: 10 mg/kg up to 400 mg) IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and ciprofloxacin, or moxifloxacin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Add vancomycin if Gram-positive diplococci are seen on Gram stain, if pneumococcal antigen assay of CSF is positive, or if the patient has known or suspected otitis media or sinusitis, or has been recently treated with a beta lactam.</li>
                    <li>Patients older than 50 years, immunocompromised patients, patients with a history of alcohol abuse or pregnant or debilitated patients are likely to need <i>Listeria</i> cover. The above regimen does not cover <i>Listeria</i></li>
                    <li>There is no evidence of any net benefit if dexamethasone is given after a patient has received antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics and dexamethasone if the CSF examination is consistent with viral meningitis. Stop dexamethasone if a cause other than <i>Haemophilus influenzae</i> type b (Hib) or <i>S. pneumoniae</i> is confirmed</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2b2 -->
        
        <!-- Start of meningitis old, pen OK, Listeria YES page: #menin2c1 -->
        <div data-role="page" id="menin2c1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) IV,</span>
                    <span class="font15"> starting before or with the first dose of antibiotic, then 6 hourly for <b>4</b> days</span>
                </h4>
                <p><b>AND</b> to cover <i>Listeria</i></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzylpenicillin 2.4 g (child: 60 mg/kg up to 2.4 g) IV,</span>
                    <span class="font15"> 4 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 4g (child 100mg/kg up to 4g) IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if patient meets any criteria outlined below <b>ADD:</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin if required is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Add vancomycin if Gram-positive diplococci are seen on Gram stain, if pneumococcal antigen assay of CSF is positive, or if the patient has known or suspected otitis media or sinusitis, or has been recently treated with a beta lactam.</li>
                    <li>There is no evidence of any net benefit if dexamethasone is given after a patient has received antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics and dexamethasone if the CSF examination is consistent with viral meningitis. Stop dexamethasone if a cause other than <i>Haemophilus influenzae</i> type b (Hib) or <i>S. pneumoniae</i> is confirmed</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2c1 -->
        
        <!-- Start of meningitis old, pen OK, Listeria NO page: #menin2c2 -->
        <div data-role="page" id="menin2c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Dexamethasone 10 mg (child: 0.15 mg/kg up to 10 mg) IV,</span>
                    <span class="font15"> starting before or with the first dose of antibiotic, then 6 hourly for <b>4</b> days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> to cover <i>Listeria</i></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 4g (child 100mg/kg up to 4g) IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g (child 50mg/kg up to 2g) IV,</span>
                    <span class="font15"> 12 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if patient meets any criteria outlined below <b>ADD:</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin</span>
                    <span class="font15"> dosed as per nomograms below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin if required is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Add vancomycin if Gram-positive diplococci are seen on Gram stain, if pneumococcal antigen assay of CSF is positive, or if the patient has known or suspected otitis media or sinusitis, or has been recently treated with a beta lactam.</li>
                    <li>There is no evidence of any net benefit if dexamethasone is given after a patient has received antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics and dexamethasone if the CSF examination is consistent with viral meningitis. Stop dexamethasone if a cause other than <i>Haemophilus influenzae</i> type b (Hib) or <i>S. pneumoniae</i> is confirmed</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin2c2 -->
        
        <!-- Start of meningitis old, pen OK, Listeria NO page: #menin1b -->
        <div data-role="page" id="menin1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">In a child &lt; 2 months meningitis should initially be treated empirically with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 50mg/kg IV,</span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 50mg/kg IV,</span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if herpes simplex encephalitis is suspected &#40;see below&#41; <b>ADD:</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Aciclovir 500mg/m<sup>2</sup> (approximately 15mg/kg) IV,</span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for cefotaxime and aciclovir is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>men</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours
                </div>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Herpes encephalitis should be suspected if focal neurological signs and symptoms are present including seizures, behavioural changes, focal neurological deficits and coma</li>
                    <li>There is insufficient evidence to support the use of dexamethasone in children &lt; 2 months of age</li>
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>If no pathogen is isolated continue empirical antibiotic therapy for a minimum of 10 days depending on response</li>
                    <li>Consider stopping antibiotics if the CSF examination is consistent with viral meningitis.</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /menin1b -->
        
        <!-- Start of meningitis < 2 months with pen allergy page: #meninx -->
        <div data-role="page" id="meninx" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Empiric meningitis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">In a child &lt; 2 months presenting with meningitis with a penicillin allergy:</span>
                    <span class="font15"></span>
                </h3>
                <p class="mrgn20b"><b>Please contact IFD for advice. Treatment is complex in patient's with penicillin hypersensitivity</b></p>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /meninx -->
        <!-- End of meningitis treatment maze -->
        
        <!-- LET THE OPEN FRACTURE MAZE BEGIN!! -->
        <!-- Start of PID page: #open -->
        <div data-role="page" id="open" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open1">No penicillin allergy</a></li>
                    <li><a href="#open2">Minor penicillin allergy</a></li>
                    <li><a href="#open3">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open -->
        
        <!-- Start of OPEN page Pen OK, Seriousness Q: #open1 -->
        <div data-role="page" id="open1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there severe tissue damage or clinical evidence of infection?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open1a">Yes</a></li>
                    <li><a href="#open1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Severe tissue damage is any fracture higher than a grade 2 on the Gustilo type chart &#40;see the surgical prophylaxis guideline on the PGC&#41; Typically this is any wound &gt;10cm in size with extensive soft tissue injury&#41;.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open1 -->
        
        <!-- Start of OPEN page Pen MILD, Seriousness Q: #open2 -->
        <div data-role="page" id="open2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <!-- /Question -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there severe tissue damage or clinical evidence of infection?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open2a">Yes</a></li>
                    <li><a href="#open2b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Severe tissue damage is any fracture higher than a grade 2 on the Gustilo type chart &#40;see the surgical prophylaxis guideline on the PGC&#41; Typically this is any wound &gt;10cm in size with extensive soft tissue injury&#41;.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open2 -->
        
        <!-- Start of OPEN page Pen BAD, Seriousness Q: #open3 -->
        <div data-role="page" id="open3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there severe tissue damage or clinical evidence of infection?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open3a">Yes</a></li>
                    <li><a href="#open3b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Severe tissue damage is any fracture higher than a grade 2 on the Gustilo type chart &#40;see the surgical prophylaxis guideline on the PGC&#41; Typically this is any wound &gt;10cm in size with extensive soft tissue injury&#41;.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open3 -->
        
        <!-- Start of OPEN page Pen OK, Debride Q: #open1b -->
        <div data-role="page" id="open1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Did debridement and washout of the wound occur within 8 hours of the injury?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open1b1">Yes</a></li>
                    <li><a href="#open1a">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open1b -->
        
        <!-- Start of OPEN page Pen MILD, Debride Q: #open2b -->
        <div data-role="page" id="open2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Did debridement and washout of the wound occur within 8 hours of the injury?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open2b1">Yes</a></li>
                    <li><a href="#open2a">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open2b -->
        
        <!-- Start of OPEN page Pen BAD, Debride Q: #open3b -->
        <div data-role="page" id="open3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Did debridement and washout of the wound occur within 8 hours of the injury?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open3b1">Yes</a></li>
                    <li><a href="#open3a">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open3b -->
        
        <!-- Start of OPEN page Pen OK, Not serious, Debrided, Wet Q?: #open1b1-->
        <div data-role="page" id="open1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient being treated in the wet or the dry season?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open1b1a">Wet season</a></li>
                    <li><a href="#open1b1b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on open fracture treatment and prophylaxis please see the NT surgical prophylaxis Guidelines on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open1b1-->
        
        <!-- Start of OPEN page Pen MILD, Not serious, Wet Q?: #open2b1-->
        <div data-role="page" id="open2b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Open Fracture:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient being treated during the wet or dry season?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#open2b1a">Wet season</a></li>
                    <li><a href="#open1b1b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on open fracture treatment and prophylaxis please see the NT surgical prophylaxis Guidelines on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open2b1-->
        
        <!-- Start of OPEN page Pen OK, Serious: #open1a -->
        <div data-role="page" id="open1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If there is serious tissue damage, delay in debridement and washout or clinical evidence of infection give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 8-hourly</span>
                </h4>
                <p class="mrgn20b">For 7 days &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>opf</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if IV treatment is to continue past one week</div>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open1a -->
        
        <!-- Start of OPEN page Pen OK, debrided, Not Serious, wet season: #open1b1a -->
        <div data-role="page" id="open1b1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If debridement has occured within 8 hours and the wound is &lt; 10cm in the wet season give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 8-hourly</span>
                </h4>
                <p class="mrgn20b">For 24 - 72 hours &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>opf</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                    <li>There is no advantage of continuing prophylaxis beyond 72 hours in the abscence of infection even if wound closure has not been achieved</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open1b1a -->
        
        <!-- Start of OPEN page Pen OK, debrided, Not Serious, dry season: #open1b1b -->
        <div data-role="page" id="open1b1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If debridement has occured within 8 hours and the wound is &lt; 10cm in the dry season give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> 8-hourly</span>
                </h4>
                <p class="mrgn20b">For 24 - 72 hours &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                    <li>There is no advantage of continuing prophylaxis beyond 72 hours in the abscence of infection even if wound closure has not been achieved</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open1b1b -->
        
        <!-- Start of OPEN page Pen OK, debrided, Not Serious, wet season: #open2b1a -->
        <div data-role="page" id="open2b1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If debridement has occured within 8 hours and the wound is &lt; 10cm in the wet season give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15">  8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg (child: 12.5mg/kg up to 500mg) IV,</span>
                    <span class="font15"> 12-hourly.</span>
                </h4>
                <p class="mrgn20b">For 24 - 72 hours &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                    <li>There is no advantage of continuing prophylaxis beyond 72 hours in the abscence of infection even if wound closure has not been achieved</li>
                    <li>Consider an early switch to oral metronidazole as it is 98&#37; orally bioavailable, tds orally dosed metronidazole will achieve higher plasma concentrations to bd IV dosing</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open2b1a -->
        
        <!-- Start of OPEN page Pen MILD, NOT debrided OR Serious, dry season: #open2a -->
        <div data-role="page" id="open2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If debridement has not occured within 8 hours or the wound is &gt; 10cm give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15">  8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg (child: 12.5mg/kg up to 500mg) IV,</span>
                    <span class="font15"> 12-hourly.</span>
                </h4>
                <p class="mrgn20b">For 7 days &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                    <li>Consider an early switch to oral metronidazole as it is 98&#37; orally bioavailable, tds orally dosed metronidazole will achieve higher plasma concentrations to bd IV dosing</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open2a -->
        
        <!-- Start of OPEN page Pen BAD, Serious or no debride: #open3a -->
        <div data-role="page" id="open3a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If there is serious tissue damage, delay in debridement and washout or clinical evidence of infection give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) IV,</span>
                    <span class="font15">  8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600mg (child: 15mg/kg up to 600mg) IV,</span>
                    <span class="font15"> 8-hourly.</span>
                </h4>
                <p class="mrgn20b">For 7 days &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin and lincomycin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>opf</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>SEVEN</b> days only. IFD must be contacted if IV treatment is to continue past one week
                </div>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                    <li>Consider an early switch to oral therapy for ciprofloxacin and lincomycin as they both have good oral bioavailability &#40;70&#37; and 90&#37; respectively&#41;</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open3a -->
        
        <!-- Start of OPEN page Pen BAD, NOT Serious, debrided, wet or dry: #open3b1 -->
        <div data-role="page" id="open3b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Open fracture treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If debridement has occured within 8 hours and the wound is &lt; 10cm give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600mg (child: 15mg/kg up to 600mg) IV,</span>
                    <span class="font15">  8-hourly</span>
                </h4>
                <p class="mrgn20b">For 24 - 72 hours &#40;or longer if there is evidence of established bone infection&#41;</p>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>opf</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul type="circle" class="line30">
                    <li>Patients with severe tissue damage, evidence of infection or delay in debridement &#40; &gt;8 hours after injury &#41; all need presumptive treatment for 7 days total. Patients with established bone infection usually require a longer duration of IV antibiotic therapy followed by oral continuation therapy</li>
                    <li>There is no advantage of continuing prophylaxis beyond 72 hours in the abscence of infection even if wound closure has not been achieved</li>
                    <li>Consider an early switch to oral therapy to oral clindamycin as it has excellent oral bioavailability &#40; 90&#37; orally bioavailable&#41;</li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /open3b1 -->
        
        <!-- start of Pelvic Inflammatory treatment maze -->
        <!-- Start of PID page: #pelvi -->
        <div data-role="page" id="pelvi" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15">See below for details on penicillin allergy severity</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3">No penicillin allergy</a></li>
                    <li><a href="#pelvi1">Minor penicillin allergy</a></li>
                    <li><a href="#pelvi2">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi -->
        
        <!-- Start of PID page Pen MILD, Sex Q: #pelvi1 -->
        <div data-role="page" id="pelvi1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have sexually or non-sexually acquired infection?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a">Sexually acquired</a></li>
                    <li><a href="#pelvi1b">Non-sexually acquired</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Sexually acquired infection is most likely in a patient who has had unprotected sex, particularly with a new partner.</li>
                    <li>Non-sexually acquired infection is likely from mechanical disruption of the cervical barrier (i.e post surgery, following IUD insertion or termination of pregnancy.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1 -->
        
        <!-- Start of PID page Pen BAD, Sex Q: #pelvi2 -->
        <div data-role="page" id="pelvi2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have sexually or non-sexually acquired infection?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi2a">Sexually acquired</a></li>
                    <li><a href="#pelvi2b">Non-sexually acquired</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Sexually acquired infection is most likely in a patient who has had unprotected sex, particularly with a new partner.</li>
                    <li>Non-sexually acquired infection is likely from mechanical disruption of the cervical barrier (i.e post surgery, following IUD insertion or termination of pregnancy.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2 -->
        
        <!-- Start of PID page Pen OK, Sex Q: #pelvi3 -->
        <div data-role="page" id="pelvi3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have sexually or non-sexually acquired infection?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3a">Sexually acquired</a></li>
                    <li><a href="#pelvi3b">Non-sexually acquired</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Sexually acquired infection is most likely in a patient who has had unprotected sex, particularly with a new partner.</li>
                    <li>Non-sexually acquired infection is likely from mechanical disruption of the cervical barrier (i.e post surgery, following IUD insertion or termination of pregnancy.</li>
                </ul>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3 -->
        
        <!-- Start of PID page Pen MILD, Sex YES, Preg Q: #pelvi1a -->
        <div data-role="page" id="pelvi1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient pregnant or breastfeeding?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1">Yes</a></li>
                    <li><a href="#pelvi1a2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a -->
        
        <!-- Start of PID page Pen MILD, Sex NO, Preg Q: #pelvi1b -->
        <div data-role="page" id="pelvi1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient pregnant or breastfeeding?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1b1">Yes</a></li>
                    <li><a href="#pelvi1b2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b -->
        
        <!-- Start of PID page Pen BAD, Sex YES, Preg Q: #pelvi2a -->
        <div data-role="page" id="pelvi2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient pregnant or breastfeeding?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvix">Yes</a></li>
                    <li><a href="#pelvi2a2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a -->
        
        <!-- Start of PID page Pen BAD, Sex NO, Preg Q: #pelvi2b -->
        <div data-role="page" id="pelvi2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient pregnant or breastfeeding?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvix">Yes</a></li>
                    <li><a href="#pelvi2b2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2b -->
        
        <!-- Start of PID page Pen BAD, Sex YES, Preg Q: #pelvi3a -->
        <div data-role="page" id="pelvi3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient pregnant or breastfeeding?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3a1">Yes</a></li>
                    <li><a href="#pelvi3a2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a -->
        
        <!-- Start of PID page Pen BAD, Sex YES, Preg Q: #pelvi3b -->
        <div data-role="page" id="pelvi3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient pregnant or breastfeeding?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3b1">Yes</a></li>
                    <li><a href="#pelvi3b2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b -->
        
        <!-- Start of PID page Pen MILD, Sex YES, PregYES: ?COMPLY #pelvi3b -->
        <div data-role="page" id="pelvi1a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a">Yes</a></li>
                    <li><a href="#pelvi1a1b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a1 -->
        
        <!-- Start of PID page Pen MILD, Sex YES, PregNO: ?COMPLY #pelvi3b -->
        <div data-role="page" id="pelvi1a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a2a">Yes</a></li>
                    <li><a href="#pelvi1a2b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a2 -->
        
        <!-- Start of PID page Pen MILD, Sex NO, PregYES: ?COMPLY #pelvi3b -->
        <div data-role="page" id="pelvi1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1b1a">Yes</a></li>
                    <li><a href="#pelvi1b1b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b1 -->
        
        <!-- Start of PID page Pen MILD, Sex NO, PregNO: ?COMPLY #pelvi1b2 -->
        <div data-role="page" id="pelvi1b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1b2a">Yes</a></li>
                    <li><a href="#pelvi1b2b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b2 -->
        
        <!-- Start of PID page Pen BAD, Sex YES, PregYES: ?COMPLY #pelvi2a1 -->
        <div data-role="page" id="pelvi2a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi2a1a">Yes</a></li>
                    <li><a href="#pelvix">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a1 -->
        
        <!-- Start of PID page Pen BAD, Sex YES, PregNO: ?COMPLY #pelvi2a2 -->
        <div data-role="page" id="pelvi2a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi2a2a">Yes</a></li>
                    <li><a href="#pelvi2a2b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a2 -->
        
        <!-- Start of PID page Pen BAD, Sex NO, PregNO: ?COMPLY #pelvi2b2 -->
        <div data-role="page" id="pelvi2b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
           
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi2b2a">Yes</a></li>
                    <li><a href="#pelvix">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2b2 -->
        
        <!-- Start of PID page Pen OK, Sex YES, PregYES: ?COMPLY #pelvi3a1 -->
        <div data-role="page" id="pelvi3a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3a1a">Yes</a></li>
                    <li><a href="#pelvi3a1b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a1 -->
        
        <!-- Start of PID page Pen OK, Sex NO, PregYES: ?COMPLY #pelvi3b1 -->
        <div data-role="page" id="pelvi3b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3b1a">Yes</a></li>
                    <li><a href="#pelvi3b1b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b1 -->
        
        <!-- Start of PID page Pen OK, Sex NO, PregYES: ?COMPLY #pelvi3b2 -->
        <div data-role="page" id="pelvi3b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3b2a">Yes</a></li>
                    <li><a href="#pelvi3b2b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2 -->
        
        <!-- Start of PID page Pen MILD, Sex YES, Preg YES, COMP YES: #pelvi1a1a -->
        <div data-role="page" id="pelvi1a1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a1a -->
        
        <!-- Start of PID page Pen MILD, Sex YES, Preg YES, COMP NO: #pelvi1a1b -->
        <div data-role="page" id="pelvi1a1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a1b -->
        
        <!-- Start of PID page Pen MILD, Sex YES, Preg NO, COMP YES: #pelvi1a2a -->
        <div data-role="page" id="pelvi1a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a2a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a2a -->
        
        <!-- Start of PID page Pen OK, Sex YES, PregNO: ?COMPLY #pelvi3a2 -->
        <div data-role="page" id="pelvi3a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to comply with outpatient treatment?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3a2a">Yes</a></li>
                    <li><a href="#pelvi3a2b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a2 -->
        
        <!-- Start of PID page Pen MILD, Sex YES, Preg NO, COMP NO: #pelvi1a2b -->
        <div data-role="page" id="pelvi1a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a2b -->
        
        <!-- Start of PID page Pen MILD, Sex NO, Preg YES, COMP YES: #pelvi1b1a -->
        <div data-role="page" id="pelvi1b1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1b1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b1a -->
        
        <!-- Start of PID page Pen MILD, Sex NO, Preg YES, COMP NO: #pelvi1b1b -->
        <div data-role="page" id="pelvi1b1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b1b -->
        
        <!-- Start of PID page Pen MILD, Sex NO, Preg NO, COMP NO: #pelvi1b2b -->
        <div data-role="page" id="pelvi1b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b2b -->
        
        <!-- Start of PID page Pen BAD, Sex YES, Preg NO, COMP YES: #pelvi2a2a -->
        <div data-role="page" id="pelvi2a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvix">Mild or Moderate</a></li>
                    <li><a href="#pelvi2a2a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a2a -->
        
        <!-- Start of PID page Pen BAD, Sex YES, Preg NO, COMP NO: #pelvi2a2b -->
        <div data-role="page" id="pelvi2a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvix">Mild or Moderate</a></li>
                    <li><a href="#pelvi2a2a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a2b -->
        
        <!-- Start of PID page Pen BAD, Sex NO, Preg NO, COMP YES: #pelvi2b2a -->
        <div data-role="page" id="pelvi2b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1b1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvix">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2b2a -->
        
        <!-- Start of PID page Pen OK, Sex YES, Preg YES, COMP YES: #pelvi3a1a -->
        <div data-role="page" id="pelvi3a1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a1a -->
        
        <!-- Start of PID page Pen OK, Sex YES, Preg YES, COMP NO: #pelvi3a1b -->
        <div data-role="page" id="pelvi3a1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a1b -->
        
        <!-- Start of PID page Pen OK, Sex YES, Preg NO, COMP YES: #pelvi3a2a -->
        <div data-role="page" id="pelvi3a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a2a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a2a -->
        
        <!-- Start of PID page Pen OK, Sex YES, Preg NO, COMP NO: #pelvi3a2b -->
        <div data-role="page" id="pelvi3a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3a2b -->
        
        <!-- Start of PID page Pen OK, Sex NO, Preg YES, COMP YES: #pelvi3b1a -->
        <div data-role="page" id="pelvi3b1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3b1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvix">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b1a -->
        
        <!-- Start of PID page Pen OK, Sex NO, Preg YES, COMP NO: #pelvi3b1b -->
        <div data-role="page" id="pelvi3b1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvix">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b1b -->
        
        <!-- Start of PID page Pen OK, Sex NO, Preg NO, COMP YES: #pelvi3b2a -->
        <div data-role="page" id="pelvi3b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi3b2a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi3b2a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2a -->
        
        <!-- Start of PID page Pen OK, Sex NO, Preg NO, COMP NO: #pelvi3b2b -->
        <div data-role="page" id="pelvi3b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1a1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi3b2a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2b -->
        
        <!-- Start of PID page Pen mild, Sex NO, Preg NO, COMP YES: #pelvi1b2a -->
        <div data-role="page" id="pelvi1b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pelvic inflammatory disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvi1b1a1">Mild or Moderate</a></li>
                    <li><a href="#pelvi1a1a2">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b2a -->
        
        <!-- Start of pyelonephritis Tx with mild Penicillin Allergy SEVERE: #pelvi2a2b -->
        <div data-role="page" id="pelvi2a2a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
                <br>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvix">Gentamicin contraindicated</a></li>
                    <li><a href="#pelvi2a2a2b">Gentamicin not contraindicated</a></li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a2a2 -->
        
        <!-- Start of Pelvic Inflammatory disease Tx PEN OK,SEX NO,PREG NO,PID BAD: Gent Q #pelvi3b2b -->
        <div data-role="page" id="pelvi3b2a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pelvic Inflammatory Disease:</h1>
                <br>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pelvix">Gentamicin contraindicated</a></li>
                    <li><a href="#pelvi3b2a2b">Gentamicin not contraindicated</a></li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2b -->
        
        <!--  PID TREATMENTS BEGIN (FOR INPATIENTS -------->
        <!-- Start of PID page Pen MILD, Sex YES, preg YES, COMP YES, PID MILD: #pelvi1a1a1 -->
        <div data-role="page" id="pelvi1a1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a non-compliant or pregnant patient:</span>
                    <span class="font15"></span>
                </h3>
                <p class="mrgn20b"><b><u>From Day 1</u></b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 1g orally</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1g IV</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400mg orally</span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <p class="mrgn20b"><b><u>AND on DAY 8</u></b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 1g orally</span>
                    <span class="font15"> as a single dose one week after initial treatment</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for azithromycin is:</span>
                    <span class="font15 bold"> 8<script> document.write(getcode())</script>pel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> doses only. IFD must be contacted if treatment is to continue past two doses. Please document this code in the comments section in eMMa for supply from pharmacy</div>
                <hr/>
                <ul class="line30">
                    <li>Caution patient not to drink alcohol while taking metronidazole</li>
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                    <li>Ensure that all sexual partners are treated with Amoxycillin 3g and probenecid 1g orally as well as a stat dose of azithromycin 1g (see the CDC guideline if patient is from outside the Top End of Australia or Central Australia)</li>		
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a1a1 -->
        
        <!-- Start of PID page Pen MILD, Sex YES, preg YES, COMP YES, PID BAD: #pelvi1a1b -->
        <div data-role="page" id="pelvi1a1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with non life threatening penicillin hypersensitivity:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2gm IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg IV,</span>
                    <span class="font15"> every 12 hours</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for intravenous azithromycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>pel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Continue IV therapy until there is a substantial clinical improvement then switch to oral. Once the patient is tolerating an oral diet oral metronidazole should be used as it is 98% bioavailable and tds dosing will provide higher levels to dosing IV BD</li>
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                    <li>Ensure that all sexual partners are treated with Amoxycillin 3g and probenecid 1g orally as well as a stat dose of azithromycin 1g (see the CDC guideline if patient is from outside the Top End of Australia or Central Australia)</li>		
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a1a2 -->
        
        <!-- Start of PID page Pen MILD, Sex YES, preg NO, COMP YES PID MILD: #pelvi1a2a1 -->
        <div data-role="page" id="pelvi1a2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with non life threatening penicillin hypersensitivity who is likely to take doxycycline:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 1g orally</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1g IV</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400mg orally</span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally</span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for oral azithromycin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>pel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>ONE</b> dose only. IFD must be contacted if treatment is to continue past one dose</div>
                <hr/>
                <ul class="line30">
                    <li>Caution patient not to drink alcohol while taking metronidazole</li>
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                    <li>Ensure that all sexual partners are treated with Amoxycillin 3g and probenecid 1g orally as well as a stat dose of azithromycin 1g (see the CDC guideline if patient is from outside the Top End of Australia or Central Australia)</li>		
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1a2a1 -->
        
        <!-- Start of PID page generic contact IFD for most pregnant or non-compliant patients: #pelvix -->
        <div data-role="page" id="pelvix" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For pelvic inflammatory disease in a pregnant or non-compliant patient not tolerant of penicillin:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvix -->
        
        <!-- Start of PID page Pen MILD, Sex NO, preg YES, COMP YES, PID MILD: #pelvi1b1a1 -->
        <div data-role="page" id="pelvi1b1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with non life threatening penicillin hypersensitivity who will take medication:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 500 mg orally,</span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400mg orally</span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin is:</span>
                    <span class="font15 bold"> 14<script> document.write(getcode())</script>pel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FOURTEEN</b> days only. IFD must be contacted if treatment is to continue past two weeks. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <ul class="line30">
                    <li>Caution patient not to drink alcohol while taking metronidazole</li>
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                    <li>Ensure that all sexual partners are treated with Amoxycillin 3g and probenecid 1g orally as well as a stat dose of azithromycin 1g (see the CDC guideline if patient is from outside the Top End of Australia or Central Australia)</li>		
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi1b1a1 -->
        
        <!--Start of PID page Pen BAD,Sex YES, preg NO, COMP YES, PID BAD,GENTOK: #pelvi2a2b2 -->
        <div data-role="page" id="pelvi2a2a2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with penicillin hypersensitivity who is not pregnant use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Lincomycin 600mg IV,</span>
                    <span class="font15"> every 8 hours until patient stable and can switch to oral clindamycin 450mg tds</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV</span>
                    <span class="font15"> as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for lincomycin and azithromycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>pel</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <ul class="line30">
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                    <li>Ensure that all sexual partners are treated with Amoxycillin 3g and probenecid 1g orally as well as a stat dose of azithromycin 1g (see the CDC guideline if patient is from outside the Top End of Australia or Central Australia)</li>		
                </ul>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30"><li>Please contact IFD if IV therapy with gentamicin is required after 72 hours</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi2a2a2b -->
        
        <!-- Start of PID page Pen OK, Sex NO, preg YES, COMP YES PID MILD: #pelvi3b1a1 -->
        <div data-role="page" id="pelvi3b1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with no penicillin allergy who will take medication:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg orally, </span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Roxithromycin 300 mg orally,</span>
                    <span class="font15"> daily for 14 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2a -->
        
        <!-- Start of PID page Pen OK, Sex NO, preg NO, COMP YES PID MILD: #pelvi3b2a1 -->
        <div data-role="page" id="pelvi3b2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with no penicillin allergy who will take medication:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg orally, </span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100 mg orally,</span>
                    <span class="font15"> every 12 hours for 14 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2a1 -->
        
        <!--Start of PID page Pen BAD,Sex YES, preg NO, PID BAD,GENTOK: #pelvi3b2a2b -->
        <div data-role="page" id="pelvi3b2a2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pelvic Inflammatory Disease:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For inpatient PID treatment in a patient with no penicillin allergy who is not pregnant:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2g IV,</span>
                    <span class="font15"> every 6 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500mg IV,</span>
                    <span class="font15"> every 12 hours until patient stable and can switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV</span>
                    <span class="font15"> as per nomograms below</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Ensure that an endocervical swab is collected for PCR testing for common STI's and gram stain and culture</li>
                    <li>Please see the CDC NT sexually transmitted infection guideline for information on testing and follow up</li>	
                    <li>Ensure that all sexual partners are treated with Amoxycillin 3g and probenecid 1g orally as well as a stat dose of azithromycin 1g (see the CDC guideline if patient is from outside the Top End of Australia or Central Australia)</li>		
                </ul>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pelvi3b2a2b -->
        <!-- END of PELVIC INFLAMMATORY DISEASE maze -->
        
        <!-- Start of Pneumonias -->
        <!-- Start of pneumonia pages: #pneum -->
        <div data-role="page" id="pneum" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">What type of pneumonia is suspected?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap">Community Acquired Pneumonia</a></li>   
                    <li><a href="#hap">Hospital Acquired Pneumonia</a></li>
                </ul>
                <ul class="line30">
                    <li>Hospital-acquired pneumonia (HAP) is pneumonia that develops in a patient who has been hospitalised for longer than 48 hours. Most bacterial HAP occurs by 'microaspiration' of bacteria that colonise the oropharynx or upper gastrointestinal tract. Atypical pathogens (eg Legionella) are much less common in HAP than in community-acquired pneumonia.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pneum -->
        
        <!-- start of Community acquired PNEUMONIA treatment maze -->
        <!-- Start of cap page/ ?age: #cap -->
        <div data-role="page" id="cap" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How old is the patient?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1">&gt; 50 years of age</a></li>
                    <li><a href="#cap2">15 to 50 years old</a></li>
                    <li><a href="#cap3a">5 to 15 years old</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap -->
            
        <!-- Start of CAP page/ old: #cap1 -->
        <div data-role="page" id="cap1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>SMARTCOP:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">What is the patients SMARTCOP score?</span>
                    <span class="font15"></span>
                </h3>
                <script>
                    var calcsmartcopo = function () {

                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resulto = 0;
                        if (parseInt($('#systolico').val()) < 90) {

                            resulto += 2;
                        } else {

                        }

                        if (parseInt($('#albumino').val()) < 35) {

                            resulto += 1;
                        } else {

                        }

                        if (parseInt($('#respo').val()) > 29) {

                            resulto += 1;
                        } else {

                        }

                        if (parseInt($('#tacho').val()) > 125) {
                            resulto += 1;
                        } else {

                        }

                        if (parseInt($('#oxyo').val() * 100) < 9010) {
                            resulto += 2;
                        } else {

                        }

                        if (parseInt($('#artero').val() * 100) < 735) {
                            resulto += 2;
                        } else {

                        }

                        console.log($('#multilobaro option:selected').val());
                        resulto += parseInt($('#multilobaro option:selected').val());
                        $('#smartcopresulto').text(resulto);


                        console.log($('#confusiono option:selected').val());
                        resulto += parseInt($('#confusiono option:selected').val());
                        $('#smartcopresulto').text(resulto);
                    }
                </script>

                <form onsubmit="return false">
                    <h4 class="color-primary mrgn20b">Enter the patient obs to calculate a <b>SMARTCOP</b> score or scroll down to skip this step</h4>
                    <hr/>
                    <div class="form-group"><label for="systolic"><b>S</b>ystolic BP:</label><input type="number" min="10" id="systolico" name="systolico" onchange="calcsmartcopo();" class="form-control"></div>
                    <div class="form-group">
                        <label for="multilobaro"><b>M</b>ultilobar chest involvement?:</label>
                        <select name="multilobaro" id="multilobaro" onchange="calcsmartcopo();" class="form-control">
                            <option value="0">No</option>
                            <option value="1">Yes</option>
                        </select>
                    </div>
                    <div class="form-group"><label for="albumino"><b>A</b>lbumin:</label><input type="number" min="0" id="albumino" name="albumino" onchange="calcsmartcopo();" class="form-control"></div>
                    <div class="form-group"><label for="respo"><b>R</b>espiratory rate (RPM):</label><input type="number" min="0" id="respo" name="respo" onchange="calcsmartcopo();" class="form-control"></div>
                    <div class="form-group"><label for="tacho"><b>T</b>achyardia? - Heart rate (BPM):</label><input type="number" min="0" id="tacho" name="tacho" onchange="calcsmartcopo();" class="form-control"></div>
                    <div class="form-group">
                        <label for="confusiono"><b>C</b>onfusion? (new onset):</label>
                        <select name="confusiono" id="confusiono" onchange="calcsmartcopo();" class="form-control">
                            <option value="0">No</option>
                            <option value="1">Yes</option>
                        </select>
                    </div>
                    <div class="form-group"><label for="oxyo"><b>O</b>xygen saturation(%):</label><input type="number" step="0.1" min="0" id="oxyo" name="oxyo" value="99"onchange="calcsmartcopo();" class="form-control"></div>
                    <div class="form-group"><label for="artero"><b>P</b>h (arterial pH):</label><input type="number" step="0.01" min="0" id="artero" name="artero" value="7.4" onchange="calcsmartcopo();" class="form-control"></div>
                    <p class="color-primary mrgn20b"><b>SMARTCOP SCORE: </b><strong><span id="smartcopresulto">0</span></strong></p>
                </form>
                <hr/>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a">Continue to treatment</a></li>   
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1 -->
            
        <!-- Start of CAP page/ young: #cap2 -->
        <div data-role="page" id="cap2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>SMARTCOP:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">What is the patients SMARTCOP score?</span>
                    <span class="font15"></span>
                </h3>
                <script>
                    var calcsmartcop = function () {

                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resulty = 0;
                        if (parseInt($('#systolicy').val()) < 90) {

                            resulty += 2;
                        } else {

                        }

                        if (parseInt($('#albuminy').val()) < 35) {

                            resulty += 1;
                        } else {

                        }

                        if (parseInt($('#respy').val()) > 24) {

                            resulty += 1;
                        } else {

                        }

                        if (parseInt($('#tachy').val()) > 125) {
                            resulty += 1;
                        } else {

                        }

                        if (parseInt($('#oxyy').val() * 100) < 9310) {
                            resulty += 2;
                        } else {

                        }

                        if (parseInt($('#artery').val() * 100) < 735) {
                            resulty += 2;
                        } else {

                        }

                        console.log($('#multilobary option:selected').val());
                        resulty += parseInt($('#multilobary option:selected').val());
                        $('#smartcopresulty').text(resulty);


                        console.log($('#confusiony option:selected').val());
                        resulty += parseInt($('#confusiony option:selected').val());
                        $('#smartcopresulty').text(resulty);
                    }


                </script>

                <form onsubmit="return false" >
                    <h4 class="color-primary mrgn20b">Enter the patient obs to calculate a <b>SMARTCOP</b> score or scroll down to skip this step</h4>
                    <div class="form-group"><label for="systolicy"><b>S</b>ystolic BP:</label><input type="number" min="10" id="systolicy" name="systolicy" onchange="calcsmartcop();" required class="form-control"></div>
                    <div class="form-group"><label for="multilobary"><b>M</b>ultilobar chest involvement?:</label>
                        <select name="multilobary" id="multilobary" onchange="calcsmartcop();" class="form-control">
                            <option value="0">No</option>
                            <option value="1">Yes</option>
                        </select>
                    </div>
                    <div class="form-group"><label for="albuminy"><b>A</b>lbumin:</label><input type="number" min="0" id="albuminy" name="albuminy" onchange="calcsmartcop();" required class="form-control"></div>
                    <div class="form-group"><label for="respy"><b>R</b>espiratory rate (RPM):</label><input type="number" min="0" id="respy" name="respy" onchange="calcsmartcop();" required class="form-control"></div>
                    <div class="form-group"><label for="tachy"><b>T</b>achyardia? - Heart rate (BPM):</label><input type="number" min="0" id="tachy" name="tachy" onchange="calcsmartcop();" required class="form-control"></div>
                    <div class="form-group"><label for="confusiony"><b>C</b>onfusion? (new onset):</label>
                        <select name="confusiony" id="confusiony" onchange="calcsmartcop();" class="form-control">
                            <option value="0">No</option>
                            <option value="1">Yes</option>
                        </select>
                    </div>
                    <div class="form-group"><label for="oxyy"><b>O</b>xygen saturation(%):</label><input type="number" step="0.1" min="0" id="oxyy" name="oxyy" onchange="calcsmartcop();" required class="form-control"></div>
                    <div class="form-group"><label for="artery"><b>P</b>h (arterial pH):</label><input type="number" step="0.01" id="artery" name="artery" onchange="calcsmartcop();" required class="form-control"></div>
                    <p class="color-primary"><b>SMARTCOP SCORE: </b><strong><span id="smartcopresulty">0</span></strong></p>
                </form>
                <hr/>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a">Continue to treatment</a></li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap2 -->
        
        <!-- Start of cap page/ ?severity: #cap1a -->
        <div data-role="page" id="cap1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pneumonia?</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Grade severity based on both clinical impression and SMARTCOP score:</span>
                    <span class="font15"></span>
                </h4>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a1">Mild (&lt;3)</a></li>
                    <li><a href="#cap1a2">Moderate (&lt;3)</a></li>
                    <li><a href="#cap1a3">Severe (&ge;3)(non-ICU)</a></li>
                    <li><a href="#cap1a4">Severe (&ge;3)(ICU)</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>If clinical impression from a medical consultant is that the pneumonia is severe it should always be treated as severe regardless of the SMARTCOP score</li>
                    <li>Any patient with a SMARTCOP score of 3 or more should be treated as severe regardless of clinical impression</li>
                    <li>Any patient which meets the criteria for severe sepsis (see IFD severe sepsis protocol for details) or any patients accepted into ICU or transferred to ICU should be treated as severe (ICU)</li>
                </ul>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a -->
        
        <!-- Start of cap page: mild ?pen all #cap1a1 -->
        <div data-role="page" id="cap1a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a1c">No penicillin allergy</a></li> 
                    <li><a href="#cap1a1a1">Minor penicillin allergy</a></li>
                    <li><a href="#cap1a1b">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1 -->
        
        <!-- Start of cap page: Moderate ?pen all #cap1a2 -->
        <div data-role="page" id="cap1a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2c">No penicillin allergy</a></li>
                    <li><a href="#cap1a2a">Minor penicillin allergy</a></li>
                    <li><a href="#cap1a2b">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2 -->
        
        <!-- Start of cap page: sev ?pen all #cap1a3 -->
        <div data-role="page" id="cap1a3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3c">No penicillin allergy</a></li>  
                    <li><a href="#cap1a3a">Minor penicillin allergy</a></li>
                    <li><a href="#cap1a3b">Penicillin anaphylaxis</a></li> 
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3 -->
        
        <!-- Start of cap page: sevICU ?pen all #cap1a4 -->
        <div data-role="page" id="cap1a4" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a4c">No penicillin allergy</a></li>
                    <li><a href="#cap1a4a1">Minor penicillin allergy</a></li>
                    <li><a href="#cap1a4a1">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a4 -->
        
        <!-- Start of cap page: mild pen OK ?melioid #cap1a1c -->
        <div data-role="page" id="cap1a1c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a1c1">Yes</a></li>
                    <li><a href="#cap1a1c2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis),
                        chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th class="bg-success">Organism</th>
                            <th class="bg-success">Number of cases</th>
                            <th class="bg-success">Percentage of total admissions</th>
                            <th class="bg-success">Number of total deaths</th>
                            <th class="bg-success">Percentage of total deaths</th>
                            <th class="bg-success">Mortality rate (%)</th>
                        </tr>

                        <tr>
                            <td class="bg-success">Streptococcus pneumoniae</td>
                            <td>100</td>
                            <td>39%</td>
                            <td>17</td>
                            <td>20%</td>
                            <td>17%</td>
                        </tr>         

                        <tr>
                            <td class="bg-success">Burkholderia pseudomallei</td>
                            <td>60</td>
                            <td>24%</td>
                            <td>30</td>
                            <td>36%</td>
                            <td>50%</td>
                        </tr>

                        <tr>
                            <td class="bg-success">Staphylococcus aureus</td>
                            <td>29</td>
                            <td>11%</td>
                            <td>11</td>
                            <td>13%</td>
                            <td>38%</td>
                        </tr>  

                        <tr>
                            <td class="bg-success">Acinetobacter baumannii</td>
                            <td>26</td>
                            <td>10%</td>
                            <td>14</td>
                            <td>17%</td>
                            <td>54%</td>
                        </tr>  
                    </table>
                </div>
                <ul class="line30">
                    <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1c -->
        
        <!-- Start of cap page: Moderate pen mild ?melioid #cap1a2a -->
        <div data-role="page" id="cap1a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1">Yes</a></li>
                    <li><a href="#cap1a2a2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis), chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th class="bg-success">Organism</th>
                            <th class="bg-success">Number of cases</th>
                            <th class="bg-success">Percentage of total admissions</th>
                            <th class="bg-success">Number of total deaths</th>
                            <th class="bg-success">Percentage of total deaths</th>
                            <th class="bg-success">Mortality rate (%)</th>
                        </tr>

                        <tr>
                            <td class="bg-success">Streptococcus pneumoniae</td>
                            <td>100</td>
                            <td>39%</td>
                            <td>17</td>
                            <td>20%</td>
                            <td>17%</td>
                        </tr>         

                        <tr>
                            <td class="bg-success">Burkholderia pseudomallei</td>
                            <td>60</td>
                            <td>24%</td>
                            <td>30</td>
                            <td>36%</td>
                            <td>50%</td>
                        </tr>

                        <tr>
                            <td class="bg-success">Staphylococcus aureus</td>
                            <td>29</td>
                            <td>11%</td>
                            <td>11</td>
                            <td>13%</td>
                            <td>38%</td>
                        </tr>  

                        <tr>
                            <td class="bg-success">Acinetobacter baumannii</td>
                            <td>26</td>
                            <td>10%</td>
                            <td>14</td>
                            <td>17%</td>
                            <td>54%</td>
                        </tr> 
                    </table>
                </div>
                <ul class="line30">
                    <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a-->
        
        <!-- Start of cap page: Moderate pen BAD ?melioid #cap1a2b -->
        <div data-role="page" id="cap1a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1">Yes</a></li>
                    <li><a href="#cap1a2b2">No</a></li>
                </ul>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis), chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th class="bg-success">Organism</th>
                            <th class="bg-success">Number of cases</th>
                            <th class="bg-success">Percentage of total admissions</th>
                            <th class="bg-success">Number of total deaths</th>
                            <th class="bg-success">Percentage of total deaths</th>
                            <th class="bg-success">Mortality rate (%)</th>
                        </tr>

                        <tr>
                            <td class="bg-success">Streptococcus pneumoniae</td>
                            <td>100</td>
                            <td>39%</td>
                            <td>17</td>
                            <td>20%</td>
                            <td>17%</td>
                        </tr>         

                        <tr>
                            <td class="bg-success">Burkholderia pseudomallei</td>
                            <td>60</td>
                            <td>24%</td>
                            <td>30</td>
                            <td>36%</td>
                            <td>50%</td>
                        </tr>

                        <tr>
                            <td class="bg-success">Staphylococcus aureus</td>
                            <td>29</td>
                            <td>11%</td>
                            <td>11</td>
                            <td>13%</td>
                            <td>38%</td>
                        </tr>  

                        <tr>
                            <td class="bg-success">Acinetobacter baumannii</td>
                            <td>26</td>
                            <td>10%</td>
                            <td>14</td>
                            <td>17%</td>
                            <td>54%</td>
                        </tr>  
                    </table>
                </div>
                <ul class="line30">
                    <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b-->
        
        <!-- Start of cap page: Moderate pen OK ?melioid #cap1a2c -->
        <div data-role="page" id="cap1a2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2c1">Yes</a></li>
                    <li><a href="#cap1a2c2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis),
                        chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th class="bg-success">Organism</th>
                            <th class="bg-success">Number of cases</th>
                            <th class="bg-success">Percentage of total admissions</th>
                            <th class="bg-success">Number of total deaths</th>
                            <th class="bg-success">Percentage of total deaths</th>
                            <th class="bg-success">Mortality rate (%)</th>
                        </tr>

                        <tr>
                            <td class="bg-success">Streptococcus pneumoniae</td>
                            <td>100</td>
                            <td>39%</td>
                            <td>17</td>
                            <td>20%</td>
                            <td>17%</td>
                        </tr>         

                        <tr>
                            <td class="bg-success">Burkholderia pseudomallei</td>
                            <td>60</td>
                            <td>24%</td>
                            <td>30</td>
                            <td>36%</td>
                            <td>50%</td>
                        </tr>

                        <tr>
                            <td class="bg-success">Staphylococcus aureus</td>
                            <td>29</td>
                            <td>11%</td>
                            <td>11</td>
                            <td>13%</td>
                            <td>38%</td>
                        </tr>  

                        <tr>
                            <td class="bg-success">Acinetobacter baumannii</td>
                            <td>26</td>
                            <td>10%</td>
                            <td>14</td>
                            <td>17%</td>
                            <td>54%</td>
                        </tr>  
                    </table>
                </div>
                <ul class="line30">
                    <li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2c-->
        
        <!-- Start of cap page: SEVERE pen MILD ?melioid #cap1a3a -->
        <div data-role="page" id="cap1a3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3a1">Yes</a></li>
                    <li><a href="#cap1a3a2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis),
                        chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <table class="table table-bordered table-striped">
                    <tr>
                        <th class="bg-success">Organism</th>
                        <th class="bg-success">Number of cases</th>
                        <th class="bg-success">Percentage of total admissions</th>
                        <th class="bg-success">Number of total deaths</th>
                        <th class="bg-success">Percentage of total deaths</th>
                        <th class="bg-success">Mortality rate (%)</th>
                    </tr>

                    <tr>
                        <td class="bg-success">Streptococcus pneumoniae</td>
                        <td>100</td>
                        <td>39%</td>
                        <td>17</td>
                        <td>20%</td>
                        <td>17%</td>
                    </tr>         

                    <tr>
                        <td class="bg-success">Burkholderia pseudomallei</td>
                        <td>60</td>
                        <td>24%</td>
                        <td>30</td>
                        <td>36%</td>
                        <td>50%</td>
                    </tr>

                    <tr>
                        <td class="bg-success">Staphylococcus aureus</td>
                        <td>29</td>
                        <td>11%</td>
                        <td>11</td>
                        <td>13%</td>
                        <td>38%</td>
                    </tr>  

                    <tr>
                        <td class="bg-success">Acinetobacter baumannii</td>
                        <td>26</td>
                        <td>10%</td>
                        <td>14</td>
                        <td>17%</td>
                        <td>54%</td>
                    </tr>  
                </table>
                <ul class="line30"><li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a-->
        
        <!-- Start of cap page: SEVERE pen BAD ?melioid #cap1a3b -->
        <div data-role="page" id="cap1a3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3b1">Yes</a></li>
                    <li><a href="#cap1a3b2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis),
                        chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th class="bg-success">Organism</th>
                            <th class="bg-success">Number of cases</th>
                            <th class="bg-success">Percentage of total admissions</th>
                            <th class="bg-success">Number of total deaths</th>
                            <th class="bg-success">Percentage of total deaths</th>
                            <th class="bg-success">Mortality rate (%)</th>
                        </tr>

                        <tr>
                            <td class="bg-success">Streptococcus pneumoniae</td>
                            <td>100</td>
                            <td>39%</td>
                            <td>17</td>
                            <td>20%</td>
                            <td>17%</td>
                        </tr>         

                        <tr>
                            <td class="bg-success">Burkholderia pseudomallei</td>
                            <td>60</td>
                            <td>24%</td>
                            <td>30</td>
                            <td>36%</td>
                            <td>50%</td>
                        </tr>

                        <tr>
                            <td class="bg-success">Staphylococcus aureus</td>
                            <td>29</td>
                            <td>11%</td>
                            <td>11</td>
                            <td>13%</td>
                            <td>38%</td>
                        </tr>  

                        <tr>
                            <td class="bg-success">Acinetobacter baumannii</td>
                            <td>26</td>
                            <td>10%</td>
                            <td>14</td>
                            <td>17%</td>
                            <td>54%</td>
                        </tr>  
                    </table>
                </div>
                <ul class="line30"><li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b-->
        
        <!-- Start of cap page: SEVERE pen OK ?melioid #cap1a3c -->
        <div data-role="page" id="cap1a3c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have any risk factors for melioid?</span>
                    <span class="font15"> (See below for a summary of melioid risk factors)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3c1">Yes</a></li>
                    <li><a href="#cap1a3c2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for melioid include: Diabetes, hazardous alcohol use, chronic lung disease (including COPD and bronchiectasis),
                        chronic renal failure (eGFR&lt;50ml/min), steroid or other immunosuppressive therapy.</li>
                    <li>Melioidosis can occur in immunocompetent individuals and should not be discounted if pneumonia becomes severe</li>
                    <li>For detailed information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC. Please see below for the 1996-1998 rates of infection for the Top End</li>
                </ul>
                <h4 class="color-primary mrgn20b">Adult community-acquired bacteremic pneumonia: RDH 1986 - 1998</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th class="bg-success">Organism</th>
                            <th class="bg-success">Number of cases</th>
                            <th class="bg-success">Percentage of total admissions</th>
                            <th class="bg-success">Number of total deaths</th>
                            <th class="bg-success">Percentage of total deaths</th>
                            <th class="bg-success">Mortality rate (%)</th>
                        </tr>

                        <tr>
                            <td class="bg-success">Streptococcus pneumoniae</td>
                            <td>100</td>
                            <td>39%</td>
                            <td>17</td>
                            <td>20%</td>
                            <td>17%</td>
                        </tr>         

                        <tr>
                            <td class="bg-success">Burkholderia pseudomallei</td>
                            <td>60</td>
                            <td>24%</td>
                            <td>30</td>
                            <td>36%</td>
                            <td>50%</td>
                        </tr>

                        <tr>
                            <td class="bg-success">Staphylococcus aureus</td>
                            <td>29</td>
                            <td>11%</td>
                            <td>11</td>
                            <td>13%</td>
                            <td>38%</td>
                        </tr>  

                        <tr>
                            <td class="bg-success">Acinetobacter baumannii</td>
                            <td>26</td>
                            <td>10%</td>
                            <td>14</td>
                            <td>17%</td>
                            <td>54%</td>
                        </tr>  
                    </table>
                </div>
                <ul class="line30"><li>Taken from the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c-->
        
        <!-- Start of cap page: MILD pen OK Melioid YES #cap1a1c1 -->
        <div data-role="page" id="cap1a1c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a1c1a">Yes</a></li>
                    <li><a href="#cap1a1c1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1c1-->
        
        <!-- Start of cap page: MILD pen OK Melioid NO #cap1a1c2 -->
        <div data-role="page" id="cap1a1c2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a1c1a">Yes</a></li>
                    <li><a href="#cap1a1c1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1c2-->
        
        <!-- Start of cap page: MODERATE pen MILD Melioid YES #cap1a2a1 -->
        <div data-role="page" id="cap1a2a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a">Yes</a></li>
                    <li><a href="#cap1a2a1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1-->
        
        <!-- Start of cap page: MODERATE pen MILD Melioid NO #cap1a2a2 -->
        <div data-role="page" id="cap1a2a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Yes</a></li>
                    <li><a href="#cap1a2a1b1">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a2-->
        
        <!-- Start of cap page: MODERATE pen BAD Melioid YES #cap1a2b1 -->
        <div data-role="page" id="cap1a2b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1a">Yes</a></li>
                    <li><a href="#cap1a2b1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1-->
        
        <!-- Start of cap page: MODERATE pen BAD Melioid NO #cap1a2b2 -->
        <div data-role="page" id="cap1a2b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1a1">Yes</a></li>
                    <li><a href="#cap1a2b1b1">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b2-->
        
        <!-- Start of cap page: MODERATE pen OK Melioid YES #cap1a2c1 -->
        <div data-role="page" id="cap1a2c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2c1a">Yes</a></li>
                    <li><a href="#cap1a2c1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2c1-->
        
        <!-- Start of cap page: MODERATE pen OK Melioid NO #cap1a2c2 -->
        <div data-role="page" id="cap1a2c2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2c2a">Yes</a></li>
                    <li><a href="#cap1a2a1b1">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2c2-->
        
        <!-- Start of cap page: SEVERE pen MILD Melioid YES #cap1a3a1 -->
        <div data-role="page" id="cap1a3a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3a1a">Yes</a></li>
                    <li><a href="#cap1a3a1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a1-->
        
        <!-- Start of cap page: SEVERE pen MILD Melioid NO #cap1a3a2 -->
        <div data-role="page" id="cap1a3a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3a2a">Yes</a></li>
                    <li><a href="#cap1a3a2b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a2-->
        
        <!-- Start of cap page: SEVERE pen BAD Melioid YES #cap1a3b1 -->
        <div data-role="page" id="cap1a3b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3b1a">Yes</a></li>
                    <li><a href="#cap1a3b1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b1-->
        
        <!-- Start of cap page: SEVERE pen BAD Melioid NO #cap1a3b2 -->
        <div data-role="page" id="cap1a3b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3b2a">Yes</a></li>
                    <li><a href="#cap1a3b2b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b2-->
        
        <!-- Start of cap page: SEVERE pen OK Melioid YES #cap1a3c1 -->
        <div data-role="page" id="cap1a3c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3c1a">Yes</a></li>
                    <li><a href="#cap1a3c1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c1-->
        
        <!-- Start of cap page: SEVERE pen OK Melioid NO #cap1a3c2 -->
        <div data-role="page" id="cap1a3c2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient likely to require atypical cover?</span>
                    <span class="font15"> (See below for a summary of when to consider atypical cover)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3c2a">Yes</a></li>
                    <li><a href="#cap1a3c2b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues
                        (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>There is a general impression that there are fewer cases of “atypical” pneumonia in patients admitted to RDH in comparison to southern hospitals. However formal assessment of this has not been undertaken and occasional cases of severe CAP from Mycoplasma pneumoniae, Legionella pneumophila or L. longbeachae are diagnosed in patients admitted to RDH intensive care unit (ICU), with some requiring ventilation.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c2-->
        
        <!--start of CAP gent q#cap1a3a1a -->
        <div data-role="page" id="cap1a3a1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a1a -->
        
        <!--start of CAP gent q#cap1a3a1b -->
        <div data-role="page" id="cap1a3a1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a1b -->
        
        <!--start of CAP gent q#cap1a3a2a -->
        <div data-role="page" id="cap1a3a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a2a -->
        
        <!--start of CAP gent q#cap1a3a2b -->
        <div data-role="page" id="cap1a3a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3a2b -->
        
        <!--start of CAP gent q#cap1a3b1a -->
        <div data-role="page" id="cap1a3b1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2b1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b1a -->
        
        <!--start of CAP gent q#cap1a3b1b -->
        <div data-role="page" id="cap1a3b1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3b1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2b1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b1b -->
        
        <!--start of CAP gent q#cap1a3b2a -->
        <div data-role="page" id="cap1a3b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2b1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b2a -->
        
        <!--start of CAP gent q#cap1a3b2b -->
        <div data-role="page" id="cap1a3b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a3b1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2b1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b2b -->
        
        <!--start of CAP gent q#cap1a3c1a -->
        <div data-role="page" id="cap1a3c1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c1a -->
        
        <!--start of CAP gent q#cap1a3c1b -->
        <div data-role="page" id="cap1a3c1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid"> 
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c1b -->
        
        <!--start of CAP gent q#cap1a3c2a -->
        <div data-role="page" id="cap1a3c2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c2a -->
        
        <!--start of CAP gent q#cap1a3c2b -->
        <div data-role="page" id="cap1a3c2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3c2b -->
        
        <!--start of CAP gent q#cap1a2a1a -->
        <div data-role="page" id="cap1a2a1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1a -->
        
        <!--start of CAP gent q#cap1a2b1a -->
        <div data-role="page" id="cap1a2b1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2b1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1a -->
        
        <!--start of CAP gent q#cap1a2b1a -->
        <div data-role="page" id="cap1a2c1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2c1a -->
        
        <!--start of CAP gent q#cap1a2a1b -->
        <div data-role="page" id="cap1a2a1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1b -->
        
        <!--start of CAP gent q#cap1a2b1b -->
        <div data-role="page" id="cap1a2b1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2b1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2b1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1b -->
        
        <!--start of CAP gent q#cap1a2c1b -->
        <div data-role="page" id="cap1a2c1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a2a1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#cap1a2a1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2c1b -->
        
        <!-- Start of cap page: SEVERE pen OK ?wet #cap1a4c -->
        <div data-role="page" id="cap1a4c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap1a4a1">Wet season</a></li>
                    <li><a href="#cap1a4c2">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a4c-->
        
        <!------TREATMENTS FOR CAP BEGIN----->
        <!-- Start of CAP Sev MILD, Pen MILD, Melioid YES, atypicals YES, : #cap1a1a1 -->
        <div data-role="page" id="cap1a1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with oral antibiotic therapy where possible:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>As either monotherapy, or with addition of either</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefuroxime 500mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g IV,</span>
                    <span class="font15"> daily for 1-3 days then switch to oral</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for cefuroxime is:</span>
                    <span class="font15 bold"> 5<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past ten days. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                    <li>NB if discharging a patient home on cefuroxime only 3.5 days of 500mg bd dosage may be supplied through the PBS. For a duration any longer than three and a half days PBS will have to be contacted for an authority prescription</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1a1a -->
        
        <!-- Start of CAP Sev MILD, Pen BAD, Melioid YES, atypicals YES, : #cap1a1b -->
        <div data-role="page" id="cap1a1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with oral antibiotic therapy where possible:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>If compliance with oral antibiotics is unlikely then consider treating as for moderate pneumonia</li> 
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1b -->
        
        <!-- Start of CAP Sev MILD, Pen MILD, Melioid YES, atypicals YES, : #cap1a1c1a -->
        <div data-role="page" id="cap1a1c1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with oral antibiotic therapy where possible:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND either</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin 1g orally,</span>
                    <span class="font15"> every 8 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzylpenicillin 1.2g I.V,</span>
                    <span class="font15"> every 6 hours for 1-3 days then switch to oral</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1c1a -->
        
        <!-- Start of CAP Sev MILD, Pen OK, Melioid YES, atypicals NO, : #cap1a1c1b -->
        <div data-role="page" id="cap1a1c1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated as an outpatient with oral antibiotic therapy where possible:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin 1g orally,</span>
                    <span class="font15"> every 8 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzylpenicillin 1.2g I.V,</span>
                    <span class="font15"> every 6 hours for 1-3 days then switch to oral</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a1c1b -->
        
        <!-- Start of CAP Sev MOD, Pen MILD, Melioid YES, atypicals YES, GENT BAD : #cap1a2a1a1 -->
        <div data-role="page" id="cap1a2a1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g IV,</span>
                    <span class="font15"> daily until results of cultures available or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone as soon as appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1a1 -->
        
        <!-- Start of CAP Sev MOD, Pen MILD, Melioid YES, atypicals YES, GENT OK : #cap1a2a1a2 -->
        <div data-role="page" id="cap1a2a1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g IV,</span>
                    <span class="font15"> daily until results of cultures available or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> dosed as per the nomograms below;</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone as soon as appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>
                    <li>Please contact IFD if IV therapy with gentamicin is required after 48 hours</li>  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1a2 -->
        
        <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals YES, GENT BAD : #cap1a2b1a1 -->
        <div data-role="page" id="cap1a2b1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400mg orally,</span>
                    <span class="font15"> daily for 5-7 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1a1 -->
        
        <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals YES, GENT OK : #cap1a2b1a2 -->
        <div data-role="page" id="cap1a2b1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400mg orally,</span>
                    <span class="font15"> daily for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> dosed as per the nomograms below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1a2 -->
        
        <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals YES,: #cap1a2c2a -->
        <div data-role="page" id="cap1a2c2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 200mg orally,</span>
                    <span class="font15"> as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 100mg orally,</span>
                    <span class="font15"> every 12 hours for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzylpenicillin 1.2g IV,</span>
                    <span class="font15"> every 6 hours until results of cultures available or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2c2a -->
        
        <!-- Start of CAP Sev MOD, Pen OK, Melioid NO, atypicals YES,: #cap1a2a1b1 -->
        <div data-role="page" id="cap1a2a1b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g IV,</span>
                    <span class="font15"> daily until results of cultures available or patient meets switch to oral criteria (usually 2-3 days)</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>   
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1b1 -->
        
        <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals YES, GENT OK : #cap1a2a1b2 -->
        <div data-role="page" id="cap1a2a1b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 2g IV,</span>
                    <span class="font15"> daily for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> dosed as per the nomograms below;</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2a1b2 -->
        
        <!-- Start of CAP Sev MOD, Pen BAD, Melioid NO, atypicals NO, GENT NO: #cap1a2b1b1 -->
        <div data-role="page" id="cap1a2b1b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400mg orally</span>
                    <span class="font15"> daily for 5-7 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1b1 -->
        
        <!-- Start of CAP Sev MOD, Pen BAD, Melioid YES, atypicals NO, GENT OK : #cap1a2b1b2 -->
        <div data-role="page" id="cap1a2b1b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Community acquired pneumonia treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400mg Orally,</span>
                    <span class="font15"> daily for 5-7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> dosed as per the nomograms below;</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>
                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>
                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a2b1b2 -->
        
        <!-- Start of CAP Sev SEVERE, Pen BAD, Melioid YES, atypicals NO, GENT BAD: #cap1a3b1b1 -->
        <div data-role="page" id="cap1a3b1b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia in a patient with previous anaphylaxis to penicillin unable to tolerate gentamicin requires consultation with IFD. Start treatment with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400mg Orally or IV,</span>
                    <span class="font15"> as a single dose until IFD can be contacted for advice.</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD as soon as possible for advice on treatment in this patient</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>ONE</b> dose only. IFD must be contacted if treatment is to continue past one dose</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and melioid serology are sent to pathology for testing. Please see the Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline on the PGC for a full list of all relevant tests required</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a3b1b1 -->
        
        <!-- Start of CAP Sev ICU, Pen MILD, Wet YES, MRSA YES : #cap1a4a1 -->
        <div data-role="page" id="cap1a4a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Meropenem 1g IV,</span>
                    <span class="font15"> every 8 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if nMRSA is suspected or confirmed</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for meropenem, azithromycin and vancomycin (if required) is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>   
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a4a1 -->
        
        <!-- Start of CAP Sev ICU, Pen MILD, Wet YES : #cap1a4c2 -->
        <div data-role="page" id="cap1a4c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin/tazobactam 4/0.5g IV,</span>
                    <span class="font15"> every 6 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if nMRSA is suspected or confirmed</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for meropenem, azithromycin and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours
                </div>
                <hr/>
                <ul class="line30">
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on the PGC</li>
                    <li>It is important to use oral agents or a penicillin rather than ceftriaxone where appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>   
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap1a4c2 -->
        
        <!--------START CAP KIDS SECTION----->
        <!-- Start of cap page/ ?severity: #cap3a -->
        <div data-role="page" id="cap3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pneumonia?</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Grade severity based on clinical impression:</span>
                    <span class="font15"></span>
                </h4>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a1">Mild to Moderate</a></li>
                    <li><a href="#cap3a2">Severe</a></li>
                    <li><a href="#cap3a3">Severe (ICU)</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Any patient which meets the criteria for severe sepsis (see IFD severe sepsis protocol for details) or any patients accepted into ICU or transferred to ICU should be treated as "Severe (ICU)"</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a -->
        
        <!-- Start of cap page: mild-mod ?pen all #cap3a1 -->
        <div data-role="page" id="cap3a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a1c">No penicillin allergy</a></li>
                    <li><a href="#cap3a1a">Minor penicillin allergy</a></li>
                    <li><a href="#cap3a1a1">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a1 -->
        
        <!-- Start of cap page: Severe ?pen all #cap3a2 -->
        <div data-role="page" id="cap3a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a2c">No penicillin allergy</a></li>  
                    <li><a href="#cap3a2a">Minor penicillin allergy</a></li>
                    <li><a href="#cap3a2b">Penicillin anaphylaxis</a></li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2 -->
        
        <!-- Start of cap page: sev (ICU) ?pen all #cap3a3 -->
        <div data-role="page" id="cap3a3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a3c">No penicillin allergy</a></li>
                    <li><a href="#cap3a3a1">Minor penicillin allergy</a></li>
                    <li><a href="#cap3a3a1">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a3 -->
        
        <!-- Start of cap page: mild pen mild ?mycoplasma #cap3a1a -->
        <div data-role="page" id="cap3a1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                    <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a1a1">Yes</a></li>
                    <li><a href="#cap3a1a2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis, rhinorrhea and ear pain.</li>
                    <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease, can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                    <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in children who do not have asthma</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a1a -->
        
        <!-- Start of cap page: mild pen OK ?mycoplasma #cap3a1b -->
        <div data-role="page" id="cap3a1c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                    <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a1a1">Yes</a></li>
                    <li><a href="#cap3a1c2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis, rhinorrhea and ear pain.</li>
                    <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease, can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                    <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in children who do not have asthma</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a1c -->
        
        <!-- Start of cap page: Severe pen MILD ?mycoplasma #cap3a2a -->
        <div data-role="page" id="cap3a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                    <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a2a1">Yes</a></li>
                    <li><a href="#cap3a2a2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis, rhinorrhea and ear pain.</li>
                    <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease, can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                    <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in children who do not have asthma</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2a -->
        
        <!-- Start of cap page: Severe pen BAD ?mycoplasma #cap3a2b -->
        <div data-role="page" id="cap3a2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                    <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a2b1">Yes</a></li>
                    <li><a href="#cap3a2b2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis, rhinorrhea and ear pain.</li>
                    <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease, can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                    <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in children who do not have asthma</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2b -->
        
        <!-- Start of cap page: Severe pen OK ?mycoplasma #cap3a2c -->
        <div data-role="page" id="cap3a2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Is <i>Mycoplasma pneumoniae</i> infection suspected?</span>
                    <span class="font15"> (See below for a summary of <i>Mycoplasma pneumoniae</i> clinical features)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a2a1">Yes</a></li>
                    <li><a href="#cap3a2a2">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li><i>Mycoplasma</i> or other atypical cover should be considered if the patient has a prodrome of &gt; 1 week, a prominent headache, dry cough, diffuse interstitial pneumonitis or epidemiological clues (contact with known cases of “atypical” pneumonia, or if there is a current outbreak)</li>
                    <li>Clinical features of <i>Mycoplasma pneumoniae</i> infection include: concurrent pharyngitis, rhinorrhea and ear pain.</li>
                    <li>Skin rash, joint involvement or symptoms indicative of gastrointestinal tract, CNS or heart disease, can also indicate <i>Mycoplasma pneumoniae</i> infection.</li>
                    <li><i>Mycoplasma pneumoniae</i> infection may worsen asthma symptoms and can produce wheezing in children who do not have asthma</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2c -->
        
        <!-- Start of cap page: SEVERE ICU pen OK ?wet #cap3a3c -->
        <div data-role="page" id="cap3a3c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Community Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid"> 
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient being treated during the wet or dry season?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cap3a3a1">Wet season</a></li>
                    <li><a href="#cap3a3c2">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a3c-->
        
        <!------TREATMENTS FOR CAP BEGIN----->
        <!-- Start of CAP Sev MILD, Pen MILD, mycoplasma YES, : #cap3a1a1 -->
        <div data-role="page" id="cap3a1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated with oral antibiotic therapy where possible:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline (child 8 years or older) 2 mg/kg up to 100 mg orally,</span>
                    <span class="font15"> 12 hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if child is younger than 8 years or doxycycline not tolerated</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500 mg orally, </span>
                    <span class="font15"> daily for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500 mg IV,</span>
                    <span class="font15"> daily for 1-3 days then switch to oral</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for oral azithromycin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past FIVE days</div>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for IV azithromycin (if patient not tolerating oral) is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30"><li>It is important to use oral agents rather than ceftriaxone or cefotaxime whenever appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a1a1a -->
        
        <!-- Start of CAP Sev MILD, Pen MILD, mycoplasma NO, : #cap3a1a2 -->
        <div data-role="page" id="cap3a1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated with oral antibiotic therapy where possible:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500 mg orally, </span>
                    <span class="font15"> daily for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500 mg IV,</span>
                    <span class="font15"> daily for 1-3 days then switch to oral</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for oral azithromycin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>FIVE</b> days only. IFD must be contacted if treatment is to continue past FIVE days</div>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for IV azithromycin (if patient not tolerating oral) is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>It is important to use oral agents rather than ceftriaxone or cefotaxime as soon as appropriate, as overuse of third-generation cephalosporins within a hospital has been shown to lead to an increased incidence of infection with multi-resistant Gram negative organisms, C.difficile and MRSA</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a1a1a -->
        
        <!-- Start of CAP Sev MILD, Pen OK, mycoplasma NO, : #cap3a1c2 -->
        <div data-role="page" id="cap3a1c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild community acquired pneumonia should be treated with oral antibiotic therapy where possible. Use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin 25 mg/kg up to 1 g orally, </span>
                    <span class="font15"> 8 hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is not tolerating oral medications use:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzylpenicillin 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> 6 hourly for 1-3 days then switch to oral</span>
                </h4>
                <hr/>
                <ul class="line30"><li>Please see the switch to oral guideline on the PGC for details on when to best make the IV to oral switch</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a1c2 -->
        
        <!-- Start of CAP Sev SEVERE, Pen MILD, mycoplasma YES #cap3a2a1 -->
        <div data-role="page" id="cap3a2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For severe community acquired pneumonia in a patient with non-life threatening penicillin allergy empirically treat with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500 mg IV,</span>
                    <span class="font15"> daily until patient can switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> either:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> 8 hourly until patient can switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> daily until patient can switch to oral</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for IV azithromycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <ul class="line30">
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology for testing.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2a1 -->
        
        <!-- Start of CAP SEVERE, Pen MILD, Mycoplasma NO : #cap3a2a2 -->
        <div data-role="page" id="cap3a2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia in a patient with non-life threatening penicillin allergy should be treated with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefotaxime 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> 8 hourly until patient can switch to oral</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> daily until patient can switch to oral</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology for testing.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2a2 -->
        
        <!-- Start of CAP SEVERE, Pen BAD, Mycoplasma YES : #cap3a2b1 -->
        <div data-role="page" id="cap3a2b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia in a patient with life threatening penicillin allergy should be treated with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> as per the nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> to cover <i>Mycoplasma</i>:</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500 mg IV,</span>
                    <span class="font15"> daily until patient can switch to oral</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and azithromycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology for testing.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2b1 -->
        
        <!-- Start of CAP SEVERE, Pen BAD, Mycoplasma NO : #cap3a2b2 -->
        <div data-role="page" id="cap3a2b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia in a patient with life threatening penicillin allergy should be treated with:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> as per the nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                    <li>Please see the switch to oral guideline on the PGC for details on when the patient can qualify for the IV to oral switch</li>
                    <li>Ensure blood cultures, sputum gram stain and cultures and mycoplasma serology are sent to pathology for testing.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a2b2 -->
        
        <!-- Start of CAP Sev ICU, Wet YES : #cap3a3a1 -->
        <div data-role="page" id="cap3a3a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia for ICU admission:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Meropenem 25mg/Kg up to 1g IV,</span>
                    <span class="font15"> every 8 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 10mg/Kg up to 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin, meropenem and azithromycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30"><li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a3a1 -->
        
        <!-- Start of CAP Sev ICU, Wet NO : #cap3a3c2 -->
        <div data-role="page" id="cap3a3c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Community Acquired pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe community acquired pneumonia for ICU admission:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin/tazobactam 100mg/Kg up to 4g (based on piperacillin component only) IV,</span>
                    <span class="font15"> every 6 hours</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Azithromycin 15mg/Kg up to 500mg IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin, azithromycin and vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getcode())</script>cap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>TWO</b> days only. IFD must be contacted if IV treatment is to continue past 48 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Timing of first trough concentration</th>
                        </tr>
                        <tr>
                            <td>Infants and children less than 12 years</td>
                            <td>15mg/kg 6 hourly</td>
                            <td>Before the sixth dose</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30"><li>Switch to oral therapy when systemic features have improved (see switch to oral guideline on the PGC for details)</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cap3a3c2 -->
        <!--------END CAP KIDS SECTION----->
        
        <!-- START of HAP treatment maze -->
        <!-- Start of HAP page: #hap -->
        <div data-role="page" id="hap" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there a chance of an MDR organism?</span>
                    <span class="font15"> (Please see below for a list of risk factors for colonisation with an Multi-Drug Resistant (MDR) organism)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap1">Low risk of MDR</a></li>
                    <li><a href="#hap2">High risk of MDR</a></li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Mulridrug Resistant Organism Risk Factors</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Lower Risk of MDR Organisms</th>
                            <th>Higher Risk of MDR Organisms</th>
                        </tr>
                        <tr>
                            <td>Hospitalisation in a lower risk ward such as 7C, 6A or 3A</td>
                            <td>Hospitalisation in a high risk ward for more than 5 days</td>
                        </tr>
                        <tr>
                            <td>Hospital stay in any ward for less than 5 days</td>
                            <td>Recent treatment with antibiotics</td> 
                        </tr>
                        <tr>
                            <td></td>
                            <td>Recent hospital admission or admission from a nursing home</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Immunosuppression</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap -->
        
        <!-- Start of hap page MDR LOW: ?severity #hap1 -->
        <div data-role="page" id="hap1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the pneumonia?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap1a">Mild</a></li>
                    <li><a href="#hap1b">Moderate</a></li>
                    <li><a href="#hap1b1">Severe</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1 -->
        
        <!-- Start of HAP MDR LOW, MILD page: penicillin Q? #hap1a -->
        <div data-role="page" id="hap1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap1a3">No penicillin allergy</a></li>
                    <li><a href="#hap1a1">Minor penicillin allergy</a></li>
                    <li><a href="#hap1a2">Penicillin anaphylaxis</a></li>    
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1a -->
        
        <!-- Start of hap page MDR LOW, SEV MODERATE: ?aspirate #hap1b -->
        <div data-role="page" id="hap1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there a chance of anaerobic infection?</span>
                    <span class="font15"> (Please see below for risk factors for anaerobic infection)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap1b1">Yes</a></li>
                    <li><a href="#hap1a">No</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for anaerobic infection include:</li>
                    <li>Putrid sputum, severe periodontal disease or a history of chronic hazardous alcohol consumption</li>
                    <li>Presence of lung abscess, empyema or necrotising pneumonia</li>>
                    <li>Failure to respond to initial empiric therapy</li>
                </ul>
                
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1b -->
        
        <!-- Start of HAP MDR NO, SEV MODER, ASPIR YES Penicillin Q? #hap1b1 -->
        <div data-role="page" id="hap1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap1b1c">No penicillin allergy</a></li>
                    <li><a href="#hap1b1a">Minor penicillin allergy</a></li>
                    <li><a href="#hap1b1b">Penicillin anaphylaxis</a></li>    
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1b1 -->
        
        <!-- Start of HAP MDR YES, Penicillin Q? #hap2 -->
        <div data-role="page" id="hap2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap2c">No penicillin allergy</a></li>
                    <li><a href="#hap2a">Minor penicillin allergy</a></li>
                    <li><a href="#hap2b">Penicillin anaphylaxis</a></li>    
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2 -->
        
        <!-- Start of hap Tx MDR NO, MILD, PEN MILD: #hap1a1 -->
        <div data-role="page" id="hap1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient is hypersensitive to penicillin (non-life threatening reaction) use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefuroxime 500 mg (child 3 months to 2 years: 10 mg/kg up to 125 mg; 2 years or older: 15 mg/kg up to 500 mg) orally or enterally,</span>
                    <span class="font15"> 12-hourly for 8 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV,</span>
                    <span class="font15"> daily for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Broader anaerobic cover is not normally required for mild hospital acquired pneumonia</li>
                    <li>If pneumonia is the likely diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                    <li>Cefuroxime is preferred to cephalexin or cefaclor due to superior antipneumococcal activity</li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1a1 -->
        
        <!-- Start of hap Tx MDR NO, MILD, PEN BAD: #hap1a2 -->
        <div data-role="page" id="hap1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient is immediately hypersensitive to penicillin (life threatening reaction) use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400 mg orally or enterally, </span>
                    <span class="font15"> daily for 8 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400 mg IV,</span>
                    <span class="font15"> daily for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for treatment options for a child immediately hypersensitive to penicillin</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 8<script> document.write(getcode())</script>hap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>EIGHT</b> days only. IFD must be contacted if treatment is to continue past eight days</div>
                <hr/>
                <ul class="line30">
                    <li>Broader anaerobic cover is not normally required for mild hospital acquired pneumonia</li>
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1a2 -->
        
        <!-- Start of hap Tx MDR NO, MILD, PEN OK: #hap1a3 -->
        <div data-role="page" id="hap1a3" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient tolerates penicillin use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg (child: 22.5+3.2 mg/kg up to 875+125 mg) orally or enterally, </span>
                    <span class="font15">12 hourly for 8 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV,</span>
                    <span class="font15"> daily for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Broader anaerobic cover is not normally required for mild hospital acquired pneumonia</li>
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1a2 -->
        
        <!-- Start of hap Tx MDR NO, MODER, PEN MILD, ASPIR NO: #hap1b1a -->
        <div data-role="page" id="hap1b1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient is hypersensitive to penicillin (non-life threatening reaction) use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefuroxime 500 mg (child 3 months to 2 years: 10 mg/kg up to 125 mg; 2 years or older: 15 mg/kg up to 500 mg) orally or enterally,</span>
                    <span class="font15"> 12-hourly for 8 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV,</span>
                    <span class="font15"> daily for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> For anaerobic cover;</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, </span>
                    <span class="font15"> 12 hourly for 8 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> 12 hourly for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <hr/>
                <ul class="line30"><li>Cefuroxime is preferred to cephalexin or cefaclor due to superior antipneumococcal activity</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1b1a -->
        
        <!-- Start of hap Tx MDR NO, MODER, ASPIR NO, PEN BAD, : #hap1b1b -->
        <div data-role="page" id="hap1b1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient is immediately hypersensitive to penicillin (life threatening reaction) use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400 mg orally or enterally, </span>
                    <span class="font15"> daily for 8 days.</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Moxifloxacin 400 mg IV,</span>
                    <span class="font15"> daily for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> For anaerobic cover</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, </span>
                    <span class="font15"> 12 hourly for 8 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> 12 hourly for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for treatment options for a child immediately hypersensitive to penicillin</span>
                </h4>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for moxifloxacin is:</span>
                    <span class="font15 bold"> 8<script> document.write(getcode())</script>hap</span>
                </h4>
                <hr/>
                <div class="alert alert-info text-center">This code is valid for <b>EIGHT</b> days only. IFD must be contacted if treatment is to continue past eight days</div>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1b1b -->
        
        <!-- Start of hap Tx MDR NO, MODER, ASPIR NO, PEN OK, : #hap1b1c -->
        <div data-role="page" id="hap1b1c" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient tolerates penicillin use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g (child 1 month or older: 50 mg/kg up to 1 g) IV,</span>
                    <span class="font15"> daily for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> For anaerobic cover</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally or enterally, </span>
                    <span class="font15"> 12 hourly for 8 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If patient is not tolerating oral or enteral medications</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> 12 hourly for 8 days or until tolerating oral antibiotics</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap1b1c -->
        
        <!-- Start of HAP MDR YES, Penicillin BAD, ?MRSA #hap2b -->
        <div data-role="page" id="hap2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>HAP Treatment:</h1>
            </div>
            <!-- /header -->
            <div class="container-fluid">
                <h4 class="mrgn20b">
                    <span class="color-primary">If patient has penicillin hypersensitivity treatment is complex, please contact IFD for advice</span>
                </h4>
            </div>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2b -->
        
        <!-- Start of HAP MDR YES, Penicillin OK, ?MRSA #hap2c -->
        <div data-role="page" id="hap2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have signs of severe sepsis?</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap2c1">Yes</a></li>
                    <li><a href="#hap2c2">No</a></li> 
                </ul>
                <hr/>
                <ul class="line30"><li>See the IFD:Initial management of severe sepsis protocol for information on identifying a septic patient</li></ul>
            </div>
            <!-- /content --> 
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2c -->
        
        <!-- Start of HAP MDR YES, Penicillin OK, ?MRSA #hap2c1 -->
        <div data-role="page" id="hap2c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there a risk of MDR gram negative pathogens?</span>
                    <span class="font15"> (See below for details)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap2c1a">Yes</a></li>
                    <li><a href="#hap2c2">No</a></li> 
                </ul>
                <hr/>
                <ul class="line30"><li>Patients with extensive previous antibiotic treatment should have additional treatment for possible Pseudomonas or MDR gram negative organisms</li> </ul>
            </div>
            <!-- /content --> 
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2c -->
        
        <!-- Start of HAP MDR YES, PEN OK, V SEPTIC YES,: Gent question #hap2c1a -->
        <div data-role="page" id="hap2c1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Hospital Acquired Pneumonia:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#hap2c1a1">Gentamicin contraindicated</a></li>
                    <li><a href="#hap2c1a2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2c2a -->
        
        <!-- Start of HAP MDR YES, Penicillin MILD, MRSA YES #hap2a -->
        <div data-role="page" id="hap2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cefepime 2 g (child: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> as per dosage nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for cefepime and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>hap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                    <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                    <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is very uncommon in this setting.</li>
                    <li>In patients with severe disease who have recently been treated with the above drugs meropenem may be required. Please contact IFD if your patient meets this criteria</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2a -->
        
        <!-- Start of HAP MDR YES, Penicillin OK, Severe sepsis; NO #hap2c2 -->
        <div data-role="page" id="hap2c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> as per dosage nomogram below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin and vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>hap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info text-center">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                    <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                    <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is very uncommon in this setting.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2c2 -->
        
        <!-- Start of HAP MDR YES, Pen OK, Severe sepsis YES, GENT NO #hap2c1a1 -->
        <div data-role="page" id="hap2c1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> as per dosage nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) IV,</span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin, piperacillin and ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>hap</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours. Please annotate when IFD are to be contacted on eMMa and in patient notes</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                    <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                    <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is very uncommon in this setting.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2c1a1 -->
        
        <!-- Start of HAP MDR YES, Pen OK, Severe YES, Gent YES #hap2c1a2 -->
        <div data-role="page" id="hap2c1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>HAP treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has not had a life threatening penicillin reaction use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) IV,</span>
                    <span class="font15"> 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> as per dosage nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin 4 to 7 mg/kg (child: 7.5 mg/kg up to 320 mg) IV,</span>
                    <span class="font15"> for the first dose, then dose as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for piperacillin, vancomycin and gentamicin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>hap</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info text-center">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td>Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td>1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td>1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td>2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td>2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td>3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>---</td>
                        </tr>
                        <tr>
                            <td>Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td>48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td>Before the 3<sup>rd</sup> dose</td>
                            <td>Before the <br/>4<sup>th</sup> dose</td>
                            <td>---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>  
                <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing (Age &lt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td rowspan ="3">neonates younger than 30 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>5 mg/kg</td>
                            <td>48-hourly</td>
                            <td>2 doses (at 0 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>postnatal age 8 to 28 days</td>
                            <td>4 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>

                        <tr>
                            <td>postnatal age 29 days or older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">neonates 30 to 34 weeks postmenstrual age</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>4.5 mg/kg</td>
                            <td>36-hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>
                        </tr>

                        <tr>
                            <td>postnatal age 8 days and older</td>
                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td colspan ="2">neonates 35 weeks postmenstrual age or older </td>

                            <td>4 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td colspan ="2">infants and children</td>
                            <td>7.5 mg/kg</td>
                            <td>24-hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>
                    </table>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing Age &gt; 12 Years</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is essential to collect blood and, if possible, expectorated sputum for cultures before antibiotics are given</li>
                    <li>Consider stopping antibiotic treatment after 48 to 72 hours when patients are improving and culture-negative, if an alternative diagnosis is likely. Otherwise, if pneumonia is the likely diagnosis, and the patient has clinically improved, and no MDR pathogens are isolated from cultures by 48 to 72 hours, consider de-escalating antibiotic therapy</li>
                    <li>Azithromycin is not required for empirical treatment of HAP or VAP unless Legionella pneumonia is strongly suspected based on clinical presentation and/or risk factors. Infection with Legionella is very uncommon in this setting.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hap2c1a2 -->
        <!-- END of HAP treatment maze -->
        <!-- End of Pneumonias YOOOOOOOOOO!-->
        
        <!-- start of pyelonephritis treatment maze -->
        <!-- Start of pyelonephritis page: #pyelo -->
        <div data-role="page" id="pyelo" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15">See below for details on penicillin allergy severity</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo3">No penicillin allergy</a></li>   
                    <li><a href="#pyelo1">Minor penicillin allergy</a></li>
                    <li><a href="#pyelo2">Penicillin anaphylaxis</a></li> 
                </ul>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy: #pyelo1 -->
        <div data-role="page" id="pyelo1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient a child? Or adult with mild or severe pyelonephritis?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo1c">Paediatric patient</a></li>
                    <li><a href="#pyelo1a">Adult, mild pyelonephritis</a></li>
                    <li><a href="#pyelo1b">Adult, severe pyelonephritis</a></li>
                </ul>
            </div>
            <hr/>
            <ul class="line30"><li>Always choose severe pyelonephritis for any adult if the patient has either fever or nausea and vomiting</li></ul>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1 -->
        
        <!-- Start of pyelonephritis Tx with mild Penicillin Allergy MILD: #pyelo1a -->
        <div data-role="page" id="pyelo1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild pyelonephritis is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 6-hourly for 10 to 14 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 10 to 14 days</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1a -->
        
        <!-- Start of pyelonephritis Tx with mild Penicillin Allergy SEVERE: #pyelo1b -->
        <div data-role="page" id="pyelo1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo1b1">Gentamicin contraindicated</a></li>
                    <li><a href="#pyelo1b2">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent BAD #pyelo1b1 -->
        <div data-role="page" id="pyelo1b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment::</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to aminoglycosides as a single drug give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1b1 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent OK #pyelo1b2 -->
        <div data-role="page" id="pyelo1b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV </span>
                    <span class="font15"> dosed as per tables below;</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1b2 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy: #pyelo2 -->
        <div data-role="page" id="pyelo2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient a child? Or adult with mild or severe pyelonephritis?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo2c">Paediatric patient</a></li>
                    <li><a href="#pyelo2a">Adult, mild pyelonephritis</a></li>
                    <li><a href="#pyelo2b">Adult, severe pyelonephritis</a></li>
                </ul>
                <hr/>
                <ul class="line30"><li>Always choose severe pyelonephritis for any adult if the patient has either fever or nausea and vomiting</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2 -->
        
        <!-- Start of pyelonephritis Tx with anaphylactic Penicillin Allergy MILD: #pyelo2a -->
        <div data-role="page" id="pyelo2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild pyelonephritis is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 10 to 14 days</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2a -->
        
        <!-- Start of pyelonephritis Tx with mild Penicillin Allergy SEVERE: #pyelo2b -->
        <div data-role="page" id="pyelo2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15">see below for contraindications</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo2b1">Gentamicin contraindicated</a></li>
                    <li><a href="#pyelo2b2">Gentamicin not contraindicated</a></li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2b -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Anaphylaxis SEVERE: Gent BAD #pyelo2b1 -->
        <div data-role="page" id="pyelo2b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid"><br>	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to aminoglycosides and previous anaphylaxis with penicillin:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2b1 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent OK #pyelo2b2 -->
        <div data-role="page" id="pyelo2b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> See below for dose and dosing interval</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing (age &gt; 12 years)</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2b2 -->
        
        <!-- Start of pyelonephritis Tx with no Penicillin Allergy: #pyelo3 -->
        <div data-role="page" id="pyelo3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient a child? Or adult with mild or severe pyelonephritis?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo3c">Paediatric patient</a></li>
                    <li><a href="#pyelo3a">Adult, mild pyelonephritis</a></li>
                    <li><a href="#pyelo3b">Adult, severe pyelonephritis</a></li>
                </ul>
                <hr/>
                <ul class="line30"><li>Always choose severe pyelonephritis for any adult if the patient has either fever or nausea and vomiting</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3 -->
        
        <!-- Start of pyelonephritis Tx with no Penicillin Allergy MILD: #pyelo3a -->
        <div data-role="page" id="pyelo3a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Mild pyelonephritis is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 875+125 mg orally,</span>
                    <span class="font15"> 12-hourly for 10 to 14 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 6-hourly for 10 to 14 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 10 to 14 days</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3a -->
        
        <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE: #pyelo3b -->
        <div data-role="page" id="pyelo3b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo3b1">Gentamicin contraindicated</a></li>
                    <li><a href="#pyelo3b2">Gentamicin not contraindicated</a></li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3b -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent BAD #pyelo3b1 -->
        <div data-role="page" id="pyelo3b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to aminoglycosides as a single agent give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 1 g IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3b1 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent OK #pyelo3b2 -->
        <div data-role="page" id="pyelo3b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin IV,</span>
                    <span class="font15"> See below for dose and dosing interval</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 2g IV,</span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <hr/>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Creatinine clearance (mL/min)</th>
                            <th>Initial dose</th>
                            <th>Dosing frequency</th>
                            <th>Maximum number of empirical doses</th>
                        </tr>

                        <tr>
                            <td>More than 60mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>24 hourly</td>
                            <td>3 doses (at 0, 24 and 48 hours)</td>
                        </tr>

                        <tr>
                            <td>40 to 60 mL/min</td>
                            <td>4 to 5 mg/kg</td>
                            <td>36 hourly</td>
                            <td>2 doses (at 0 and 36 hours)</td>       
                        </tr>

                        <tr>
                            <td>less than 40mL/min</td>
                            <td>4mg/kg</td>
                            <td colspan="2">Single dose, then seek expert advice for subsequent dosing or selection of alternative drug</td>      
                        </tr>
                    </table>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                    <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a dose of 7mg/kg may be appropriate</li>  
                </ul>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3b2 -->
        
        <!-- Start of pyelonephritis Tx with mild Penicillin Allergy child: #pyelo1c -->
        <div data-role="page" id="pyelo1c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the child younger than 1 month? Or showing signs of severe illness?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo1c1">&lt;1 month/severe illness</a></li>
                    <li><a href="#uti1d">&gt;1 month with non-severe illness</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>If patient has any risk factors for severe illness (i.e. dehydration, inability to maintain oral intake, immunocompromise) please choose option 1</li>
                    <li>Signs of severe illness include sepsis, dehydration or inability to maintain oral intake.</li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1c -->
        
        <!-- Start of pyelonephritis Tx with anaphylactic Penicillin Allergy child: #pyelo2c -->
        <div data-role="page" id="pyelo2c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the child younger than 1 month? Or showing signs of severe illness?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo2c1">&lt;1 month/severe illness</a></li>
                    <li><a href="#pyelo2c2">&gt;1 month with non-severe illness</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Signs of severe illness include sepsis, dehydration or inability to maintain oral intake.</li>
                    <li>If patient has any risk factors for severe illness (i.e. dehydration, inability to maintain oral intake, immunocompromise) please choose option 1</li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2c -->
        
        <!-- Start of pyelonephritis Tx with no Penicillin Allergy child: #pyelo3c -->
        <div data-role="page" id="pyelo3c" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the child younger than 1 month? Or showing signs of severe illness?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo3c1">&lt;1 month/severe illness</a></li>
                    <li><a href="#pyelo3c2">&gt;1 month with non-severe illness</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Signs of severe illness include sepsis, dehydration or inability to maintain oral intake.</li>
                    <li>If patient has any risk factors for severe illness (i.e. dehydration, inability to maintain oral intake, immunocompromise) please choose option 1</li> 
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3c -->
        
        <!-- Start of pyelonephritis Tx mild Penicillin Allergy child <1month or severe: #pyelo1c1 -->
        <div data-role="page" id="pyelo1c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo1c1a">Gentamicin contraindicated</a></li>
                    <li><a href="#pyelo1c1b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1c1 -->
        
        <!-- Start of pyelonephritis Tx anaphylactic Penicillin Allergy child <1month or severe: #pyelo2c1 -->
        <div data-role="page" id="pyelo2c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo2c1a">Gentamicin contraindicated</a></li>
                    <li><a href="#pyelo2c1b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2c1 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Pyelo mild #pyelo2c2 -->
        <div data-role="page" id="pyelo2c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to penicillin for non severe pyelonephritis give:</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 4+20 mg/kg (up to 160+800 mg) orally,</span>
                    <span class="font15">  12-hourly for 7 to 10 days</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2c2 -->
        
        <!-- Start of pyelonephritis Tx mild Penicillin Allergy child <1month or severe: #pyelo1c1 -->
        <div data-role="page" id="pyelo3c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Pyelonephritis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#pyelo3c1a">Gentamicin contraindicated</a></li>
                    <li><a href="#pyelo3c1b">Gentamicin not contraindicated</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3c1 -->
        
        <!-- Start of pyelonephritis Tx with NO Penicillin Allergy : Pyelo mild #pyelo3c2 -->
        <div data-role="page" id="pyelo3c2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Pyelonephritis Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to penicillin for non severe pyelonephritis give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 4+20 mg/kg (up to 160+800 mg) orally,</span>
                    <span class="font15">  12-hourly for 7 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 12.5 mg/kg (up to 500mg) orally,</span>
                    <span class="font15">  6-hourly for 7 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 22.5+3.2 mg/kg up to 875+125 mg orally,</span>
                    <span class="font15">  12-hourly for 7 to 10 days</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3c2 -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent BAD #pyelo1c1a -->
        <div data-role="page" id="pyelo1c1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe pyelonephritis treatment with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1c1a -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy mild: Gent OK #pyelo1c1b -->
        <div data-role="page" id="pyelo1c1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe pyelonephritis treatment with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient does not have a contraindication to aminoglycosides give as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">gentamicin 7.5 mg/kg</span>
                    <span class="font15">(dosed based on either ideal bodyweight or actual bodyweight if lower)</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">g up to 320 mg IV,</span>
                    <span class="font15"> daily.</span>
                </h4>
                <p class="mrgn20b">Use culture and susceptibility data to guide ongoing therapy within 72 hours of intiating gentamicin.</p>                
                <hr/>
                <ul class="line30">
                    <li>If ongoing gentamicin therapy is required, AUC monitoring should be performed in collaboration with pharmacy. Please contact pharmacy before the third dose for instructions</li>
                    <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1c1b -->
        
        <!-- Start of pyelonephritis Tx with anaphyl Penicillin Allergy SEVERE: Gent BAD #pyelo2c1a -->
        <div data-role="page" id="pyelo2c1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe pyelonephritis treatment with severe penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to aminoglycosides and penicillin hypersensitivity:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Please contact IFD for advice</span>
                    <span class="font15"></span>
                </h4>
                <hr/>
                <ul class="line30"><li>It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2c1a -->
        
        <!-- Start of pyelonephritis Tx with Penicillin Allergy mild: Gent OK #pyelo2c1b -->
        <div data-role="page" id="pyelo2c1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe pyelonephritis treatment with severe penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient does not have a contraindication to aminoglycosides give as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin 7.5 mg/kg</span>
                    <span class="font15"> (dosed based on either ideal bodyweight or actual bodyweight if lower)  up to 320 mg IV, daily.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>If ongoing gentamicin therapy is required, AUC monitoring should be performed in collaboration with pharmacy. Please contact pharmacy before the second dose for instructions</li>
                    <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of intiating gentamicin.</li>
                    <li>For neonate dosing please refer to the Therapeutic Guidelines: Antibiotic</li>
                    <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo2c1b -->
        
        <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE: Gent BAD #pyelo3c1a -->
        <div data-role="page" id="pyelo3c1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe pyelonephritis treatment with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ceftriaxone 50 mg/kg up to 1 g IV,</span>
                    <span class="font15"> daily</span>
                </h4>
                <hr/>
                <ul class="line30"><li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo3c1a -->
        
        <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE: Gent OK #pyelo3c1b -->
        <div data-role="page" id="pyelo3c1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Severe pyelonephritis treatment with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin 7.5 mg/kg </span>
                    <span class="font15"> (dosed based on either ideal bodyweight or actual bodyweight if lower)  up to 320 mg IV,  daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ampicillin 50 mg/kg up to 2 g IV,</span>
                    <span class="font15"> 6-hourly</span>
                </h4>
                <p class="mrgn20b">Use culture and susceptibility data to guide ongoing therapy within 72 hours of intiating gentamicin.</p>
                <hr/>
                <ul class="line30">
                    <li>If long term gentamicin therapy is required AUC monitoring should be performed early with the first dose in collaboration with pharmacy. AUC monitoring MUST be performed if more than three doses are to be given</li>
                    <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for culture and susceptibility testing are taken prior to administration of antibiotics for targeted therapy</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /pyelo1c1b -->
        <!-- pyelonephritis IS NOW FINISHED -->
        
        <!-- LET THE SCABIES MAZE BEGIN! -->
        <!-- Start of scabies page/ ?severity: #scab -->
        <div data-role="page" id="scab" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Scabies grading calculator</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">
                <!--scabies calculator body content-->
                <script>
                    var calcscabies = function () {

                        //console.log('updating value');
                        //console.log($('#systolic').val());
                        var resultscab = 0;

                        console.log($('#extent option:selected').val());
                        resultscab += parseInt($('#extent option:selected').val());
                        $('#scabscore').text(resultscab);


                        console.log($('#crusting option:selected').val());
                        resultscab += parseInt($('#crusting option:selected').val());
                        $('#scabscore').text(resultscab);

                        console.log($('#pastscab option:selected').val());
                        resultscab += parseInt($('#pastscab option:selected').val());
                        $('#scabscore').text(resultscab);

                        console.log($('#scabskin option:selected').val());
                        resultscab += parseInt($('#scabskin option:selected').val());
                        $('#scabscore').text(resultscab);

                    }
                </script>
                <form onsubmit="return false" >
                    <h4 class="color-primary mrgn20b">Please enter scabies details into the calculator to determine the scabies grading or skip this step:</h4>
                    <div class="form-group">
                        <label for="extent">Distribution / extent of the crusting:</label>
                        <select name="extent" id="extent" onchange="calcscabies();" class="form-control">
                            <option value="0">-</option>
                            <option value="1">Wrists, webspaces, feet only (&lt; 10% BSA)</option>
                            <option value="2">Above plus forearms, lower legs, buttocks, trunk or (10-30% BSA)</option>
                            <option value="3">Above plus scalp OR &gt;30% TBSA</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="crusting">Crusting/Shedding:</label>
                        <select name="crusting" id="crusting" onchange="calcscabies();" class="form-control">
                            <option value="0">-</option>
                            <option value="1">Mild crusting (&lt;5mm depth of crust), minimal skin shedding</option>
                            <option value="2">Moderate (5-10mm) crusting, moderate skin shedding</option>
                            <option value="3">Severe (&gt;10mm), profuse skin shedding</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="pastscab">Past episodes:</label>
                        <select name="pastscab" id="pastscab" onchange="calcscabies();" class="form-control">
                            <option value="0">-</option>
                            <option value="1">Never had it before</option>
                            <option value="2">1-3 prior hospitalizations for crusted scabies OR depigmentation of elbows, knees</option>
                            <option value="3">&ge;4 prior hospitalizations for crusted scabies OR depigmentation as above PLUS legs/back or residual skin thickening / ichthyosis</option>
                        </select>
                    </div>
                    <div class="form-group">
                        <label for="scabskin">Skin condition:</label>
                        <select name="scabskin" id="scabskin" onchange="calcscabies();" class="form-control">
                            <option value="0">-</option>
                            <option value="1">No cracking or pyoderma</option>
                            <option value="2">Multiple pustules and/or weeping sore and/or superficial skin cracking</option>
                            <option value="3">Deep skin cracking with bleeding, widespread purulent exudates</option>
                        </select>
                    </div>
                    <p class="color-primary mrgn20b"><b>SCABIES SCORE: </b><strong><span id="scabscore">0</span></strong></p>
                </form>
                <h4 class="color-primary mrgn20b">Scabies Grading Table</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Scabies Score</th>
                            <th>Grade</th>
                        </tr>

                        <tr>
                            <td>4-6</td>
                            <td>Grade 1</td>
                        </tr>

                        <tr>
                            <td>7-9</td>
                            <td>Grade 2</td>
                        </tr>  

                        <tr>
                            <td>10-12</td>
                            <td>Grade 3</td>
                        </tr>          
                    </table>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Select scabies grade to treat:</h4>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#scab1">Grade 1</a></li>
                    <li><a href="#scab2">Grade 2</a></li>
                    <li><a href="#scab3">Grade 3</a></li>     
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /scab -->
        
        <!-- Start of scabies grade 1: #scab1 -->
        <div data-role="page" id="scab1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Grade 1 Scabies Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For grade 1 scabies:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ivermectin 200mcg/kg rounded up to the nearest 1.5mg orally</span>
                    <span class="font15"> for three doses on days 0,1 and 7.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> either</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzyl benzoate with added tea tree oil at 5% concentration</span>
                    <span class="font15">(available from pharmacy) 2nd daily for first week, and twice weekly thereafter until cured</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Permethrin 5%</span>
                    <span class="font15"> 2nd daily for the first week, then twice weekly thereafter until cured</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-info">With either of the above topical agents, on non treatment days give:</span>
                    <span class="color-primary"> Calmurid&reg; (urea 10&#37;, lactic acid 5&#37;) </span>
                    <span class="font15"> second daily until hyperkeratosis has resolved. </span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Ensure topical agents are applied after the patient normally bathes or showers for the day</li>
                    <li>For each admission take skin scrapings, FBC, CRP, LFTs, U+E, blood cultures and pregnancy test for females prior to ivermectin</li>
                    <li>Ensure ivermectin is taken with a high fat meal to ensure absorption</li>
                    <li>It is important to ensure that the dosage of ivermectin is rounded to the nearest 1.5mg to ensure that half tablets can be given.</li>
                    <li>Ensure all household members are treated with topical therapy, bed linen and clothes are washed and the house is fumigated before patient is discharged home</li>
                    <li>Patients with crusted scabies should remain in isolation until approved for clearance by infection control and IFD</li>
                    <li>The non-Government organisation ‘One Disease’ is tackling the issue of Crusted Scabies in the Top End. They can assist with education and follow-up of patients and education/treatment of household contacts.  They should be notified of all cases of confirmed crusted scabies. The contact person is Leonie Wald, mob 0448 011 522</li>
                    <li>Antibiotics may be required for secondary bacterial sepsis, which may not be clinically evident and may involve multiple organisms, including Gram-negatives in addition to S. aureus and S. pyogenes. Please contact IFD if sepsis or secondary infection is suspected</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /scab1 -->
        
        <!-- Start of scabies grade 2: #scab2 -->
        <div data-role="page" id="scab2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Grade 2 Scabies Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For grade 2 scabies:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ivermectin 200mcg/kg rounded up to the nearest 1.5mg orally</span>
                    <span class="font15"> for five doses on days 0,1,7,8 and 14.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> either</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzyl benzoate with added tea tree oil at 5% concentration</span>
                    <span class="font15"> (available from pharmacy) 2nd daily for first week, and twice weekly thereafter until cured</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Permethrin 5%</span>
                    <span class="font15"> 2nd daily for the first week, then twice weekly thereafter until cured</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-info">With either of the above topical agents, on non treatment days give:</span>
                    <span class="color-primary"> Calmurid&reg; (urea 10&#37;, lactic acid 5&#37;) </span>
                    <span class="font15"> second daily until hyperkeratosis has resolved.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Ensure topical agents are applied after the patient normally bathes or showers for the day</li>
                    <li>For each admission take skin scrapings, FBC, CRP, LFTs, U+E, blood cultures and pregnancy test for females prior to ivermectin</li>
                    <li>Ensure ivermectin is taken with a high fat meal to ensure absorption</li>
                    <li>It is important to ensure that the dosage of ivermectin is rounded to the nearest 1.5mg to ensure that half tablets can be given.</li>
                    <li>Ensure all household members are treated with topical therapy, bed linen and clothes are washed and the house is fumigated before patient is discharged home</li>
                    <li>Patients with crusted scabies should remain in isolation until approved for clearance by infection control and IFD</li>
                    <li>The non-Government organisation ‘One Disease’ is tackling the issue of Crusted Scabies in the Top End. They can assist with education and follow-up of patients and education/treatment of household contacts.  They should be notified of all cases of confirmed crusted scabies. The contact person is Leonie Wald, mob 0448 011 522</li>
                    <li>Antibiotics may be required for secondary bacterial sepsis, which may not be clinically evident and may involve multiple organisms, including Gram-negatives in addition to S. aureus and S. pyogenes. Please contact IFD if sepsis or secondary infection is suspected</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /scab2 -->
        
        <!-- Start of scabies grade 3: #scab3 -->
        <div data-role="page" id="scab3" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Grade 3 Scabies Treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For grade 3 scabies:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ivermectin 200mcg/kg rounded up to the nearest 1.5mg orally</span>
                    <span class="font15"> for seven doses on days 0,1,7,8,14,21 and 28.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> either</p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Benzyl benzoate with added tea tree oil at 5% concentration</span>
                    <span class="font15"> (available from pharmacy) 2nd daily for first week, and twice weekly thereafter until cured</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Permethrin 5%</span>
                    <span class="font15"> 2nd daily for the first week, then twice weekly thereafter until cured</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-info">With either of the above topical agents, on non treatment days give:</span>
                    <span class="color-primary"> Calmurid&reg; (urea 10&#37;, lactic acid 5&#37;)</span>
                    <span class="font15"> second daily until hyperkeratosis has resolved.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>Ensure topical agents are applied after the patient normally bathes or showers for the day</li>
                    <li>For each admission take skin scrapings, FBC, CRP, LFTs, U+E, blood cultures and pregnancy test for females prior to ivermectin</li>
                    <li>Ensure ivermectin is taken with a high fat meal to ensure absorption</li>
                    <li>It is important to ensure that the dosage of ivermectin is rounded to the nearest 1.5mg to ensure that half tablets can be given.</li>
                    <li>Ensure all household members are treated with topical therapy, bed linen and clothes are washed and the house is fumigated before patient is discharged home</li>
                    <li>Patients with crusted scabies should remain in isolation until approved for clearance by infection control and IFD</li>
                    <li>The non-Government organisation ‘One Disease’ is tackling the issue of Crusted Scabies in the Top End. They can assist with education and follow-up of patients and education/treatment of household contacts.  They should be notified of all cases of confirmed crusted scabies. The contact person is Leonie Wald, mob 0448 011 522</li>
                    <li>Antibiotics may be required for secondary bacterial sepsis, which may not be clinically evident and may involve multiple organisms, including Gram-negatives in addition to S. aureus and S. pyogenes. Please contact IFD if sepsis or secondary infection is suspected</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /scab3-->
        <!-- END OF SCABIES MAZE -->
        
        <!-- START OF SEPSIS MAZE -->
        <!-- Start of sepsis ?penicillin: #sepsis-->
        <div data-role="page" id="sepsis" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Severe Sepsis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#sepsis3">No penicillin allergy</a></li> 
                    <li><a href="#sepsis1">Minor penicillin allergy</a></li>
                    <li><a href="#sepsis1">Penicillin anaphylaxis</a></li>   
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /sepsis -->
        
        <!-- Start of sepsis pen OK ?wet: #sepsis3-->
        <div data-role="page" id="sepsis3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Severe sepsis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient being treated during the wet or dry season?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#sepsis1">Wet season</a></li>
                    <li><a href="#sepsis3b">Dry season</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Typically the wet season is from November 1st to April 30th, however this may vary year to year.</li>
                    <li>For more information on pneumonia in the Top End of the Northern Territory please see 'Adult Community Acquired Pneumonia in the Top End of the NT - RDH Guideline' on PGC</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /sepsis3-->
        
        <!-- Start of sepsis pen mild: #sepsis1-->
        <div data-role="page" id="sepsis1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Sepsis treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Severe sepsis treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Meropenem 1g (child 20mg/Kg to a maximum of 1g) IV, </span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <p class="color-danger mrgn20b"><b>Give meropenem very cautiously in a critical care area to monitor for reaction if patient has a history of penicillin anaphylaxis.</b></p>
                <p class="mrgn20b"><b>AND THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>AND CHART REGULAR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15">dosed as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for meropenem and vancomycin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>sep</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>ONE</b> day only. IFD must be contacted once treatment is to continue past 24 hours</div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info text-center">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>If the patient only has a single IV line it is important to give meropenem before vancomycin as it has the shortest infusion time</li>
                    <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                    <li>Door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                    <li>Repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                    <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer (senior emergency doctor or registrar/consultant if on a ward), refer for urgent ICU assessment and change ongoing resuscitation fluid to Plasmalyte. Please see the severe sepsis protocol on the PGC for details on the management of severe sepsis</li>
                    <li>Please contact IFD within 24 hours to rationalise antibiotics once blood culture results return.</li>
                    <li>Ensure urgent baseline bloods are taken following initiation of antibiotics; FBC, UEC, LFT's, Coags, CRP and CaMgP</li>
                </ul>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /sepsis1 -->
        
        <!-- Start of sepsis page pen OK and DRY #sepsis3b -->
        <div data-role="page" id="sepsis3b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Sepsis treatment:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For sepsis treatment in the dry season give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Piperacillin/tazobactam 4/0.5g (child: 100mg/kg dosed based on piperacillin component only to a maximum 4g) IV, </span>
                    <span class="font15"> 6 hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND THEN</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">A vancomycin loading dose of 25mg/Kg IV</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>AND CHART REGULAR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Vancomycin IV,</span>
                    <span class="font15"> dosed as per nomograms below</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for vancomycin and piperacillin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>sep</span>
                </h4>
                <div class="alert alert-info text-center">
                    This code is valid for <b>ONE</b> day only. IFD must be contacted once treatment is to continue past 24 hours
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th colspan ="2">Age</th>
                            <th>Starting Dose (use actual body weight)</th>
                            <th>Dosing frequency</th>
                            <th>Timing of first trough concentration</th>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates younger than 30 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>18 hourly</td>
                            <td>Before the second dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 30 to 36 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 14 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 14 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td rowspan ="2">Neonates 37 to 44 weeks postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age 0 to 7 days</td>
                            <td>15mg/kg</td>
                            <td>12 hourly</td>
                            <td>Before the third dose</td>
                        </tr>

                        <tr>
                            <td>postnatal age 7 days or older</td>
                            <td>15mg/kg</td>
                            <td>8 hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>

                        <tr>
                            <td colspan = "2">Infants and children &#40;NB2&#41;</td>
                            <td>15mg/kg up to 750mg</td>
                            <td>6 hourly</td>
                            <td>Before the fifth dose</td>
                        </tr>
                    </table>
                </div>
                <div class="alert alert-info">
                    <p><b>NB1</b>- Postmentstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</p>
                    <p><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12 hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</p>
                </div>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body weight (kg)</td>
                            <td>CrClr &lt; 20 mL/min</td>
                            <td>CrClr 20-60 mL/min</td>
                            <td>CrClr &gt; 60 mL/min</td>
                            <td class="bg-success">Administer over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td>Call IFD</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10mg/min to avoid <span class="color-danger bold">Red Man</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul class="line30">
                    <li>Please contact IFD within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>If the patient only has a single IV line it is important to give piperacillin before vancomycin as it has the shortest infusion time</li>
                    <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                    <li>Door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                    <li>Repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                    <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer (senior emergency doctor or registrar/consultant if on a ward), refer for urgent ICU assessment and change ongoing resuscitation fluid to Plasmalyte. Please see the severe sepsis protocol on the PGC for details on the management of severe sepsis</li>
                    <li>Please contact IFD within 24 hours to rationalise antibiotics once blood culture results return.</li>
                    <li>Ensure urgent baseline bloods are taken following initiation of antibiotics; FBC, UEC, LFT's, Coags, CRP and CaMgP</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /sepsis3b -->
        <!-- SEPSIS MAZE COMPLETE -->
        
        <!-- LET THE SHINGLES MAZE BEGIN -->
        <!-- Start of Shingles page: ?onset #shing -->
        <div data-role="page" id="shing" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Shingles:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">How long has it been since rash onset?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#shinga">Less than 72 hours</a></li>
                    <li><a href="#shingb">More than 72 hours</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shing -->
        
        <!-- Start of Shingles page onset<72h: ?immuno #shinga -->
        <div data-role="page" id="shinga" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Shingles:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient immunocompromised?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#shingb1">Yes</a></li>
                    <li><a href="#shingb1b">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shingb -->
        
        <!-- Start of Shingles page onset>72h: ?immuno #shingb -->
        <div data-role="page" id="shingb" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Shingles:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient immunocompromised?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#shingb1">Yes</a></li>
                    <li><a href="#shingx">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shingb -->
        
        <!-- Start of shingles page onset>72h, immuno YES: #shingb1 -->
        <div data-role="page" id="shingb1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Shingles:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there widespread, disseminated disease?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#shingb1a">Yes</a></li>
                    <li><a href="#shingb1b">No</a></li>
                </ul>
                <hr/>
                <ul class="line30"><li>Widespread disease can be characterised by multidermatomal rash, or the presence of systemic 'flu-like' symptoms</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shingb1 -->
        
        <!-- Start of shingles page onset>72h, immuno YES shing BAD: #shingb1a -->
        <div data-role="page" id="shingb1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Shingles treatment:</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">If patient is immunocompromised and has disseminated shingles:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Aciclovir 10 to 12.5 mg/kg IV</span>
                    <span class="font15"> 8 hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient is a child<p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Aciclovir 500mg/m&#178; IV,</span>
                    <span class="font15"> 8 hourly. (For paediatric patients < 12 years of age)</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for aciclovir is:</span>
                    <span class="font15 bold"> 3<script> document.write(getcode())</script>shi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>THREE</b> days only. IFD must be contacted if IV treatment is to continue past 72 hours</div>
                <hr/>
                <ul class="line30">
                    <li>After significant clinical improvement switch to oral antiviral therapy</li>
                    <li>If ocular involvement is present or suspected please contact opthalmology for review</li>
                    <li>For patients over 60 years of age a vaccine is available and may be indicated despite previous herpes zoster infection. See the Australian Immunisation Handbook on the library database for details</li>
                    <li>To calculate body surface area in paediatrics use:<br><span style="white-space: nowrap; font-size:larger">&radic;<span style="text-decoration:overline;">&nbsp;(Height (cm) x Weight (Kg)) &divide; 3600 &nbsp;</span></span></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shingb1a -->
        
        <!-- Start of shingles page onset>72h, immuno YES shing BAD: #shingb1b -->
        <div data-role="page" id="shingb1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Shingles treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Uncomplicated shingles treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Famciclovir 250mg orally,</span>
                    <span class="font15"> 8 hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Valaciclovir 1g orally,</span>
                    <span class="font15"> 8 hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Aciclovir 800 mg orally</span>
                    <span class="font15"> Five times daily for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient is a child<p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Aciclovir 20mg/kg up to 800mg orally,</span>
                    <span class="font15"> Five times daily for 7 days</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for aciclovir, famciclovir or valaciclovir is:</span>
                    <span class="font15 bold"> 7<script> document.write(getcode())</script>shi</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>SEVEN</b> days only. IFD must be contacted if treatment is to continue past one week</div>
                <hr/>
                <ul class="line30">
                    <li>There is evidence that famciclovir and valaciclovir are more effective than aciclovir in reducing pain</li>
                    <li>If ocular involvement is present or suspected please contact opthalmology for review</li>
                    <li>Although there is more safety data to support the use of aciclovir in pregnancy there is some evidence that valaciclovir is safe in pregnancy</li>
                    <li>For patients over 60 years of age a vaccine is available and may be indicated despite previous herpes zoster infection. See the Australian Immunisation Handbook on the library database for details</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shingb1a -->
        
        <!-- Start of shingles page onset>72h, immuno NO shing OK: #shingx -->
        <div data-role="page" id="shingx" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Shingles treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Uncomplicated shingles treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="color-primary mrgn20b">In a non-immunocompromised patient there is little benefit from antiviral therapy if the rash has developed more than 72 hours prior to presentation.</h4>
                <hr/>
                <ul class="line30">
                    <li>For patients over 60 years of age a vaccine is available and may be indicated despite previous herpes zoster infection. See the Australian Immunisation Handbook on the library database for details</li>
                    <li>If ocular involvement is present or suspected please contact opthalmology for review</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /shingx -->
        
        <!-- Surgical Prophylaxis Maze Begins -->
        <!-- Start of Surgical prophylaxis page: #surgpro -->
        <div data-role="page" id="surgpro" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">What type of surgery is being performed?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="surgicalprophylaxis" class="listview"> 
                    <li><a href="#vancr">Amputation of a lower limb</a></li>
                    <li><a href="#cephmet">Appendicectomy</a></li>
                    <li><a href="#biliar">Biliary surgery</a></li>
                    <li><a href="#lscs">Caesarean section</a></li>
                    <li><a href="#cephmet">Colorectal surgery</a></li>
                    <li><a href="#ceph2">Gastroduodenal surgery</a></li>
                    <li><a href="#head">Head and neck surgery</a></li>
                    <li><a href="#hernia">Hernia repair</a></li>
                    <li><a href="#hyster">Hysterectomy</a></li>
                    <li><a href="#ceph2">Oesophageal surgery</a></li>
                    <li><a href="#ortho">Orthopaedic surgery</a></li>
                    <li><a href="#small">Small intestinal surgery</a></li>
                    <li><a href="#stop">Surgical termination of pregnancy</a></li>
                    <li><a href="#ceph2">Thoracic surgery</a></li> 
                    <li><a href="#urol">Urological surgery</a></li>
                    <li><a href="#vasc">Vascular surgery</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /surgpro -->
        
        <!-- Start of vancomycin for amputation page: #vancr -->
        <div data-role="page" id="vancr" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to be, or at risk of colonisation with MRSA?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr1">MRSA colonised or at risk</a></li>
                    <li><a href="#vancr2">No MRSA colonisation or risk</a></li>
                </ul>
                
                <p class="mrgn20b"><b>Risk factors for MRSA colonisation are:</b></p>
                <ul class="line30">
                    <li>Hospital stay for >5 days immediately prior to surgery</li> 
                    <li>Previous colonisation with MRSA which has not been cleared</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr -->
        
        <!-- Start of vancomycin for amputation page: #vancr1 -->
        <div data-role="page" id="vancr1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr1b">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#vancr1a">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1 -->
        
        <!-- Start of vancomycin for amputation page: #vancr -->
        <div data-role="page" id="vancr2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr2b">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#vancr2a">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr2 -->
        
        <!-- Start of vancomycin for amputation page: #vancr1a -->
        <div data-role="page" id="vancr1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the limb ischemic?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr1a1">Yes</a></li>
                    <li><a href="#vancr1a2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1a -->
        
        <!-- Start of vancomycin for amputation page: #vancr1b -->
        <div data-role="page" id="vancr1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the limb ischemic?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr1b1">Yes</a></li>
                    <li><a href="#vancr1b2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1b -->
        
        <!-- Start of vancomycin for amputation page: #vancr2a -->
        <div data-role="page" id="vancr2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the limb ischemic?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr1a1">Yes</a></li>
                    <li><a href="#vancr1a2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr2a -->
        
        <!-- Start of vancomycin for amputation page: #vancr2b -->
        <div data-role="page" id="vancr2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the limb ischemic?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr2b1">Yes</a></li>
                    <li><a href="#vancr2b2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr2b -->
        
        <!-- Start of vancomycin for amputation MRSA penic anaphylaxis ischaem  page: #vancr1a1 -->
        <div data-role="page" id="vancr1a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Amputation of lower limb treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis prior to amputation of an ischaemic lower limb in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary"> Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary"> Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 5 mg/kg IV, </span>
                    <span class="font15">within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then consider repeating the dose after 12 hours</span>
                </h4>
                <hr/>
                <ul class="line30"><li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1a1 -->
        
        <!-- Start of vancomycin for amputation MRSA penic anaphylaxis ischaem  page: #vancr1a2 -->
        <div data-role="page" id="vancr1a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Amputation of lower limb treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis prior to amputation of a non-ischaemic lower limb in a patient with penicillin hypersensitivity:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>                
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4> 
                <h4 class="mrgn20b">
                    <span class="color-primary">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</span>
                    <span class="font15"></span>
                </h4> 
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 5 mg/kg IV, </span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4> 
                <hr/>
                <ul class="line30">
                    <li>Gentamicin should be dosed based on ideal body weight or actual body weight (whichever is lower)</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1a2 -->
        
        <!-- Start of vancomycin for amputation MRSA penic anaphylaxis ischaem  page: #vancr1b1 -->
        <div data-role="page" id="vancr1b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Amputation of lower limb treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis prior to amputation of a lower limb in a patient tolerating penicillin at risk of MRSA use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then consider repeating the dose after 12 hours</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1b1 -->
        
        <!-- Start of vancomycin for amputation MRSA penic anaphylaxis ischaem  page: #vancr1b2 -->
        <div data-role="page" id="vancr1b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient tolerating penicillin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <h4 class="mrgn20b color-primary">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr1b2 -->
        
        <!-- Start of vancomycin for amputation MRSA penic anaphylaxis ischaem  page: #vancr2b1 -->
        <div data-role="page" id="vancr2b1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Amputation of lower limb treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis prior to amputation of a lower limb in a patient tolerant of penicillin at low risk of MRSA use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then consider repeating the dose after 12 hours.</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr2b1 -->
        
        <!-- Start of vancomycin for amputation MRSA penic anaphylaxis not ischaem  page: #vancr2b2 -->
        <div data-role="page" id="vancr2b2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Amputation of lower limb treatment:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis prior to amputation of a lower limb in a patient tolerant of penicillin at low risk of MRSA use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vancr2b2 -->
        
        <!-- Start of Cephmet page for appendicitis and bowel: #cephmet -->
        <div data-role="page" id="cephmet" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephmet2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#cephmet1">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephmet -->
        
        <!-- Start of generic ceph penicillin BAD, gent question: #cephmet1 -->
        <div data-role="page" id="cephmet1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below for contraindications)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephmet1a">Gentamicin contraindicated</a></li>
                    <li><a href="#cephmet1b">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>

                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>

                        </tr>

                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>

                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>

                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephmet -->
        
        <!-- Start of cephmet treatment penicillin hypersensitive gent OK: #cephmet1b -->
        <div data-role="page" id="cephmet1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For Colorectal surgery and appendicectomy in patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <br><hr/>
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephmet1b -->
        
        <!-- Start of cephmet treatment penicillin hypersensitive gent BAD: #cephmet1a -->
        <div data-role="page" id="cephmet1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgery in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 5+25 mg/kg up to 160+800 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephmet1a -->
        
        <!-- Start of cephmet treatment penicillin OK: #cephmet2 -->
        <div data-role="page" id="cephmet2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis recommendation:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient who can tolerate penicillin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephmet1 -->
        
        <!-- Start of biliary surgery page : #biliar -->
        <div data-role="page" id="biliar" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is antibiotic prophylaxis confirmed as necessary?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph2">Yes</a></li>
                </ul>
                <ul class="line30">
                    <li>Antibiotic prophylaxis is only recommended if there is a high risk of infective complications:</li>
                    <li>Risk factors for infection include; patient age>70 years, diabetes, obstructive jaundice, cholecystitis, open cholecystectomy or a non functioning gall bladder</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /biliar -->
        
        <!-- Start of generic ceph2 page: #ceph2 -->
        <div data-role="page" id="ceph2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to be, or at risk of colonisation with MRSA?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph2a">MRSA colonised or at risk</a></li>
                    <li><a href="#ceph2b">No MRSA colonisation or risk</a></li>
                </ul>
                <p class="mrgn20b"><b>Risk factors for MRSA colonisation are:</b></p>
                <ul class="line30">
                    <li>Hospital stay for >5 days immediately prior to surgery</li>
                    <li>Previous colonisation with MRSA which has not been cleared</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ceph2 -->
        
        <!-- Start of generic ceph2 page MRSA colonised: #ceph2a -->
        <div data-role="page" id="ceph2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph2a2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#cephhyp">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->

            <!-- Start of generic ceph2 page MRSA yes penicillin BAD: #ceph2a2 -->
            <div data-role="page" id="ceph2a2" data-theme="a">
                <div data-role="header" class="secondpage">
                    <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
                </div>
                <!-- /header -->
                <div data-role="header" class="frontpage">
                    <h1>Surgical Prophylaxis:</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">	
                    <h3 class="mrgn20b">
                        <span class="color-primary">For surgical prophylaxis in a patient at risk of MRSA, and tolerant of penicillin use:</span>
                        <span class="font15"></span>
                    </h3>
                    <h4 class="mrgn20b">
                        <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                        <span class="font15"></span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b></p>
                    <h4 class="mrgn20b">
                        <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                        <span class="font15"></span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b></p>
                    <h4 class="mrgn20b">
                        <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                        <span class="font15"></span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b></p>
                    <h4 class="mrgn20b">
                        <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                        <span class="font15"></span>
                    </h4>
                    <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</p>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="mrgn20b">
                        <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                        <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                    </h4>
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /ceph2a2 -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ceph2a -->
        
        <!-- Start of generic cephazolin page No MRSA risk: #ceph2b -->
        <div data-role="page" id="ceph2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephok">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#cephhyp">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ceph2 -->
        
        <!-- Start of generic ceph penicillin BAD, gent question: #cephhyp -->
        <div data-role="page" id="cephhyp" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephhyp1">Gentamicin contraindicated</a></li>
                    <li><a href="#cephhyp2">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs1 -->
        
        <!-- Start of generic cephazolin alternative for hypersensitivity gent BAD; cephhyp1-->
        <div data-role="page" id="cephhyp1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally</span>
                    <span class="font15"> 60 minutes before surgical incision.</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephhyp1 -->
        
        <!-- Start of generic cephazolin alternative for hypersensitivity gent OK; cephhyp2-->
        <div data-role="page" id="cephhyp2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV, </span>
                    <span class="font15"> (within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.)</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephhyp2 -->
        
        <!-- Start of generic cephazolin 2g treatment ; cephok-->
        <div data-role="page" id="cephok" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient which can tolerate penicillin, use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt;40kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephok -->
        
        <!-- Start of biliary LSCS page : #lscs -->
        <div data-role="page" id="lscs" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient hypersensitive to penicillin?</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#lscs2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#lscs1">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs -->
        
        <!-- Start of caesarean LSCS gent question for hypersensitive page: #lscs1 -->
        <div data-role="page" id="lscs1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#lscs1a">Gentamicin contraindicated</a></li>
                    <li><a href="#lscs1b">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs1 -->
        
        <!-- Start of caesarean LSCS gent question for pen OK page: #lscs2 -->
        <div data-role="page" id="lscs2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#lscs2a">Gentamicin contraindicated</a></li>
                    <li><a href="#lscs2b">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs2 -->
        
        <!-- Start of LSCS treatment penicillin hypersensitive gent OK: #lscs1a -->
        <div data-role="page" id="lscs1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For caesarean section in patient with penicillin hypersensitivity intolerant of gentamicin use:</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300mg PO</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 600mg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>lsc</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>A SINGLE DOSE</b> only. IFD must be contacted if treatment is to continue past a single prophylactic dose.</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs1a -->
        
        <!-- Start of LSCS treatment penicillin hypersensitive gent OK: #lscs1b -->
        <div data-role="page" id="lscs1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Caesarean section:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For caesarean section in patient with penicillin hypersensitivity tolerant of gentamicin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin 3 mg/kg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 600mg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>lsc</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>A SINGLE DOSE</b> only. IFD must be contacted if treatment is to continue past a single prophylactic dose.</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs1b -->
        
        <!-- Start of LSCS treatment penicillin OK, gent BAD: #lscs2a -->
        <div data-role="page" id="lscs2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Caesarean section:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For caesarean section in patient tolerant of penicillin but gentamicin intolerant use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2g IV,</span>
                    <span class="font15"> (or 50mg/kg if patient weight &lt; 40Kg) within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300mg PO</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs2a -->
        
        <!-- Start of LSCS treatment penicillin OK gent OK: #lscs2b -->
        <div data-role="page" id="lscs2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient tolerant of gentamicin and penicillin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2g IV,</span>
                    <span class="font15"> (or 30mg/kg if patient weight &lt; 60Kg) within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin 3 mg/kg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs2b -->
        
        <!-- Start of head and neck mucosal question: #head -->
        <div data-role="page" id="head" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Will the incision be through mucosal surfaces?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#head1">Yes</a></li>
                    <li><a href="#ceph3">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /head -->
        
        <!-- Start of Head & Neck penicillin hypersensitive page : #head1 -->
        <div data-role="page" id="head1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephmet2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#head1a">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs -->
        
        <!-- Start of head and neck treatment penicillin BAD no mucosal: #head1a -->
        <div data-role="page" id="head1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Head, neck or hysterectomy prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For a hysterectomy, head, neck or thoracic surgery without incision through mucosal surfaces for a patient who is hypersensitive to penicillin use:</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Clindamycin 600 mg (child:15mg/kg up to 600 mg) IV</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for clindamycin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>hea</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>A SINGLE DOSE</b> only. IFD must be contacted if treatment is to continue past a single prophylactic dose.</div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /head1a -->
        
        <!-- Start of hernia surgery page : #hernia -->
        <div data-role="page" id="hernia" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is prophylaxis confirmed as necessary?</span>
                    <span class="font15"> (See below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph2">Yes</a></li>
                </ul>
                <ul class="line30">
                    <li>The majority of hernia repair surgery does not require prophylactic antibiotics. All hernia repair without the insertion of prosthetic mesh will not require antibiotics. In patient groups with insertion of prosthetic material only patients with significant risk factors for infection should receive antibiotics:</li>
                    <li>Risk factors for infection include; patient age>70 years, diabetes, immounocompromise, reoperation, prolonged duration of surgery, or need for surgical drains</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hernia -->
        
        <!-- Start of hysterectomy page : #hyster -->
        <div data-role="page" id="hyster" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the hysterectomy abdominal or vaginal?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph3">abdominal</a></li>
                    <li><a href="#hyster2">vaginal</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hyster -->
        
        <!-- Start of hysterectomy via abdo page: #hyster1 -->
        <div data-role="page" id="hyster2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephmet2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#head1a">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /hyster2 -->
        
        <!-- Start of generic ceph3 for clinda alternative page: #ceph3 -->
        <div data-role="page" id="ceph3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephok">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#head1a">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /cephmet3 -->
        
        <!-- Start of orthopaedic page: #ortho -->
        <div data-role="page" id="ortho" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (See below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ortho2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#ortho1">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ortho -->
        
        <!-- Start of orthopaedic page penicillin BAD ?arthroplasty: #ortho1 -->
        <div data-role="page" id="ortho1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the procedure a major elective arthroplasty?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ortho1a">yes</a></li>
                    <li><a href="#ortho1b">no</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ortho1 -->
        
        <!-- Start of orthopaedic page penicillin OK ?arthroplasty: #ortho2 -->
        <div data-role="page" id="ortho2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the procedure a major elective arthroplasty?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vancr1b2">yes</a></li>
                    <li><a href="#cephok">no</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ortho2 -->
        
        <!-- Start of ortho penicillin BAD arthro YES: #ortho1a -->
        <div data-role="page" id="ortho1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Major joint arthroplasty prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For major orthopaedic surgery in a patient hypersensitive to penicillin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery for major joint arthroplasty.</p>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /head1a -->
        
        <!-- Start of ortho penicillin BAD arthro NO: #ortho1b -->
        <div data-role="page" id="ortho1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Minor elective orthopaedic surgery prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For orthopaedic surgery in a patient hypersensitive to penicillin use as a single dose:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Use a single dose only</p>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ortho1b -->
        
        <!-- Start of Surgical Termination of Pregnancy: #stop -->
        <div data-role="page" id="stop" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical termination of pregnancy as a single dose give:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Doxycycline 400mg PO</span>
                    <span class="font15">1-12 hours prior to the procedure. (This is often given 12 hours prior to the procedure to allow administration with food)</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /stop -->
        
        <!-- Start of small intestinal surgery page: #small -->
        <div data-role="page" id="small" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is there any obstruction present?</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Obstruction could be due to postoperative adhesions, malignancy, Crohn disease or hernia</span>
                    <span class="font15"></span>
                </h4>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephmet">Yes</a></li>
                    <li><a href="#ceph2">No</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /small -->
        
        <!-- Start of urological surgery page : #urol -->
        <div data-role="page" id="urol" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is antibiotic prophylaxis confirmed as necessary?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1">Yes</a></li>
                </ul>
                <ul class="line30">
                    <li>Antibiotic prophylaxis is only recommended if:</li>
                    <li>The patient has signs of bacteruria prior to surgery</li>
                    <li>The patient is immunocompromised, there is urinary tract obstruction, abnormality, urinary stones or an indwelling catheter</li>	
                    <li>A transurethral resection of the prostate, or transrectal prostatic biopsy is being perfomed</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /biliar -->
        
        <!-- Start of urological surgery page after check: #urol1 -->
        <div data-role="page" id="urol1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">What type of procedure is being performed?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1a">Endoscopic procedure</a></li>
                    <li><a href="#urol1b">TURP (transurethral resection of prostate)</a></li>
                    <li><a href="#urol1c">Transrectal prostatic biopsy</a></li>
                    <li><a href="#urol1d">Open or laparoscopic procedure</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1 -->
        
        <!-- Start of urol endo page: #urol1a -->
        <div data-role="page" id="urol1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to have urinary colonisation or a UTI with MRSA?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1a1">Urinary MRSA colonised</a></li>
                    <li><a href="#urol1a2">No urinary MRSA colonisation</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a -->
        
        <!-- Start of urol endo MRSA colonised ?pen OK: #urol1a1 -->
        <div data-role="page" id="urol1a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy</span>
                    <span class="font15"> (see below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph2a2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#cephhyp">Penicillin Hypersensitive</a></li>
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ceph2a -->
        
        <!-- Start of urol endo No MRSA risk: #urol1a2 -->
        <div data-role="page" id="urol1a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy</span>
                    <span class="font15"> (see below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephok">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#urol1a2a">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a2 -->
        
        <!-- Start of urol endo penicillin BAD, no MRSA gent question: #urol1a2a -->
        <div data-role="page" id="urol1a2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1a2a1">Gentamicin contraindicated</a></li>
                    <li><a href="#urol1a2a2">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a2a -->
        
        <!-- Start of urol endo pen BAD no MRSA gent BAD; urol1a2a1-->
        <div data-role="page" id="urol1a2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity intolerant of gentamicin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally</span>
                    <span class="font15"> 60 minutes before surgical incision.</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a2a1 -->
        
        <!-- Start of urol endo pen BAD no MRSA gent OK; urol1a2a2-->
        <div data-role="page" id="urol1a2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV, </span>
                    <span class="font15">within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a2a2 -->
        
        <!-- Start of urol TURP page: #urol1b -->
        <div data-role="page" id="urol1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to have urinary colonisation or a current UTI with MRSA?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1b1">Urinary MRSA colonised</a></li>
                    <li><a href="#urol1b2">No urinary MRSA colonisation</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a -->
        
        <!-- Start of urol TURP MRSA pos gent question: #urol1b1 -->
        <div data-role="page" id="urol1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephhyp1">Gentamicin contraindicated</a></li>
                    <li><a href="#cephhyp2">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1b1 -->
        
        <!-- Start of urol TURP MRSA pos gent question: #urol1b2 -->
        <div data-role="page" id="urol1b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1b2a">Gentamicin contraindicated</a></li>
                    <li><a href="#urol1a2a2">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1b2 -->
        
        <!-- Start of urol TURP no MRSA colonised Gent BAD ?pen OK: #urol1b2a -->
        <div data-role="page" id="urol1b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (see below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#cephok">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#urol1b2a1">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1b2a -->
        
        <!-- Start of urol TURP no MRSA gent BAD pen BAD; urol1b2a1-->
        <div data-role="page" id="urol1b2a1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity intolerant of gentamicin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally</span>
                    <span class="font15"> 60 minutes before surgical incision.</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1a2a1 -->
        
        <!-- Start of urol transrect prostate biopsy; urol1c-->
        <div data-role="page" id="urol1c" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis for transrectal prostatic biopsy use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Ciprofloxacin 500 mg orally,</span>
                    <span class="font15"> as a single dose, 60 to 120 minutes before the procedure.</span>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center">
                    <span class="color-success">Code for ciprofloxacin is:</span>
                    <span class="font15 bold"> 1<script> document.write(getcode())</script>uro</span>
                </h4>
                <div class="alert alert-info text-center">This code is valid for <b>A SINGLE DOSE</b> only. IFD must be contacted if any further doses are to be given</div>
                <p class="mrgn20b">If the procedure is delayed beyond 6 hours the 500mg dose should be repeated prior to surgery</p>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1c -->
        
        <!-- Start of urol open lap page : #urol1d -->
        <div data-role="page" id="urol1d" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Will any prosthetic devices be implanted?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1">Yes</a></li>
                    <li><a href="#urol1a">No</a></li>
                </ul>
                <ul class="line30">
                    <li>Such as penile prostheses, artificial urinary sphincter or mesh</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d -->
        
        <!-- Start of urol open with prosthet gent question: #urol1d1 -->
        <div data-role="page" id="urol1d1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1a">Gentamicin contraindicated</a></li>
                    <li><a href="#urol1d1b">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1 -->
        
        <!-- Start of urol open with prosth gent BAD ?pen OK: #urol1d1a -->
        <div data-role="page" id="urol1d1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient hypersensitive to penicillin?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1a2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#urol1d1a1">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a -->
        
        <!-- Start of urol open gent BAD Pen BAD page: #urol1d1a1 -->
        <div data-role="page" id="urol1d1a1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to have urinary colonisation or a current UTI with MRSA?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1a1a">Urinary MRSA colonised</a></li>
                    <li><a href="#urol1d1a1a">No urinary MRSA colonisation</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a1 -->
        
        <!-- Start of urol open gent BAD Pen OK page: #urol1d1a2 -->
        <div data-role="page" id="urol1d1a2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to have urinary colonisation or a current UTI with MRSA?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1a2a">Urinary MRSA colonised</a></li>
                    <li><a href="#urol1d1a2b">No urinary MRSA colonisation</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a2 -->
        
        <!-- Start of urol open gent BAD pen BAD MRSA YES: #urol1d1a1a -->
        <div data-role="page" id="urol1d1a1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Use a single dose only</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300mg orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a1a -->
        
        <!-- Start of urol open gent BAD pen OK MRSA YES: #urol1d1a2a -->
        <div data-role="page" id="urol1d1a2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures where gentamicin is contraindicated and patient has MRSA infection:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Use a single dose only</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40kg: 50 mg/kg up to 2 g) IV, </span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300mg orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a2a -->
        
        <!-- Start of urol open gent BAD pen OK MRSA YES: #urol1d1a2a -->
        <div data-role="page" id="urol1d1a2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures where gentamicin is contraindicated and patient has MRSA infection:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Use a single dose only</p>
                <p><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV, </span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300mg orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a2a -->
        
        <!-- Start of urol open gent BAD pen OK MRSA NO: #urol1d1a2a -->
        <div data-role="page" id="urol1d1a2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures where gentamicin is contraindicated and patient has MRSA infection:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/Kg up to 2 g) IV, </span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300mg orally,</span>
                    <span class="font15"> 60 minutes before surgical incision</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a2a -->
        
        <!-- Start of urol open with prosth gent OK ?pen OK: #urol1d1b -->
        <div data-role="page" id="urol1d1b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient hypersensitive to penicillin?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1b2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#urol1d1b1">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1b -->
        
        <!-- Start of urol open gent OK Pen BAD page: #urol1d1b1 -->
        <div data-role="page" id="urol1d1b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to have urinary colonisation or a current UTI with MRSA?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1b1a">Urinary MRSA colonised</a></li>
                    <li><a href="#urol1d1b1a">No urinary MRSA colonisation</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1b1 -->
        
        <!-- Start of urol open gent OK Pen OK page: #urol1d1b2 -->
        <div data-role="page" id="urol1d1b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urological Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to have urinary colonisation or a current UTI with MRSA?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#urol1d1b2a">Urinary MRSA colonised</a></li>
                    <li><a href="#urol1d1b2b">No urinary MRSA colonisation</a></li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1b1 -->
        
        <!-- Start of urol open gent OK pen BAD MRSA YES: #urol1d1b1a -->
        <div data-role="page" id="urol1d1b1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Use a single dose only</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1a1a -->
        
        <!-- Start of urol open gent OK pen OK MRSA YES: #urol1d1b2a -->
        <div data-role="page" id="urol1d1b2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Use a single dose only</p>>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1b2a -->
        
        <!-- Start of urol open gent OK pen OK MRSA NO: #urol1d1b2b -->
        <div data-role="page" id="urol1d1b2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">For open or laparoscopic urological procedures:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <hr/>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /urol1d1b2b -->
        
        <!-- Start of vascular surgery page: Is it serious? #vasc -->
        <div data-role="page" id="vasc" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Vascular Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is this complicated or routine vascular surgery?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#ceph2">Routine surgery</a></li>
                    <li><a href="#vasc2">Complicated surgery</a></li>
                </ul>
                <hr/>
                <ul class="line30"><li>Complicated vascular surgery includes vascular reconstruction or amputation of an ischaemic limb and may require 24 hours of surgical prophylaxis, whilst routine surgery such as arteriovenous fistula formation should only require a single dose of surgical prophylaxis</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vasc -->
        
        <!-- Start of generic vasc2 page: #vasc2 -->
        <div data-role="page" id="vasc2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Vascular Surgery:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient known to be, or at risk of colonisation with MRSA?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vasc2a">MRSA colonised or at risk</a></li>
                    <li><a href="#vasc2b">No MRSA colonisation or risk</a></li>
                </ul>
                <p class="mrgn20b"><b>Risk factors for MRSA colonisation are:</b></p>
                <ul class="line30">
                    <li>Hospital stay for >5 days immediately prior to surgery</li>
                    <li>Previous colonisation with MRSA which has not been cleared</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vasc2 -->
        
        <!-- Start of generic vasc2 page MRSA colonised: #vasc2a -->
        <div data-role="page" id="vasc2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient hypersensitive to penicillin?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vasc2a2">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#vaschyp">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vasc2a -->
        
        <!-- Start of generic vasc2 page MRSA yes penicillin BAD: #vasc2a2 -->
        <div data-role="page" id="vasc2a2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient at risk of MRSA tolerant of penicillin use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt; 40Kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vasc2a2 -->
        
        <!-- Start of generic cephazolin page No MRSA risk: #vasc2b -->
        <div data-role="page" id="vasc2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient hypersensitive to penicillin?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vascok">No Penicillin Allergy or Mild Reaction</a></li>
                    <li><a href="#vaschyp">Penicillin Hypersensitive</a></li>
                </ul>
                <ul class="line30">
                    <li>Penicillin hypersensitivity is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vasc2 -->
        
        <!-- Start of generic ceph penicillin BAD, gent question: #vaschyp -->
        <div data-role="page" id="vaschyp" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical Prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#vaschyp1">Gentamicin contraindicated</a></li>
                    <li><a href="#vaschyp2">No gentamicin contraindications</a></li>
                </ul>
                <h4 class="mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Contraindications</th>
                            <th>Precautions</th>
                        </tr>
                        <tr>
                            <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                            <td>Pre-existing significant auditory impairment</td>
                        </tr>
                        <tr>
                            <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                            <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>       
                        </tr>
                        <tr>
                            <td>Myasthenia gravis</td>
                            <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating renal function</td>
                        </tr>
                        <tr>
                            <td></td>
                            <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /lscs1 -->
        
        <!-- Start of generic cephazolin alternative for hypersensitivity gent BAD; vaschyp1-->
        <div data-role="page" id="vaschyp1" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"> (see below)</span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally</span>
                    <span class="font15"> 60 minutes before surgical incision, then consider up to two repeat doses every 12 hours after surgery.</span>
                </h4>
                <hr/>
                <ul class="line30"><li>For cardiac surgery, vascular reconstruction or amputation of an ischaemic limb there is some evidence for ongoing surgical prophylaxis for up to 24 hours after the operation. For other procedures (eg arteriovenous fistula formation), a single preoperative dose is recommended.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vaschyp1 -->
        
        <!-- Start of generic cephazolin alternative for hypersensitivity gent OK; vaschyp2-->
        <div data-role="page" id="vaschyp2" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient with penicillin hypersensitivity use:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult 60-120kg: Teicoplanin 800mg,</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &lt; 60kg: Teicoplanin 600mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Adult &gt; 120kg: Teicoplanin 1200mg</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Paediatric patient: Teicoplanin 20mg/Kg (up to 800mg)</span>
                    <span class="font15"></span>
                </h4>
                <p class="mrgn20b">Give Teicoplanin within the 60 minutes (ideally 15 to 30 minutes) before surgical incision. Consider a repeat dose of vancomycin (adult and child) 15 mg/kg IV 12 hours post surgery.</p>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Gentamicin (adult and child) 2 mg/kg IV, </span>
                    <span class="font15">within the 60 minutes (ideally 15 to 30 minutes) before surgical incision.</span>
                </h4>
                <hr/>
                <ul class="line30"><li>For cardiac surgery, vascular reconstruction or amputation of an ischaemic limb there is some evidence for ongoing surgical prophylaxis for up to 24 hours after the operation. For other procedures (eg arteriovenous fistula formation), a single preoperative dose is recommended.</li></ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vaschyp2 -->
        
        <!-- Start of generic cephazolin 2g treatment ; vascok-->
        <div data-role="page" id="vascok" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Recommended surgical prophylaxis:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">For surgical prophylaxis in a patient which can tolerate penicillin, use as a single agent:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephazolin 2 g (child or adult &lt;40kg: 50 mg/kg up to 2 g) IV,</span>
                    <span class="font15"> within the 60 minutes (ideally 15 to 30 minutes) before surgical incision, then 8-hourly for up to 2 further doses.</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>For cardiac surgery, vascular reconstruction or amputation of an ischaemic limb there is some evidence for ongoing surgical prophylaxis for up to 24 hours after the operation. For other procedures (eg arteriovenous fistula formation), a single preoperative dose is recommended.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /vascok -->
        
        <!-- Urinary Tract Infection Maze Begins -->
        <!-- Start of urinary tract infection page: #uti -->
        <div data-role="page" id="uti" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urinary Tract Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> (see below for details on penicillin allergy severity)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#uti3">No penicillin allergy</a></li>
                    <li><a href="#uti1">Minor penicillin allergy</a></li>
                    <li><a href="#uti2">Penicillin anaphylaxis</a></li>    
                </ul>
                <hr/>
                <ul class="line30">
                    <li>Penicillin anaphylaxis is defined as a clear history of: Bronchospasm, rash, anaphylaxis, SJS or DRESS immediately after administration of a penicillin</li>
                    <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti -->
        
        <!-- Start of urinary tract infection with mild penicillin allergy page: #uti1 -->
        <div data-role="page" id="uti1" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urinary Tract Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient a child, male, female or pregnant?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#uti1a">nonpregnant woman</a></li>
                    <li><a href="#uti1b">pregnant woman</a></li>
                    <li><a href="#uti1c">male patient</a></li> 
                    <li><a href="#uti1d">child > 1 month old</a></li>   		  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti1 -->
        
        <!-- Start of urinary tract infection with anaphylactic penicillin allergy page: #uti2 -->
        <div data-role="page" id="uti2" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urinary Tract Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient a child, male, female or pregnant?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#uti2a">nonpregnant woman</a></li>
                    <li><a href="#uti2b">pregnant woman</a></li>
                    <li><a href="#uti2c">male patient</a></li>
                    <li><a href="#uti2d">child > 1 month old</a></li>  	  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti2 -->
        
        <!-- Start of urinary tract infection with no penicillin allergy page: #uti3 -->
        <div data-role="page" id="uti3" data-theme="a">
            <div data-role="header" class="frontpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Urinary Tract Infection:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Is the patient a child, male, female or pregnant?</span>
                    <span class="font15"></span>
                </h3>
                <ul data-role="listview"  data-inset="true" id="antimicrobials" class="listview"> 
                    <li><a href="#uti3a">nonpregnant woman</a></li>
                    <li><a href="#uti3b">pregnant woman</a></li>
                    <li><a href="#uti3c">male patient</a></li>
                    <li><a href="#uti3d">child > 1 month old</a></li>  		  
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti3 -->
        
        <!-- Start of urinary tract infection with mild penicillin allergy nonpregnant page: #uti1a -->
        <div data-role="page" id="uti1a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with non-life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti1a -->
        
        <!-- Start of urinary tract infection with anaphylactic penicillin allergy nonpregnant page: #uti2a -->
        <div data-role="page" id="uti2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with a life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti2a -->
        
        <!-- Start of urinary tract infection with no penicillin allergy nonpregnant page: #uti3a -->
        <div data-role="page" id="uti3a" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 500+125 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti3a -->
        
        <!-- Start of urinary tract infection with mild penicillin allergy pregnant page: #uti1b -->
        <div data-role="page" id="uti1b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with a non-life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti1b -->
        
        <!-- Start of urinary tract infection with anaphylactic penicillin allergy pregnant page: #uti2b -->
        <div data-role="page" id="uti2b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with a life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti2b -->
        
        <!-- Start of urinary tract infection with no penicillin allergy pregnant page: #uti3b -->
        <div data-role="page" id="uti3b" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 500+125 mg orally,</span>
                    <span class="font15"> 12-hourly for 5 days</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti3b -->
        
        <!-- Start of urinary tract infection with mild penicillin allergy child page: #uti1d -->
        <div data-role="page" id="uti1d" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with non-life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole (child 1 month or older) 4+20 mg/kg up to 160+800 mg orally,</span>
                    <span class="font15"> 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 12.5 mg/kg up to 500 mg orally,</span>
                    <span class="font15"> 6-hourly</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or older.</li>
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti1d -->
        
        <!-- Start of urinary tract infection with anaphylactic penicillin allergy child page: #uti2d -->
        <div data-role="page" id="uti2d" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with a life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole (child 1 month or older) 4+20 mg/kg up to 160+800 mg orally,</span>
                    <span class="font15"> 12-hourly</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or older.</li>
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti2d -->
        
        <!-- Start of urinary tract infection with no penicillin allergy child page: #uti3d -->
        <div data-role="page" id="uti3d" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Urinary tract infection with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim+sulfamethoxazole (child 1 month or older) 4+20 mg/kg up to 160+800 mg orally,</span>
                    <span class="font15"> 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 12.5 mg/kg up to 500 mg orally,</span>
                    <span class="font15"> 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 22.5+3.2 mg/kg up to 875+125 mg orally,</span>
                    <span class="font15"> 12-hourly.</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or older.</li>
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti1d -->
        
        <!-- Start of UTI with mild penicillin allergy man page: #uti1c -->
        <div data-role="page" id="uti1c" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Adult male urinary tract infection with non-life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 12-hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 7 days</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>All adult men presenting with a UTI require further investigation to look for abnormality which may cause a UTI</li>
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti1c -->
        
        <!-- Start of UTI with anaphylactic penicillin allergy man page: #uti2c -->
        <div data-role="page" id="uti2c" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Adult male urinary tract infection with a life threatening penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary"> Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 7 days</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>All adult men presenting with a UTI require further investigation to look for abnormality which may cause a UTI</li>
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti2c -->
        
        <!-- Start of UTI with no penicillin allergy man page: #uti3c -->
        <div data-role="page" id="uti3c" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Adult male urinary tract infection with no penicillin allergy:</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">Urinary tract infection treatment:</span>
                    <span class="font15"></span>
                </h3>
                <h4 class="mrgn20b">
                    <span class="color-primary">Cephalexin 500 mg orally,</span>
                    <span class="font15"> 12-hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Trimethoprim 300 mg orally,</span>
                    <span class="font15"> daily for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Amoxycillin+clavulanate 500+125 mg orally,</span>
                    <span class="font15"> 12-hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="mrgn20b">
                    <span class="color-primary">Nitrofurantoin 100 mg orally,</span>
                    <span class="font15"> 12-hourly for 7 days</span>
                </h4>
                <hr/>
                <ul type="circle">
                    <li>All adult men presenting with a UTI require further investigation to look for abnormality which may cause a UTI</li>
                    <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.</li>
                    <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /uti3c -->
        <!-- Urinary Tract Infection IS NOW FINISHED -->
        
        <!-- References and Acknowledgements Begin -->
        <!-- Start of References Page: #ref -->
        <div data-role="page" id="ref" data-theme="a">
            <div data-role="header" class="secondpage">
                <img src="img/nt-flower.png" alt="TEAMS - Top End Antimicrobial Stewardship"/><h1>TEAMS - Top End Antimicrobial Stewardship</h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>References and Acknowledgements</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <div class="alert alert-success mrgn20t" role="alert">
                    All recommendations from TEAMS are taken preferentially from RDH internal guidelines available on the PGC. If an internal guideline does not exist then the Therapeutic Guidelines Antibiotic is the sole reference in all other instances
                </div>
                <div class="panel panel-default">
                    <div class="panel-heading">
                        <h3 class="panel-title">References:</h3>
                    </div>
                    <div class="panel-body">
                        <ul class="list-group text-left">
                            <li class="list-group-item">Therapeutic Guidelines Limited; 2014 Nov. Melbourne: http://etg.tg.com.au/ip/</li>
                            <li class="list-group-item">Ralph, A. 2014. <i>RDH Guideline</i> Diabetic Foot Infection Management RDH Guideline. Royal Darwin Hospital</li>         
                            <li class="list-group-item">Josh Davis, Bart Currie, Krispin Hajkowicz 2014. <i>RDH Guideline</i> Adult Community Acquired Pneumonia in Top End of the NT RDH Guideline. Royal Darwin Hospital</li>        
                            <li class="list-group-item">Matthew Pitman, Anna Ralph, Sarah Whiting 2014. <i>RDH Guideline</i> Post Operative Infection Reduction Strategy for Elective Insertion of Prosthetic Joint Replacement RDH Guideline. Royal Darwin Hospital</li>                 
                            <li class="list-group-item">Anna Beecham 2014. <i>RDH Guideline</i> Planned Caesarean Section RDH Guideline. Royal Darwin Hospital</li>         
                            <li class="list-group-item">Infectious diseases, oncology and haematology staff 2014. <i>RDH Guideline</i> Febrile Neutropenia - Initial Management RDH Pathway. Royal Darwin Hospital</li>
                            <li class="list-group-item">Bart Currie, Josh Davis 2014. <i>RDH Guideline</i> Crusted (Norwegian) Scabies Grading Scale and Treatment RDH Plan. Royal Darwin Hospital</li>     
                            <li class="list-group-item">Sarah McGloughlin, Josh Davis, Dianne Stephens, Didier Palmer, Bart Currie 2014. <i>RDH Guideline</i> Severe Sepsis - Initial Management RDH Guideline. Royal Darwin Hospital</li>
                            <li class="list-group-item">Boutlis, C. 2015. <i>RDH Guideline</i> Vancomycin – Adults and Children &ge; 12 years NT Hospitals Guideline. Royal Darwin Hospital</li>
                        </ul>
                    </div>
                </div>
                <div class="panel panel-default">
                    <div class="panel-heading">
                        <h3 class="panel-title">Acknowledgements: (in alphabetical order)</h3>
                    </div>
                    <div class="panel-body">
                        <div class="table-responsive">
                            <table class="table table-bordered table-striped">
                                <tr>
                                    <th>Name</th>
                                    <th>Designation</th>
                                </tr>
                                <tr>
                                    <td>Amelia Arandiga</td>
                                    <td>Mental health senior pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Alison Buete</td>
                                    <td>Oncology senior pharmacist Royal Darwin Hospital</td>
                                </tr>
                                <tr>
                                    <td>Jackie Crofton</td>
                                    <td>Pharmacy clinical services manager Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Tien Dinh</td>
                                    <td>Renal pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Steven Fowler</td>
                                    <td>ICU senior pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Joshua Francis</td>
                                    <td>Paediatric infectious disease specialist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Amali Laine</td>
                                    <td>Clinical pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Melanie Morrow</td>
                                    <td>Specialist clinical pharmacist NTCTRC Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Nicola Morris</td>
                                    <td>Emergency senior pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Charlie Pedlingham</td>
                                    <td>Dispensary manager Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Tristen Pogue</td>
                                    <td>Medication safety senior pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Anna Ralph</td>
                                    <td>Infectious diseases consultant Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Peter Shanks</td>
                                    <td>Web programmer at AssessCheck and SproutLabs</td>
                                </tr>

                                <tr>
                                    <td>John Shanks</td>
                                    <td>AMS pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Helen Sun</td>
                                    <td>Clinical pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Loganathan Sivarajan</td>
                                    <td>Clinical pharmacist Royal Darwin Hospital</td>
                                </tr>

                                <tr>
                                    <td>Lynley Vains</td>
                                    <td>eMMa pharmacist Katherine Hospital</td>
                                </tr>

                                <tr>
                                    <td>Joanna Wallace</td>
                                    <td>Pharmacy Director Royal Darwin Hospital</td>
                                </tr>
                            </table>
                        </div>
                        <div class="alert alert-info" role="alert">
                            All acknowledgements in the above table have checked one or more components of TEAMS for consistency with guidelines and for functionality
                        </div>
                    </div>
                </div>
                <div class="footer">
                    <a href="#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /uti3c -->
        </div>
        <script src="bootstrap/js/script.js"></script>
    </body>
</html>
